Investigation of unique marine environments for microbial natural products by McPhail, Kerry L. et al.
AN ABSTRACT OF THE DISSERTATION OF
Christopher  C.  Thornburg  for  the  degree  of  Doctor  of  Philosophy i n  Pharmacy 
presented on March 25, 2013.
Title: Investigation of Unique Marine Environments for Microbial Natural Products 
Abstract approved: 
Kerry L. McPhail
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more diverse than originally considered, and is an almost untapped reservoir for the 
potential  discovery  of  microbial  natural  products.  Despite  numerous  advances  in 
culturing,  biosynthetic engineering  and  genomic-based screening  efforts to uncover 
much of this diversity in relatively accessible environments, a high rediscovery rate 
has resulted in the investigation of unique, relatively unexplored ecosystems harboring 
phylogenetically diverse communities of marine organisms. The focus of this research 
was to establish a culture repository of microorganisms collected from the Red Sea 
and from deep-sea hydrothermal vents, and to assess their biosynthetic potential for 
the production of new chemical scaffolds. Cultivation of marine cyanobacteria from 
the Red Sea has led to the identification of five new cyclic depsipeptides, apratoxin H, 
grassypeptolides D and E, Ibu-epidemethoxylyngbyastin 3 and leptochelin, the latter 
possessing a unique chemical scaffold capable of binding metals. A collection of deep-
sea hydrothermal vent sediment and microbial mat samples led to the isolation of 64 
unique bacterial strains, with eight assigned as members of the order Actinomycetales. 
Importantly,  these  isolates,  along  with  a  collection  of  deep-vent  invertebrates and 
microbes, have led to the development of methods for the collection, culturing and 
biological screening  of organisms from this extreme  environment for future natural 
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General Introduction
Christopher C. Thornburg Microbial Natural Products
  The  biochemical  molecules  and  receptors  involved  in  the  many  pathways 
required for cellular function have enormous structural diversity, suggesting the need 
for a  complementary level  of diversity among  small  molecule  ligands to modulate 
each of these processes, both selectively and efficaciously (Dobson, 2004; Lipinski & 
Hopkins, 2004). In this regard, it is well recognized that natural product-based drugs 
provide a foundation of chemotherapy (Newman & Cragg, 2012) and trace back to the 
use of terrestrial plants and intertidal marine algae as traditional medicines thousands 
of years ago (Schmidt et al., 2008). More recently, terrestrial microorganisms (fungi 
and  bacteria)  have  had  a  major  impact  on  the  development of  antimicrobial  and 
antitumor compounds since the original discovery of penicillin in 1929 (Drews, 2000). 
In fact, actinomycete  soil bacteria  (order Actinomycetales) are the  source of nearly 
45% of all biologically active microbial metabolites and are responsible for over 50% 
of  the  microbial  antibiotics  discovered  to  date, most  of which  originate  from  the 
Streptomyces and Micromonospora genera (Berdy, 2005). In the last 65 years, and as 
technologies have advanced, the search for new natural product sources of biologically 
active compounds has expanded from terrestrial plants and microbes, to shallow water 
reef  marine  algae  and  invertebrates  with  their  associated  symbionts  and  ocean 
sediment-derived  marine  microbes  (Cragg  &  Newman,  2006;  Kingston,  2010; 
Newman & Hill, 2006).
Marine Bacterial Natural Products
	
 When marine  actinomycetes taxonomically related to  known  terrestrial  genera 
were  first  isolated  from  shallow  coastal  sediments,  they were  largely believed  to 
originate from dormant spores deposited in marine sediments from terrestrial run-off 
(Fenical  &  Jensen,  2006;  Lam,  2006).  However,  since  the  first description  of  an 
2autochthonous marine actinomycete species, Rhodococcus marinononascens (Helmke 
& Weyland, 1984), many obligate halophiles have been characterized, including many 
new taxa. Over the last 15 years, seminal research by Fenical and Jensen (2006) has 
firmly established actinobacteria  from shallow and deep-sea  marine sediments as a 
valuable  source  of  drug  discovery  leads  (Figure  1.1).  More  recently,  deep-sea 
invertebrates and microorganisms have emerged as a rich source of natural products 
(Skropeta, 2008), at a time when there is a dire need for new drug templates to combat 
the escalating problem of drug resistance, especially in infectious diseases and cancer. 
Considering the largely unexplored natural product potential of deep-sea hydrothermal 
vent environments, of specific interest is that new actinomycetes have been isolated 
from  hydrothermal  vent  fluids  in  the  Mariana  Trough  (ca.  2850  m)  and  Suiyo 
Seamount (ca.  1390  m;  Naganuma  et  al.,  2007),  and  from  hydrothermally active 
sediments  of  the  Guaymas  Basin  (ca.  2005  m;  Teske  et  al.,  2002).  Furthermore, 
filamentous bacteria (possibly Actinobacteria) have been observed in the guts of vent 
invertebrates  (Baross  &  Deming,  1985).  However,  of  the  few  reports  of  natural 
products from deep-sea vent organisms, none are from actinomycetes. Chapter Five of 
this dissertation will review the microbial diversity at deep-sea hydrothermal vents in 
more detail, as well as discuss the methods employed to screen for bioactive natural 
products from hydrothermal vent invertebrates and cultured actinomycetes.
  To date, more  than 22,000 marine-derived natural products (MNPs) have  been 
discovered (Blunt et al., 2013).  However, somewhat concerning  is that the rate  of 
discovery of  new natural  products  from  marine  invertebrates and  microorganisms 
appeared  to have peaked  in the late  1990’s and  to  be  declining  at the  turn  of the 
century.  However,  increasing  numbers  of  new,  biologically  active  marine  natural 
products are once again being reported: 961 new compounds were reported in 2007 
versus 779 new compounds in 2006 (Blunt et al., 2009), and 2008 marked the first 
year that the  number of  new MNPs  (1065) reported  exceeded  1000  (Blunt et al., 
2010). Remarkably, subsequent to 2008 the number of new compounds reported from 
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Figure 1.1. Structures of seminal natural products from marine actinomycetes with the 
producing organism,  antimicrobial /  cytotoxicity data,  therapeutic class,  or stage of 
clinical trial listed below each name. References: 1, (Kwon et al., 2006); 2, (Bala et al., 
2004; Sensi et al., 1959); 3, (Kim et al., 2006); 4,  (Floss & Yu, 2005); 5, (Funato et al., 
1994; Omura et al., 1977); 6,  7 ("Novartis Oncology US," 2013); 8,  (He et al., 2001); 
9,  (Renner  et  al.,  1999);  10,  (Schultz  et  al.,  2008);  11,  (Fenical  et  al.,  2009);  12, 
("Nereus Pharmaceuticals, Inc.," 2013).
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Omarine organisms has averaged over 1000 per year (Blunt et al., 2012, 2013; Blunt, 
Copp et al., 2011). This dramatic increase  is attributable  primarily to an increased 
focus on marine microorganisms. Furthermore, the continued dominance of marine 
invertebrates  (sponges,  tunicates,  soft  corals,  gorgonians)  as  a  source  of  new 
compounds  is  consistent  with  the  diverse  assemblages  of  microbial  symbionts 
associated with these relatively collectable organisms, many compounds from which 
are of putative or proven microbial origin (Dunlap et al., 2007; Simmons et al., 2008). 
Perhaps the most acclaimed of the microbial-derived marine natural products are the 
dolastatins from  the  sea  hare  Dolabella auricularia. The  low yields of dolastatins 
(typically 10-6  to  10-8  %  wet wt.)  suggested  that these  compounds were  actually 
produced microbially and or sequestered through the sea  hare’s diet (Luesch et al., 
2002; Pettit et al., 1989; Pettit et al., 1987). The cyanobacterial origin of dolastatin 10 
and  several  closely  related  peptides  was  subsequently  confirmed  by  their  direct 
isolation from the marine cyanobacterium Symploca (Harrigan et al., 1998; Taori et al., 
2009). These and examples of other clinically relevant marine  natural  products of 
putative microbial/symbiont biogenetic origin are highlighted in Figure 1.2, together 
with their FDA-approved derivatives.
Marine Cyanobacterial Natural Products
  Marine cyanobacteria are among  the oldest life forms on earth, with the oldest 
fossils discovered dating back ~2.15 billion years ago (Rasmussen et al., 2008). Since 
this time,  eons  of evolution  have  optimized  their  arsenal  of  chemical  weapons to 
defend against a diverse army of grazers (Nagle & Paul, 1999), resulting  in highly 
specific  natural  products with sub-nanomolar  potency. However, the emergence  of 
marine  cyanobacteria  as  a  valuable  source  of  natural  products  was  only  realized 
through the pioneering  work of Richard E. Moore at the University of Hawaii in the 
1970s  to  early  2000s  (Cardellina  &  Moore,  2010).  Currently there  are  over  800 
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Figure 1.2. Marine natural products of putative microbial/symbiont biogenetic origin 
approved by the U.S. Food and Drug Administration (FDA), European Commission 
(EC) or in various stages of clinical trial. References: 1, (Sakai et al., 1986); 2, (Hill et 
al., 2005); 3, (Winkler et al., 2006); 4, (Uemura et al., 1985); 5, (Pettit et al., 1991); 6, 
(Pettit et al., 1993); 7, (Litaudon et al., 1994); 8, ("Eisai Oncology," 2013); 9, (Pettit et 
al., 1982); 10, (Sudek et al., 2006); 11, ("NIH ClinicalTrials," 2013); 12, (Pettit et al., 
1987); 13, (Luesch et al., 2001); 14, (Francisco et al., 2003); 15, ("Seattle Genetics," 
2013); 16, (Rinehart et al., 1981); 17, (Tsukimoto et al., 2011); 18, (Sakai et al., 1996); 
19, ("PharmaMar," 2013a); 20, (Rinehart et al., 1990; Wright et al., 1990); 21, (Moss 
et al., 2003; Rath et al., 2011); 22, ("PharmaMar," 2013b).bioactive metabolites that have been reported from marine cyanobacteria, the majority 
of which result from the integration of two biosynthetic classes, nonribosomal peptide 
synthetases (NRPSs) and polyketide synthases (PKSs; Choi et al., 2012). There are 
more  than 500 non-proteinogenic  amino acid building  blocks reported  for NRPSs, 
coupled with an array of tailoring enzymes that further diversify these amino acids and 
PKS building blocks with unusual oxidations, methylations and halogenations (Walsh 
& Fischbach, 2010). It is clear that the immense structural diversity and complexity of 
cyanobacterial metabolites has only begun to be realized (Figure 1.3). Incredibly, a 
majority of cyanobacterial metabolites (> 330) reported to date have been ascribed to 
the genus Lyngbya, with nearly 75% assigned to the species Lyngbya majuscula (Choi 
et al., 2012; Tidgewell et al., 2010). However, recent molecular-based phylogenetics 
(16S  rRNA),  coupled  with  traditional  morphology-based  methods  for  the 
identification  of  cyanobacteria,  has shown  that  several  genera  of  morphologically 
similar cyanobacteria are polyphyletic, which may account for the perceived chemical 
richness of  the  ‘morpho-species’ Lyngbya  (Castenholz,  2001;  Engene  et al.,  2011; 
Sharp et al., 2009; Thacker & Paul, 2004). In fact, one of the phylogenetically distant 
lineages  identified  in  the  genus  Lyngbya  has  recently  been  proposed  as  a  new 
cyanobacterial  genus,  Moorea,  which  includes  the  incorrectly  classified  species 
Lyngbya majuscula (N. Engene et al., 2012). The importance of including  molecular 
tools in the identification of marine cyanobacteria is further exemplified in Chapter 
Two of this dissertation, where analogues of the grassypeptolides originally isolated 
from  Lyngbya  confervoides ( K w a n  e t  a l . ,  2 0 1 0 )  w e r e  i d e n t i f i e d  f r o m  a  
phylogenetically distant Red Sea cyanobacterium of the genus Leptolyngbya.
  Over the last 65 years, the marine environment has proven to be a rich resource 
for discovering biologically relevant natural products with the potential to aid our fight 
against infectious diseases  and  cancer  (Molinski  et al.,  2009;  Newman  &  Cragg, 
2012), and with over two-thirds of  the Earth covered by oceans, many unexplored 
repositories remain. Accordingly, screening  of  phylogenetically diverse  and unique 
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Figure  1.3. Examples of natural products from marine cyanobacteria that showcase 
their enormous structural diversity,  potent cytotoxicity and profound selectivity. For 
each  structure  the  producing  organism,  cytotoxicity  data,  molecular  target  or 
mechanism of action is listed. References: 1, (Gerwick et  al.,  1994); 2, (Gao et al., 
2010; Teruya et al., 2009); 3, (Nogle & Gerwick, 2002); 4, (Wrasidlo et al., 2008); 5, 
(Marquez et al., 2002); 6, (Matthew et al., 2007; Taori et al., 2007); 7, (Taori et al., 
2008); 8, (Hong & Luesch, 2012); 9, (Medina et al., 2008).organisms from rare or extreme ecosystems is a rational approach to discover novel 
chemotypes with medicinally relevant biological activities (Cragg & Newman, 2002). 
Furthermore,  advances in  analytical  tools  for  molecular structure  elucidation  have 
progressed  to  permit  routine  characterization  of  microgram  quantities  of  pure, 
unprecedented  natural  products.  However,  the  characterization  of  new chemotypes 
from  complex  extract mixtures  that also  comprise  a  substantial  mass of  inorganic 
contaminants  still  requires  significant  biomass  of  source  organisms.  Thus,  field 
collections  of  cyanobacteria,  deep-sea  vent invertebrates  and  collectable  microbial 
mats may need to be several liters in volume, which is often not possible given the 
paucity  of  many  marine  organisms.  Laboratory  cultivation  of  microorganisms  of 
interest is therefore  highly desirable, and can facilitate further investigation  of the 
pharmacology, biosynthesis and genetics of  the bioactive  compounds produced. As 
such, this dissertation focuses on the isolation and structure elucidation of bioactive 
natural products from cultured microorganisms inhabiting unique environments.
Thesis Overview
  Chapters 2–4 describe five new bioactive natural products from cultured marine 
cyanobacteria collected from the Red Sea, one of the most saline and pristine water 
bodies in the world. The text of Chapter Two is included as it appears in: Thornburg, 
C.  C., Thimmaiah,  M., Shaala,  L. A., Hau, A.  M.,  Malmo,  J. M.,  Ishmael,  J. E., 
Youssef, D. T. A., & McPhail, K. L. (2011). Cyclic Depsipeptides, Grassypeptolides D 
and  E  and  Ibu-epidemethoxylyngbyastatin  3,  from  a  Red  Sea  Leptolyngbya 
Cyanobacterium.  J.  Nat.  Prod.,  74(8),  1677-1685.  The  dissertation  author  is  the 
primary author of this manuscript. It is important to note that Figure 1, as it appears in 
the manuscript, has been updated to include the currently accepted nomenclature and 
additional  SSU  (16S)  rRNA  gene  sequences  obtained  for  each  of  the  Red  Sea 
cyanobacterial isolates included in this dissertation. 
9	
 Chapter Three presents a new apratoxin A analogue from a Red Sea Moorea sp.   
with equipotent nanomolar activity against NCI-H460 human lung  cancer cells, and 
thus provides further insight into the structure–activity relationships of the apratoxin 
family.  In  addition,  the  phylogenetic  relationships  of  the  apratoxin-producing 
cyanobacterial  strains  collected  pantropically  reveal  a  method  for  predicting  the 
biosynthetic  capacity of closely related  marine  cyanobacteria.  The  text of  Chapter 
Three is included in the manuscript format for submission to the Journal of Natural 
Products in March, 2013.
  In Chapter Four, a highly modified and previously unresolved metabolite from an 
Indonesian Leptolyngbya sp. is revisited as we have re-isolated it from a  Red Sea 
Leptolyngbya  sp.  and  assigned  its  planar  structure.  This  unique  structure  further 
reveals  the  capacity of  marine  cyanobacteria  to  produce  structurally diverse  and 
complex natural products. Furthermore, the ability of this compound to chelate metal 
ions, for which it has been termed leptochelin, aided in the assignment of its planar 
structure and significantly increased its potency against human NCI-H460 human lung 
cancer and HeLa cervical carcinoma cells. Importantly, between these two cell lines, 
the  metal  free  compound shows selectivity to human NCI-H460 lung  cancer  cells, 
which may indicate a cancer specific cellular target for this natural product.
  Chapter Five describes the method development for the collection, culturing and 
screening of deep-sea hydrothermal vent organisms for bioactive natural products. In 
particular,  the  isolation  and  chemical  screening  of  several  marine  actinomycetes 
(Dietzia  and  Rhodococcus  spp.)  and  a  bright  blue  carpet-like  mat identified  as a 
folliculinid  ciliate  (Folliculinopsis  sp.)  collected  during  the  2009  and  2010  New 
Millennium Observatory (NeMO) expeditions will be discussed. Finally, the diversity 
of  cultured  microbes  as  wells  as  pyrosequencing  results  obtained  on  a  tubeworm 
associated hydrothermal vent mat will be presented. Given that deep-sea hydrothermal 
vents are a newly explored environment for natural products research, the introductory 
text of  this chapter  is  included  as  it  appears  in  an  extensive  review  of  deep-sea 
10hydrothermal  vents: Thornburg,  C. C., Zabriskie, T.  M., &  McPhail,  K. L. (2010). 
Deep-Sea Hydrothermal Vents: Potential Hot Spots for Natural Products Discovery? J. 
Nat.  Prod.,  73(3),  489-499.  The  dissertation  author  is  the  primary  author  of  this 
manuscript.
  Chapter Six  concludes the dissertation with a general discussion of the  results 
obtained in the  preceding  chapters, and presents future research that should follow 
these discoveries.
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19Abstract
  Two new grassypeptolides and a lyngbyastatin analogue, together with the known 
dolastatin 12, have been isolated from field collections and laboratory cultures of the 
marine cyanobacterium Leptolyngbya sp. collected from the SS Thistlegorm shipwreck 
in the Red Sea. The overall stereostructures of grassypeptolides D (1) and E (2) and 
Ibu-epidemethoxylyngbyastatin 3 (3) were determined by a combination of 1D and 2D 
NMR experiments, mass spectrometric analysis, Marfey’s methodology and HPLC-
MS.  Compounds  1  and  2  contain  2-methyl-3-aminobutyric  acid  (Maba)  and  2-
aminobutyric  acid  (Aba),  while  biosynthetically  distinct  3  contains  3-amino-2-
methylhexanoic  acid  (Amha)  and  the  β-keto  amino  acid  4-amino-2,2-dimethyl-3-
oxopentanoic  acid  (Ibu).  Grassypeptolides  D  (1)  and  E  (2)  showed  significant 
cytotoxicity to  HeLa  (IC50  = 335  and  192 nM,  respectively)  and  mouse  neuro-2a 
blastoma  cells  (IC50  =  599  and  407  nM,  respectively),  in  contrast  to  Ibu-
epidemethoxylyngbyastatin  3  (neuro-2a  cells,  IC50  >  10  µM)  and  dolastatin  12 
(neuro-2a cells, IC50 > 1 µM).
20Introduction
  Microbial metabolites appear to be characteristic of certain biotopes, both on an 
environmental  and  a  species  level,  which  has  provided  a  diversity  of  chemical 
structures unparalleled by even the largest combinatorial libraries (Clardy & Walsh, 
2004). Our research has recently focused on the isolation and structure elucidation of 
biologically  active  natural  products  from  microorganisms  inhabiting  unique 
environments.  The  Red  Sea  represents  an  unexplored  repository  of  diverse 
cyanobacteria,  although  in  low  abundance.  This  may result from  the  low  annual 
rainfall, minimal freshwater input and high evaporation rate that make the Red Sea 
one of the most saline  and pristine water bodies in the world (Fenton et al., 2000). 
Despite these conditions, we have collected specimens from a range of cyanobacterial 
genera including  Moorea, Phormidium, Symploca, and the Leptolyngbya that is the 
subject of this report. Thus, we are interested to compare the biosynthetic capabilities 
of  these  Red  Sea organisms with  those  collected  pantropically. As is the  case  for 
natural products in general, cyanobacterial metabolites often occur as sets of related 
analogues that possess varying biological selectivity, putatively for optimal adaptation 
to  a  range  of  environments  (Tan,  2010).  In  addition,  the  capacity  of  any  one 
cyanobacterium to produce several biosynthetically distinct metabolites (Harrigan et 
al., 1998), as well  as the production of the same  or biosynthetically related natural 
products by different genera of cyanobacteria is the  subject of intense investigation 
(Niclas Engene  et al., 2010).  One  proposal  is that common  heterotrophic  bacteria 
associated with cyanobacteria may be the biosynthetic origin of the isolated products. 
Alternatively, horizontal  gene  transfer  between  different cyanobacteria  or  between 
heterotrophic  bacteria  may account for  the  presence  of multiple  biosynthetic  gene 
clusters in cyanobacterial  genomes (Hess, 2008). Remarkably, a  Floridian  Lyngbya 
confervoides has afforded lyngbyastatins 4-6 (Matthew et al., 2007; Taori et al., 2007), 
pompanopeptins A and B (Matthew et al., 2008), largamides A–H (Matthew et al., 
212009a), tiglicamides A–C (Matthew et al., 2009b), and grassypeptolides A-C (Kwan et 
al., 2010). Here we report the isolation of grassypeptolides D (1) and E (2) and Ibu-
epidemethoxylyngbyastatin 3 (3), as well  as the  known dolastatin 12  (Pettit et al., 
1989),  from  a  marine  Leptolyngbya  cyanobacterium  collected  from  the  Red  Sea 
shipwreck SS Thistlegorm (46 – 98 ft). All  four macrocyclic depsipeptides are also 
produced  by the  laboratory-cultured  (monoclonal)  Red  Sea  Leptolyngbya.  While 
grassypeptolide  D  (1)  is  ~1.5-fold less cytotoxic  to  HeLa  cervical  carcinoma  and 
neuro-2a  mouse  blastoma  cells  than  grassypeptolide  E  (2),  these  threonine/N-
methylleucine  diastereomers  do  not  show  the  dramatic  natural  structure-activity 
relationship observed between the N-methyl phenylalanine epimers grassypeptolides 
A and C (Kwan et al., 2010). Ibu-epidemethoxylyngbyastatin 3 (3, IC50 > 10 µM) was 
significantly less cytotoxic  to neuro-2a  cells than the  grassypeptolides and  related 
dolastatin 12 (IC50 > 1 µM).
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23Results and Discussion
  A crude organic extract of the Red Sea Leptolyngbya was subjected to bioassay-
guided fractionation via normal phase vacuum liquid chromatography (NP VLC) using 
a stepped gradient of hexanes to EtOAC to MeOH. The fraction eluting  with 25% 
MeOH-EtOAC was highly cytotoxic to mouse neuro-2a neurobastoma cells (30 mg/
mL  reduced  cell  viability  by  99.6%).  This  VLC  fraction  was  separated  by  C18 
reversed-phase (RP18) solid phase extraction (SPE) and exhaustive RP-HPLC to yield 
three minor cytotoxic metabolites (1, 1.5 mg; 2, 0.5 mg and 3, 2.9 mg) and the known 
depsipeptide dolastatin 12 (5.0 mg) as the major component.
  A molecular formula of C57H81N9O10S2 for both grassypeptolides D (1) and E (2) 
was provided by HRMS ([M + Na]+ m/z 1138.5515 and 1138.5413, respectively) and 
supported by NMR spectroscopic (Table 2.1) data. The  1H and 13C NMR spectra for 
each  compound  were  very similar,  and  indicated  peptidic  metabolites  due  to  the 
presence of three NH doublets (δH 6.45–7.50), three N-methyl substituents (δH  3.1–
3.5),  nine  α-H  multiplets  (δH  3.4–5.9),  numerous  overlapped  methyl  doublets (δH 
0.74–0.99) and  ten  putative ester/amide  carbonyl  13C signals (δC  168–175 ppm) in 
each case. These data suggested that 1 and 2 were structurally related to the Floridian 
Lyngbya  confervoides m e t a b o l i t e s  g r a s s y p e p t o l i d e s  A - C ,  a n d  v e r y  s i m i l a r  t o  
grassypeptolide C in particular (Kwan et al., 2010). However, the 1D NMR spectra for 
both 1 and 2 contain a 3H singlet (δH-27 1.35 and 1.38, respectively) and a quaternary 
carbon  (δC-25  84.0)  not present  in  the  spectra  for  grassypeptolide  C.  In  addition, 
comparison  of  the  α-CH chemical  shifts for  1,  2  and  grassypeptolide  C  revealed 
significant differences between compounds 1  and 2 (Table  2.1),  whereas the  α-CH 
chemical  shifts  for  1  more  closely  matched  those  for  grassypeptolide  C.  These 
differences led us to investigate the structures of 1 and 2 more closely.
24Table 2.1. 1H (700 MHz) and 13C (175 MHz) NMR Spectroscopic Data for 
Grassypeptolides D (1) and E (2) in CDCl3.
unit position
Grassypeptolide D (1) Grassypeptolide D (1) Grassypeptolide E (2) Grassypeptolide E (2)
unit position δH, mult. (J in Hz) δC, mult. δH, mult. (J in Hz) δC, mult.
Maba 1 172.4, C 172.9, C
2 2.50, dq (7.0, 6.8) 45.6, CH 2.51, dq (7.0, 4.5) 45.5, CH
3 4.22, m 48.5, CH 4.23, m 47.0, CH
4 1.19, d (6.7) 19.9, CH3 1.10, d (7.0) 19.3, CH3
5 1.12, d (7.0) 14.4, CH3 1.16, d (7.0) 14.4, CH3
NH 7.70, br  6.45, d (9.9)
Thr 6 169.3, C 170.5, C
7 4.45, dd (6.8, 6.1) 59.1, CH 3.36, dd (6.9, 3.3) 57.0, CH
8 4.02, m 69.1, CH 3.30, m 67.9, CH
9 1.22, d (6.4) 19.7, CH3 0.87, d (6.5) 19.4, CH3
OH 4.00, br
NH 6.90, d (7.3) 6.90, d (6.9)
N-Me-Leu 10 170.3, C 170.0, C
11 4.70, br 57.5, CH 5.15, t (7.7) 54.6, CH
12a 1.97, m 37.2, CH2 1.78, m  37.1, CH2
12b 1.67, m
13 1.58, m 25.3, CH 1.52, m 25.3, CH
14 0.98, d (6.4) 23.2, CH3 0.98, d (6.6) 23.2, CH3
15 0.94, d (6.5) 22.8, CH3 0.93, d (6.7) 22.4, CH3
16 3.20, s 33.2, CH3 3.49, s 30.7, CH3
Aba-thn-ca 17 170.4, C 169.3, C
18 5.29, m 78.1, CH 5.07, m 75.9, CH
19a 3.60, m 33.3, CH2 4.15, br dd 35.5, CH2
19b 3.26, m 3.44, dd (-11.2, 8.5)
20 178.0, C 175.0, C
21 4.55, m 54.2, CH 4.71, ddd (9.0, 4.0, 2.7) 53.2, CH
22a 2.11, m 25.2, CH2 1.95, dqd (-11.5, 7.4, 4.0) 28.5, CH2
22b 1.86, m 1.48, m 
23 0.96, t (6.9) 11.6, CH3 0.74, t (7.4) 10.0, CH3
NH 7.10, d (7.7) 7.50, d (9.0)
N-Me-Phe-thn-ca 24 173.7, C 168.9, C
25 84.0, C 84.0, C
26a 3.74, d (-11.5) 43.1, CH2 3.29, d (-11.6) 41.5, CH2
26b 3.17, d (-11.3) 3.18, d (-11.7)
27 1.35, s 24.3, CH3 1.38, s 23.9, CH3
25Table 2.1 (continued). 1H (700 MHz) and 13C (175 MHz) NMR Spectroscopic Data 
for Grassypeptolides D (1) and E (2) in CDCl3.
Grassypeptolide D (1) Grassypeptolide D (1) Grassypeptolide E (2) Grassypeptolide E (2)
unit position δH, mult. (J in Hz) δC, mult. δH, mult. (J in Hz) δC, mult.
N-Me-Phe-thn-ca 28 173.9, C 173.9, C
29 5.39, dd (10.7, 6.4) 58.9, CH 5.87, dd (12.2, 3.0) 55.8, CH
30a 3.24, m 36.0, CH2 3.55, br  36.1, CH2
30b 3.16, m 3.28, m
31 135.5, C 137.7, C
32/36 7.33, m 129.2, CH 7.18, m 129.6, CH
33/35 7.22, m 128.5, CH 7.03, br  129.3, CH
34 7.20, m 127.6, CH 7.08, m 127.3, CH
37 3.21, s 30.7, CH3 3.17, s 30.2, CH3
Pro 38 172.7, C 171.2, C
39 4.84, dd (8.8,5.1) 57.5, CH 5.10, br 58.8, CH
40a 2.22, m 27.5, CH2 2.30, m 31.2, CH2
40b 1.93, m 2.10, m
41a 1.99, m 24.9, CH2 2.01, m 21.7, CH2
41b 1.63, m
42a 3.97, m 47.8, CH2 3.80, m 46.9, CH2
42b 3.53, m 3.69, m
N-Me-Val 43 168.6, C 168.5, C
44 4.98, d (11.0) 60.0, CH 5.01, d (10.8) 58.1, CH
45 2.32, m 27.4, CH 2.35, m 28.1, CH
46 0.98, d (6.4) 19.6, CH3 0.95, d (6.7) 19.5, CH3
47 0.88, d (6.6) 18.0, CH3 0.85, d (6.7) 18.6, CH3
48 3.12, s 30.0, CH3 3.20, s 30.3, CH3
Pla 49 170.2, C 171.4, C
50 5.33, dd (9.9, 3.2) 72.4, CH 5.33, dd (9.7, 3.8) 72.4, CH
51a 3.09, dd (-14.5, 9.9) 36.9, CH2 3.16, m 36.9, CH2
51b 3.04, dd (-14.4, 3.2) 3.01, m
52 134.9, C 136.1, C
53/57 7.22, m 129.1, CH 7.12, m 129.1, CH
54/56 7.24, m 129.5, CH 7.31, m 129.5, CH
55 7.27, m 127.6, CH 7.24, m 127.4, CH
 
26  Analysis of the 2D NMR spectra in CDCl3 for 1 and 2 (HSQC, HSQC-TOCSY, 
HMBC,  COSY, ROESY)  confirmed that grassypeptolides D (1) and E (2)  had the 
same  connectivity  of  planar  structure  as  grassypeptolide  C.  An  HSQC-TOCSY 
experiment for 1 identified spin systems for Thr, Leu, Pro and Val amino acid side 
chains, and key HMBC (supported by COSY  and ROESY) correlations established 
that Leu and Val were N-methylated as in grassypeptolide C. A pair of doublet methyl 
signals (δH-4 1.19 and δH-5 1.12) correlated to two vicinally coupled methine multiplets 
(δH-2  2.50  and  δH-3  4.22)  distinguished  the  β-amino  acid  residue  2-methyl-3-
aminobutyric acid (Maba). COSY correlations from an upfield methyl doublet (δH-23 
0.96) to a relatively shielded methylene (δH-22 2.11/1.86), in turn coupled to a methine 
(δH-21 4.55), supported a 2-aminobutyric acid (Aba) residue. An HMBC correlation to 
the  putative  carbonyl  13C  of  Aba  from  a  relatively  deshielded  methylene  (δH-19 
3.60/3.26), which also correlated to a second deshielded quaternary 13C (δC-17 170.4), 
was consistent with an Aba-derived thiazoline carboxylic acid (Aba-thn-ca). Chemical 
shift  comparison  with  grassypeptolide  C  and  HMBC  analysis  (see  Supporting 
Information,  Table  2.2)  also  confirmed  the  presence  of  two  aromatic  residues, 
phenyllactic acid (Pla) and N-methylphenylalanine (N-Me-Phe). The latter residue is 
incorporated into a  thiazoline carboxylic  acid in grassypeptolide C. However, no –
CHCH2–  motif  consistent with this remaining  thiazoline  ring  was apparent in  the 
spectra  for  grassypeptolide  D  (1).  Instead,  an  AB  spin  system  of  a  fifth  isolated 
methylene (δH-26 3.74/3.17) showed  HMBC correlations to  a  methyl (δC-27 24.3), a 
midfield quaternary (δC-25 84.0) and two deshielded quaternary (δC-28 173.9 and δC-24 
173.7) carbons. This indicated the presence of a 2-methylthiazoline carboxylic  acid 
derived from N-methylphenylalanine (N-Me-Phe-4-Me-thn-ca). Although none of the 
previously reported grassypeptolides A–C contain a methylated thiazoline carboxylic 
acid, this unit has been reported in largazole (Taori et al., 2008) and the hoiamides 
(Choi et al., 2010) from marine cyanobacteria, as well as several terrestrial bacteria. 
27  Analysis of the 2D NMR data for 2 revealed the same sequence of units as found 
in 1. However, the α-CH chemical shifts for Thr (δH/δC-7 3.36/ 57.0) and N-Me-Leu 
(δH/δC-11 5.15/54.6) in 2 were substantially different from those observed for 1 (Thr, 
δH/δC-7 4.45/59.1; N-Me-Leu, δH/δC-11 4.70/57.5) and grassypeptolide C (Thr, δH/δC-7 
4.44/59.2; N-Me-Leu, δH/δC-11 4.70/57.6). Furthermore, the N-CH3-16 singlet (δH 3.49) 
for 2 was shifted slightly downfield compared to those for 1 and grassypeptolide C (δH 
3.20  and  3.17,  respectively).  Overall,  these  chemical  shift  differences  suggested 
different  configurations  for  both  Thr  and  N-Me-Leu  in  2  relative  to 1  and 
grassypeptolide C.
  The absolute configurations of grassypeptolides D (1) and E (2) were determined 
by a combination of acid hydrolysis and oxidative ozonolysis followed by chiral LC-
MS  or  Marfey’s  analysis.  Chiral  LC-MS  of  the  acid  hydrolysates  of  1  and  2 
established the presence of L-Pla, while analysis by RP18 HPLC of the ozonolysis and 
acid  hydrolysate  products  of  1 a n d  2 d e r i v a t i z e d  w i t h  N-α-(5-fluoro-2,4-
dinitrophenyl-)-L-leucinamide (Marfey’s reagent) indicated the presence of N-Me-L-
Val, L-Pro, N-Me-L-Phe, (2S)-MeCysA, D-Aba, L-Cya and (2R, 3R)-Maba. Consistent 
with  the  observed  differences  in  the  α-CH chemical  shifts of  Thr  and  N-Me-Leu 
described  above,  Marfey’s  analysis  of  the  grassypeptolide  D  (1)  ozonolysis  and 
hydrolysis product matched the configurations observed for grassypeptolide C (D-allo-
Thr  and  N-Me-D-Leu),  while  grassypeptolide  E  (2)  hydrolysate  retention  times 
indicated the presence of L-Thr and N-Me-L-Leu. 
  Ibu-epidemethoxylyngbyastatin 3 (3) was isolated from the  same first tier RP-
HPLC  fraction  as  the  grassypeptolides.  The  molecular  composition  of  3 w a s  
established as C51H82N8O11 from HRFTMS  data ([M + Na]+ m/z 1005.5983). While 
the 1H NMR spectrum for compound 3 also exhibited resonances typical of a peptide, 
it  was  significantly  different to  those  for  grassypeptolides  1  and  2.  In  addition, 
inspection  of  the  13C  NMR  spectrum  for  compound  3  revealed  the  absence  of  a 
midfield quaternary (δC 84.0 ppm) and the presence of a downfield quaternary carbon 
28(δC 208.4 ppm), which in combination with the reduced molecular mass, suggested a 
different planar structure for 3 relative to compounds 1 and 2. Instead, the 1D spectra 
for 3 were  very similar to those for dolastatin 12, isolated as the major component 
from the preceding first tier HPLC fraction. Examination of the 2D NMR data for 3 
confirmed that an additional methyl triplet (δH 0.86 ppm) in the 1H NMR spectrum for 
3  and  increase  of  14  mass  units  relative  to  dolastatin  12  were  attributable  to  the 
presence of 3-amino-2-methylhexanoic acid (Amha) in 3, rather than the 3-amino-2-
methylpentanoic acid (Ampa) in dolastatin 12. Thus, the planar structure of 3 could 
best be designated as demethoxylyngbyastatin 3, indicating  replacement of the N,O-
dimethylTyr in lyngbyastatin 3 (Williams et al., 2003) with N-methylPhe in 3. The 
configurational assignment of the  Ibu unit in the lyngbyastatin/dolastatin series has 
proven  arduous  given  the  propensity of  this unit to  decarboxylate  and  epimerize 
during acid hydrolysis to yield (2R/S)-2-amino-4-methylpentan-3-one (Amp; Carter et 
al.,  1984;  Harrigan  et  al.,  1998).  The  analysis  and  comparison  of  this  series  of 
depsipeptides containing Ibu is further confounded by whether or not the neighboring 
Ala  unit  is  N-methylated.  Williams  and  coworkers  (2003)  deduced  that  their 
cyanobacterial samples of dolastatin 12 and lyngbyastatins 1 and 3 each comprised Ibu 
epimeric mixtures following NaBH4 reduction of the natural products, acid hydrolysis 
and comparisons with the reduced Ibu standards, (3R/S, 4S)-4-amino-2,2-dimethyl-3-
hydroxy-pentanoic  acid  (Adhpa).  It was  shown  that  very little  enolization  occurs 
during the NaBH4 reduction itself, which is performed to avoid extensive enolization 
of the β-keto moiety in Ibu during subsequent acid hydrolysis. To investigate further 
the timing of epimerization at C-15 in 3 and dolastatin 12 during acid hydrolysis, we 
first undertook an alternate strategy. Compound 3 and dolastatin 12 were subjected to 
Marfey’s  analysis  following  acid  hydrolysis  under  two  different  conditions:  (A) 
hydrolysis with  6N HCl  for 50 seconds using  a  microwave and Ace high-pressure 
tube; and (B) treatment with 6N HCl  at 110 °C for 18 h. Analysis of the reaction 
products of 3 by RP18-HPLC revealed the presence of both enantiomers of Amp in the 
29S/R ratio of 4.1:1 and 1:2.2 for treatments A and B, respectively. A similar result was 
obtained  in  the  analysis  of  dolastatin  12  under  these  conditions,  suggesting  that 
racemization of the Ibu unit likely occurs more slowly than peptide hydrolysis; a rapid 
acid hydrolysis reaction results in less enolization of the Ibu substrate. In tandem with 
the lack of extremely broad peaks (characteristic of the R-Ibu epimer lyngbyastatin 1; 
Bai et al., 2002) in the 1H NMR spectra for 3 and dolastatin 12, these data suggest that 
both compounds contain S-Ibu. Given the  relatively sharp 1H NMR signals for the 
natural products, it is unlikely that epimerization from an R-Ibu to S-Ibu occurred prior 
to amide hydrolysis, despite that the S-Ibu configuration is thermodynamically favored 
(Bai  et  al.,  2002).  Noteworthy  also  is  that  the  analysis  of  the  S-Amp  standard 
derivatized  with  Marfey’s reagent under  standard  reaction conditions  (40  °C, 1  h) 
showed the presence of both enantiomers in the S/R ratio of 6.7:1, whereas Marfey’s 
derivatization for 24 h resulted in the ratio of 1.8:1. Thus, further enolization of the 
Amp unit  in  the  natural  product  hydrolysate  may occur  during  the  derivatization 
process. 
  To corroborate our assignment of S-Ibu following the method of Williams et al. 
(2003) compound 3 was reduced with NaBH4, subjected to microwave hydrolysis, and 
the  Marfey’s  derivatives  compared  to  synthetically  prepared  Adhpa  standards. 
Analysis of the reaction products of 3 by RP18 HPLC-MS revealed the presence of 
enantiomers  of  Adhpa  in the  S/R  ratio  13.8:1.  The  absolute  configurations of  the 
remaining  chiral  centers  in  Ibu-epidemethoxylyngbyastatin  3  were  assigned  by a 
combination of chiral LC-MS and Marfey’s analysis using commercially available or 
synthetic (Amha) standards. Following acid hydrolysis of 3, chiral  LC-MS analysis 
revealed the presence of (2S, 3S)-HMPA. Derivatization of the acid hydrolysate of 3 
with Marfey’s reagent, followed by RP18 HPLC or LC-MS established the presence of 
N-Me-L-Ala, N-Me-L-Val, N-Me-L-Phe and N-Me-L-Leu, and (2S, 3R)-Amha.
  Diastereomeric  grassypeptolides  D  (1)  and  E  (2)  both  showed  significant 
cytotoxicity to HeLa (IC50 335 and 192 nM, respectively) and neuro-2a (IC50 599 and 
30407 nM, respectively) cells. The small (~1.5-fold) difference in cytotoxicity between 1 
and 2 indicates that the chirality of the N-Me-Leu and Thr α position is not critical for 
activity and that this region is not central to the pharmacophore of these structures. In 
contrast, Kwan et al. (2010) conclude that the N-Me-Phe region of grassypeptolides A-
C is critical for their cytotoxicity given that grassypeptolide C (N-Me-L-Phe) showed 
16-23- and 65-fold greater potency, respectively, than grassypeptolides A and B (both 
N-Me-D-Phe) against colorectal adenocarcinoma HT29 and cervical carcinoma HeLa 
cells. In addition the ethyl sidechain of the Aba-thn-ca in grassypeptolides A and C is 
associated with enhanced activity over the methyl of the Ala unit in grassypeptolide B 
(Kwan et al., 2010). Like grassypeptolide C, grassypeptolides D (1) and E  (2) also 
contain Aba  and  N-Me-L-Phe  thiazoline  carboxylic  acid units. The  only structural 
difference between 1 (IC50 335 nM, HeLa cells) and grassypeptolide C (IC50 45 nM, 
HeLa cells) is a methylated thiazoline of opposite chirality (25S). The apparent ~7.5-
fold  difference  in  cytotoxicity between  grassypeptolides D (1)  and C  supports the 
hypothesis  that  the  N-Me-Phe-thn-ca-Aba-thn-ca  motif  is  central  to  the 
pharmacophore  of  the  grassypeptolides.  While  lyngbyastatin  3  was  reported 
previously to be potently cytotoxic to KB (epithelial carcinoma, subline of HeLa) and 
LoVo (colon carcinoma) cell lines (IC50 = 32 and 400 nM, respectively; Williams et 
al.,  2003),  we  observed  little  effect  of  Ibu-epidemethoxylyngbyastatin  3  (3)  on 
neuro-2a  cells  (IC50  >  10  µM).  Similarly  dolastatin  12  was  only  slightly  more 
cytotoxic to these cells than 3 (IC50 > 1 µM). 
  A majority of the more than 300 known marine cyanobacterial metabolites have 
been reported  from  the  genus formerly known as  Lyngbya (Tan,  2010). However, 
metabolites closely related to these “Lyngbya compounds” have  also been reported 
from non-Lyngbya species, as in the case of the four compounds reported here. This 
has lead to  an inability to define  strong  chemotaxonomic trends for cyanobacterial 
genera.  The  taxonomic  description  of  cyanobacteria  has  transitioned  from  the 
traditional phycological system  to the  modern  bacteriological  system, supported by 
31use of the 16S rRNA gene for phylogenetic determinations. Phylogenetic revision of 
cyanobacterial  taxonomy  is  in  progress  for  several  genera,  including  the  newly 
proposed cyanobacterial genus Moorea gen. nov. for the pan-tropical group incorrectly 
classified as the genus Lyngbya (Niclas Engene et al., 2010; N. Engene et al., 2012). In 
tandem with confirmation of the biogenetic source of compounds isolated from mixed 
field collections, this may clarify chemotaxonomic relationships. Although it belongs 
to a less commonly reported genus and is collected from a unique habitat, the Red Sea 
Leptolyngbya sp. RS03 reported here shows biosynthetic capabilities comparable to 
cyanobacteria  collected  pantropically.  Bis-thiazoline-containing  grassypeptolides  D 
(1) and E (2) are closely related to grassypeptolide C, one of three structural analogues 
reported from a Florida Keys collection of Lyngbya confervoides (Kwan et al., 2010), 
while Ibu-epidemethoxylyngbyastatin 3 (3) and dolastatin 12 are additional congeners 
of the large family of lyngbyastatins and micropeptins. A systematic classification of 
the  cultured  Red  Sea  Leptolyngbya  sp.  RS03  indicates  that  this  organism  is 
Leptolyngbya  ectocarpi  (Gomont)  Anagnostidis  et  Komárek  1988,  according  to 
Komárek and Anagnostidis (2005). A phylogenetic analysis of the partial 16S rRNA 
sequences from Leptolyngbya sp. RS03 (GenBank Acc. No. JF518829) and the marine 
Leptolyngbya reference strain Leptolyngbya ectocarpi ATCC 29409 revealed a distinct 
cluster  of  Leptolyngbya  spp.  from  various  marine  habitats  (Figure  2.1),  with  the 
exception of Phormidium persicinium SAG 80.79. However, the latter shares ~99.7% 
16S rRNA gene sequence identity with the Leptolyngbya reference strains included in 
this  analysis  and  may  represent  the  same  organism  that  has  been  maintained  in 
different culture collections (Marquardt &  Palinska,  2007). Noteworthy is  that the 
Floridian Lyngbya cf. confervoides VP0401 clusters with members of the Phormidium 
subgenus Geitlerinema Anagnostidis et Komárek 1988, which seemingly supports the 
notion  that  horizontal  gene  transfer  plays  an  important  role  in  the  evolution  of 
cyanobacteria (Komárek & Anagnostidis, 2005). Also included in this analysis, is a 
separate  cultured  Red Sea  Leptolyngbya  sp.  (RS02)  that produces  the  brominated 
32macrolide phormidolide (Williamson et al., 2003), which was previously isolated from 
an Indonesian Phormidium sp. Further chemical and biological characterization of this 
second  Red  Sea  Leptolyngbya  is  in  progress.  While  it  is  well  recognized  that 
organisms isolated from their native environment may not produce the same secondary 
metabolites in laboratory culture (Scherlach & Hertweck, 2009), LC-MS analysis of 
extracts of monoclonal cultures of the Red Sea Leptolyngbya sp. RS03 confirmed its 
production  of  the  four metabolites reported  here. The  stereoisomerism  and natural 
SAR  within  the  grassypeptolide  series  presents  an  intriguing  example  of  the 
biosynthetic  flexibility of  cyanobacteria.  Characterization  and  manipulation  of  the 
biosynthetic pathways for these natural products may provide exciting opportunities to 
produce new biologically active metabolites.
33Figure 2.1. Phylogenetic relationship of Red Sea filamentous cyanobacteria with other 
cyanobacterial groups based on SSU (16S) rRNA gene sequences. The tree topology 
was constructed  using  a  maximum-likelihood (PhyML) algorithm  with  the  support 
values at important nodes indicated as bootstrap and posterior probability (bayesian 
inference; MrBayes). Labels on the terminal nodes indicate the taxa, strain, GenBank 
accession numbers in parenthesis and collection sites for relevant strains. Reference 
(R) or type strains (T) are included within each cyanobacterial group. Strains with SSU 
(16S) rRNA gene sequences determined in this study are indicated in blue. Support 
values < 60 are not indicated (* = bootstrap of > 95% and a posterior probability of 
1.0). The scale bar indicates 0.03 expected nucleotide substitutions per site. Note that 
this figure is modified from the published manuscript to include the currently accepted 
nomenclature and the additional SSU (16S) rRNA gene sequences from each of the 
Red Sea cyanobacterial isolates included in this thesis.
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  General Experimental Procedures. Optical rotations were measured on a Jasco 
P-1010  polarimeter.  UV  spectra  were  measured  on  a  SpectraMax190  (Molecular 
Devices). NMR data were acquired in CDCl3 referenced to residual CHCl3 chemical 
shifts (δC 77.2, δH 7.26) on a Bruker Avance III 700 MHz spectrometer equipped with 
a 5mm 13C cryogenic probe for compound 2. NMR data for 1 and 3 were acquired in 
CDCl3 on a Bruker DPX 400 MHz spectrometer equipped with a 5mm BBI probe and 
also  in  CD3OD (residual  CH3OH,  δC  49.2,  δH  3.31) on  a  Bruker  DRX 600  MHz 
spectrometer equipped with a 5 mm TXI probe. High-resolution mass spectrometry 
was performed in positive ion mode on Thermo Scientific LTQ FT Ultra Hybrid and 
AB SCIEX Triple TOF 5600 mass spectrometers. LC-ESIMS data were obtained on 
an  AB  SCIEX  3200  Q TRAP  mass  spectrometer.  HPLC  was  performed  using  a 
Shimadzu dual LC-20AD solvent delivery system with a Shimadzu SPD-M20A UV/
VIS photodiode array detector. 
  Collection, Isolation and  Culture of the Red Sea Leptolyngbya. An apparent 
mixed assemblage of cyanobacteria was collected by hand using SCUBA from the SS 
Thistlegorm shipwreck (46 – 98 ft) in the Red Sea (N 27° 48.849' E 33° 55.222') on 
May 27,  2007. Morphological  characterization  was  performed  using  a  Zeiss phase 
contrast microscope (×100 objective) and the specimen was identified systematically 
according  to  Komárek  and Anagnostidis (2005).  Live  cyanobacteria  were  isolated 
microscopically (Olympus SZ40 stereomicroscope) and grown in triplicate in 24-well 
culture  plates at 27  °C with a  12  hour  light-dark  cycle  (~5  µmol  photons s-1 m -2 
provided by 40W cool-white fluorescent lights). Four different enrichment mediums 
were used to investigate optimal conditions for survival in laboratory culture. These 
included 0.2 µm-filtered seawater from the Red Sea (RSW); RSW amended with soil 
extract; BG-11 medium containing  DN vitamin mix  (Castenholz, 1988), which had 
been  modified  to  closely  resemble  conditions  of  the  cyanobacterium’s  natural 
36environment (RSM; pH 8.4 and salinity 41 ‰); and RSM + RSW (1:1). Monoclonal 
cultures  of  Leptolyngbya  were  isolated  microscopically  from  serial  dilutions  of 
enrichment  cultures  in  which  exceptional  growth  was  present  (RSM:RSW)  and 
maintained in RSM (see Supporting Information Figure S-2.1). 
  DNA  Extraction and Amplification of  Cyanobacterial 16S rRNA. Prior  to 
DNA  extraction,  heterotrophic  bacteria  within  the  cyanobacterial  cultures  were 
reduced  by  sequential  treatment  through  sonication,  washing  and  addition  of 
antibiotics as previously described (Han  et al.). Genomic  DNA was then  extracted 
from approximately 40 mg  of freeze-dried cyanobacterial  tissue  using  the Wizard® 
Genomic DNA purification kit (Promega Inc., A1120) following  the manufacturer’s 
protocol. The isolated genomic DNA was subjected to further purification using  an 
anion exchange column (Qiagen, Genomic-tip 20/G). DNA concentration and purity 
was measured  on  a  Bio-Rad  SmartSpecTM 3000  spectrophotometer. Approximately 
650 bp of the upstream cyanobacterial 16S rRNA sequence was amplified from these 
genomic extracts using the cyanobacteria-specific primers, CYA106F and CYA781Ra/
b (Nubel et al., 1997), while the cyanobacteria-specific primer (CYA359F) and general 
bacterial primer (1509R) were used to amplify 1,150 bp downstream(Martínez-Murcia 
et al., 1995).  Sequences were  amplified  from  approximately 50  ng  of  DNA using 
GoTaq  Hot  Start  polymerase  (0.5  µL,  Promega)  according  to  manufacturer’s 
specifications. Polymerase  chain reactions (PCR)  were performed  in an Eppendorf 
Mastercycler gradient thermal cycler (Eppendorf, Hauppauge, NY, USA) as follows: 
initial denaturation at 95 °C for 3 min; 15 cycles of Touch Down PCR: 95 °C for 30 
sec, 65 °C for 45 sec (decreased by 1 °C per cycle), and 72 °C for 1 min; 15 additional 
cycles of amplification: 95 °C for 20 sec, 50 °C for 20 sec, and 72 °C for 1.5 min; and 
final elongation at 72 °C for 3 min. PCR products were gel-purified, cleaned with the 
QIAquick® Gel Extraction kit (cat. no. 28704, Promega) and directly sequenced on an 
ABI 3730  capillary sequencer by the  Oregon  State University Center  for Genome 
Research  and  Biocomputing  DNA  Sequencing  Core  Facility.  The  amplification 
37primers described above were used as sequencing primers with the addition of reverse 
complement primers CYA359R and CYA781Fa/b for additional sequence coverage at 
the end regions of the 16S rRNA gene amplification product. The 16S rRNA partial 
gene sequences were inspected visually and assembled using CAP3 (Huang & Madan, 
1999).  The  resulting  contig  was  analyzed  for  chimeric  sequences  using  Pintail 
(Ashelford et al., 2005) and compared to sequences in the Ribosomal Database Project 
database  (http://rdp.cme.msu.edu) and  GenBank (http://www.ncbi.nlm.nih.gov). The 
consensus sequence was deposited in GenBank under accession number JF518829.
  Phylogenetic Analysis. A 16S rRNA gene library of 60 marine and freshwater 
cyanobacteria was produced from in house SSU (16S) rRNA sequence data for Red 
Sea cyanobacterial isolates and from sequences collected from the GenBank sequence 
database.  The  library  was  screened  for  chimeric  sequences  using  the  computer 
program  Mallard (Ashelford et al., 2006), aligned using  ClustalW  in Geneious 5.6 
(Drummond  et al., 2010),  and  the  resulting  alignment edited  to  exclude  gaps and 
missing  data,  for  a  total  of  1275  positions  (90.3  %  identity)  in  the  final  dataset 
covering  the V2 to V8  hypervariable  regions within  the  16S  rRNA gene. Prior to 
phylogenetic  predictions,  a  statistical  selection  of  best-fit  models  of  nucleotide 
substitutions  for  the  SSU  (16S)  rRNA  data  set  was  selected  using  Akaike  and 
Bayesian  information  criteria  (AIC  and  BIC)  in  jModelTest 0.1.1  (Posada,  2008). 
Phylogenetic  trees were  calculated  using  the  Bayesian  (MrBayes;  Huelsenbeck  & 
Ronquist,  2001)  and  phylogenetic  maximum  likelihood  (PhyML  v3.0;  Guindon & 
Gascuel, 2003) algorithms in  Geneious 5.6 (Drummond et al., 2010). The  PhyML 
analysis  was performed  with  500  bootstrap replicates  using  the  GTR+I+G  model 
(selected by AIC and BIC  in  jModelTest;  proportion of  invariable  sites (pINV)  = 
0.450, shape parameter (α) = 0.387, number of rate categories = 4). Bayesian analysis 
was performed with the GTR substitution model (number of rate categories = 4). The 
Markov chain  length  (three  heated)  was set to  3 million with sampling  performed 
every 100 generations (25% burn-in).
38  Extraction  and  Isolation  of  Compounds  1-3  and  Dolastatin  12.  The  field 
collection  of  Leptolyngbya  (500  mL,  collection code  EHu5-27-07-1)  for chemical 
extraction was stored in 2-propanol at -20 °C until extraction to yield 1.26 g organic 
extract (CH2Cl2-MeOH, 2:1). The organic extract was subjected to bioassay-guided 
fractionation via NP VLC using a stepped gradient of hexanes to EtOAc to MeOH. 
The fraction eluting with 25% MeOH-EtOAc was further separated by RP18 SPE using 
a stepped gradient of MeOH-H2O from 50% MeOH-H2O to 100% MeOH, followed 
by 100% CH2Cl2.  Isocratic  RP-HPLC  (column:  Synergi Fusion-RP,  10  x  250 mm, 
70%  MeCN-H2O,  3  mL/min)  of  the  SPE  fraction  C  eluting  in  70%  MeOH-H2O 
yielded  two  impure  HPLC  peaks  targeted  for  further  purification.  RP-HPLC 
(Chirobiotic TAG, 4.6 x 250 mm, 98% EtOH-H2O, 0.5 mL/min) of the less polar of 
these fractions yielded Ibu-epidemethoxylyngbyastatin 3 (3, 2.9 mg) and a mixture of 
grassypeptolides D (1, 1.5 mg) and E (2, 0.5 mg), which were finally separated on the 
Chirobiotic  TAG column using  75% MeOH-H2O (0.5 mL/min). Dolastatin 12 was 
also isolated from the 25% MeOH-EtOAc NP VLC fraction H. Repeated isocratic RP-
HPLC (column: Synergi Fusion-RP, 10 x 250 mm, 70% MeCN-H2O, 3 mL/min) of the 
SPE  fraction (H2) eluting  in 70% MeOH-H2O fraction yielded dolastatin 12 as the 
major component. Subsequent LC-MS profiling (Synergi Fusion-RP, 2 x 100 mm, 0.2 
mL/min, linear gradient of 65 to 100% MeCN in 0.1% [v/v] aqueous TFA) of extracts 
from monoclonal Leptolyngbya cultures (2 x  1.5 L) yielded m/z 1138.6 (1 and 2, [M
+Na]+), 1005 (3, [M+Na]+) at the same retention times as 1, 2 and 3 purified from the 
original field collection.
  Grassypeptolide  D  (1):  colorless,  amorphous  solid;  [α]21D  +25.9  (c  0.15, 
CH2Cl2); UV (MeOH) λmax (log ε) 212 (3.82), 260 (3.56); 1H and 13C NMR data, see 
Table 2.1 and Supporting  Information (Table S-2.2); HRFTMS m/z 1138.5515 [M + 
Na]+  (calcd  for C57H81N9O10S2Na, 1138.5445), m/z 1116.5458  [M + H]+ (calcd  for 
C57H82N9O10S2, 1116.5620).
39  Grassypeptolide  E  (2):  colorless,  amorphous  solid;  [α]21D  +13.2  (c  0.15, 
CH2Cl2); UV (MeOH) λmax (log ε) 212 (3.73), 256 (3.48); 1H and 13C NMR data, see 
Table 2.1 and Supporting Information (Table S-2.3); HRTOFMS m/z 1138.5413 [M + 
Na]+(calcd  for C57H81N9O10S2Na,  1138.5445),  m/z  1116.5603  [M +  H]+  (calcd  for 
C57H82N9O10S2, 1116.5620).
  Ibu-epidemethoxylyngbyastatin 3 (3): white, amorphous solid; [α]21D –48.6 (c 
0.5, CHCl3); UV (MeOH) λmax (log ε) 212 (3.98), 256 (3.81);  1H and 13C NMR data, 
see Supporting Information (Table S-2.4); HRFTMS m/z 1005.5983 [M + Na]+ (calcd 
for  C51H82N8O11Na,  1005.6001),  m/z  983.6162  [M +  H]+  (calcd  for  C51H83N8O11, 
983.6175).
  Dolastatin 12: white, amorphous solid; [α]21D -79.8 (c 0.5, CHCl3); UV (MeOH) 
λmax (log ε) 212 (3.71), 256 (3.57); 1H and 13C NMR data, see Supporting Information 
(Figures A-2.16 and 2.17) and (Pettit et al., 1989) HRTOFMS m/z 969.6035 [M + H]+ 
(calcd for C50H81N8O11, 969.6019).
  Absolute Configuration of Grassypeptolides D (1) and E (2). The amino acid 
standards relevant to compounds 1 and 2 were obtained commercially or as gifts and 
prepared as 50 mM solutions in H2O. Standards for (2R)-  and (2S)-methylcysteine 
were  kindly provided  by Dr. W.H.  Gerwick,  Scripps  Institution  of  Oceanography, 
University  of  California,  San  Diego.  A  portion  of  each  standard  (5.0  mg)  was 
dissolved in 720 µL HCO2H at 0 °C. Next, 80 µL of H2O2 (30%) was added dropwise 
with continuous stirring and the reaction was carried out at 0 °C for 2 h to yield either 
(2R)- or (2S)-methylcysteic acid (MeCysA). The product mixture was dried under a 
steady stream of N2 gas and resuspended in H2O (50 mM). The N-benzoyl O-methyl 
ester of (2R,3S)-2-methyl-3-aminobutyric acid (Maba) was gratefully received from 
Dr.  Hendrik  Luesch,  Department  of  Medicinal  Chemistry,  University of  Florida. 
Approximately 0.4 mg  was deprotected with 500 µL 6 N HCl at 110 °C for 24 h, 
evaporated to  dryness and  resuspended in H2O (50 mM).  Each  standard  was then 
derivatized for Marfey’s analysis by adding 10 µL of 1 M NaHCO3 and 50 µL of N-α-
40(5-fluoro-2,4-dinitrophenyl-)-L-leucinamide (L-FDLA or D-FDLA, 1% w/v in acetone) 
to 25 µL of each standard solution. The mixture was heated at 40 °C for 1 h with 
continuous  stirring,  cooled  to  room  temperature,  acidified  with  5  µL  2N  HCl, 
evaporated to dryness and resuspended in 250 µL MeCN-H2O (1:1).
  Approximately 0.1 mg  of 1 and 0.2 mg of 2 were dissolved separately in 3 mL 
CH2Cl2 (-78  °C).  Ozone was then bubbled through  each solution  for 15 min. The 
solution was dried under a stream of N2 gas, followed by an oxidative workup of the 
residue (0.6 mL of H2O2-HCOOH 1:2 at 70 °C for 20 min). The oxidation product was 
concentrated under vacuum and hydrolyzed with 1 mL of 6 N HCl at 110 °C for 18 h. 
The hydrolyzed products were resuspended in 25 µL H2O and derivatized for Marfey’s 
analysis  in  a  similar  manner  to  the  derivatized  chromatographic  standards.  The 
Marfey’s products  of  1  and  2  were  resuspended  in  50  µL  MeCN-H2O  (1:1)  and 
analyzed by reversed-phase HPLC (Gemini C18 110 A, 4.6 x 150 mm, 5 µm, 1.0 mL/
min, UV detection at 340 nm) using a linear gradient of 30 to 70% MeCN in 0.1% (v/
v)  aqueous  TFA over  50  min.  The  retention  time  (tR  min)  of the  residues  in  the 
hydrolysate of 1 matched standards for D-Aba (21.9; L-Aba, 17.1), L-Cya (7.1; D-Cya, 
6.5), (2S)-MeCysA [6.2; (2R)-MeCysA, 7.8], N-Me-D-Leu (27.8; N-Me-L-Leu, 24.5), 
(2R, 3R)-Maba L-FDLA [18.8; (2R,3R)-Maba D-FDLA, 25.6; (2R,3S)-Maba L-FDLA, 
18.6; (2R,3S)-Maba D-FDLA, 20.8], L-Pro (14.1; D-Pro, 17.0), N-Me-L-Phe (22.7; N-
Me-D-Phe,  24.6),  N-Me-L-Val  (21.2;  N-Me-D-Val,  25.6),  D-allo-Thr  (12.6;  L-Thr, 
10.2;  L-allo-Thr,  11.1;  D-Thr,  14.4).  The  retention  times  for  the  residues  in  the 
hydrolysate of 2 were consistent with the results for 1, with the exception of N-Me-L-
Leu (24.5)  and  L-Thr (10.2)  standards matching  the corresponding  residues in the 
hydrolysate of 2. The configuration of the Pla residue in the hydrolysates of both 1 and 
2 was determined by chiral LC-MS. The retention time [Chirobiotic TAG, 4.6 x  250 
mm; MeOH-10  mM NH4OAc  (3:2, pH 5.50); flow rate, 0.4  mL/min;  detection by 
ESIMS in negative ion mode] of the natural product hydrolysate matched that for L-
Pla (7.4 min; D-Pla, 8.5).
41  Absolute Configuration of Ibu-epidemethoxylyngbyastatin (3). 
  Approximately 0.4 mg of 3 in 0.2 mL anhydrous MeOH was added to a solution 
of NaBH4 (2 mg) in anhydrous MeOH at 0 °C. After stirring for 30 min, the solution 
was acidified with  1N HCl until  pH 6. The solution was then  partitioned  between 
EtOAc  and  H2O,  and  the  organic  layer  concentrated  to  dryness  for  analysis  by 
reversed-phase HPLC (Synergi Fusion-RP, 10 x  250 mm, 62% MeCN-H2O, 3.5 mL/
min). A single  product  consistent  with  the  dihydro-form  of  3 ( tR  18.9  min)  was 
present, while unreduced compound 3 (tR 21.3 min) was not detected. This reduction 
product and  an additional  ~0.4  mg  of  3 were  separately hydrolyzed with  6N HCl 
(method A: Ace  high-pressure  tube, 1200W  microwave  for  50 s  and  immediately 
cooled to 0 °C; or method B: 110 °C for 18 h), evaporated to dryness and resuspended 
in H2O (50 mM). Standards for the 3-amino-2-methylhexanoic acid (Amha) unit were 
kindly provided by Dr. David Horgen, College  of Natural Sciences, Hawaii Pacific 
University. The other amino acid standards relevant to compound 3 were available 
commercially  or  from  synthesis  (Amp  and  Adhpa,  see  Experimental)  and  also 
prepared  as  50  mM solutions  in  H2O.  Marfey’s  derivatization  was  performed  by 
adding  10  µL  of  1M NaHCO3  and  50  µL  of  N-α  -(5-fluoro-2,4-dinitrophenyl)-L-
leucinamide  (L-FDLA, 1% w/v in acetone) to 25 µL of each 50 mM solution. The 
mixture  was  heated  at 40  °C  for  1  h  with  stirring,  cooled  to  room  temperature, 
acidified with 5 µL 2N HCl and evaporated to dryness. The derivatized product was 
resuspended  in  250  µL  MeCN-H2O  (1:1)  for  each  standard  or  100  µL  for  the 
hydrolysate of 3 and analyzed by reversed-phase HPLC (Gemini C18 110A, 4.6 x 150 
mm, 5 µm, 1.0 mL/min, UV detection at 340 nm) using a linear gradient of 30 to 70% 
MeCN in 0.1% (v/v) aqueous TFA over 50 min. The retention times (tR min) of the 
derivatized residues in the hydrolysate of 3 matched N-Me-L-Ala (16.2; N-Me-D-Ala, 
16.8), (2S,3R)-Amha [28.6; (2S,3S)-Amha, 23.2; (2R,3R)-Amha; (2R,3S)-Amha, 22.5] 
and N-Me-L-Val (21.2; N-Me-D-Val, 25.5). The retention times of N-Me-L-Phe (23.2) 
and N-Me-D-Phe (24.5) standards overlapped with (2S,3S)-Amha (23.2) and N-Me-L-
42Leu  (24.5)  standards.  Thus,  the  derivatized  hydrolysate  was  subjected  to  LC-MS 
analysis (Gemini C18, 2.0 x  150 mm, 3 µm, 0.2 mL/min, UV and ESIMS detection, 
340 nm and negative ion mode, respectively) using a linear gradient of 30 to 70% of 
0.1% (v/v) formic acid in MeCN and 0.1% (v/v) formic acid in H2O over 50 min. The 
retention times (tR min, base peak m/z) of the derivatized residues in the hydrolysate 
matched N-Me-L-Phe (23.1, 472.1) and N-Me-L-Leu (24.9, 439.1). For the assignment 
of the Ibu unit, both the  decarboxylated product, (2S)-amino-4-methylpentan-3-one 
(Amp),  and  the  reduced  Ibu  unit,  (3R/S,  4S)-4-amino-2,2-dimethyl-3-hydroxy-
pentanoic acid (Adhpa) were prepared. Portions were then separately derivatized with 
L-FDLA and D-FDLA reagents and analyzed by reversed-phase HPLC (Kinetex XB-
C18 110A, 4.6 x 100 mm, 2.6 µm, 1.8 mL/min, UV detection at 340 nm) using a linear 
gradient of  30  to 70% MeCN in 0.1% (v/v)  aqueous TFA over 15 min or LC-MS 
(Gemini C18, 2.0 x 150 mm, 3 µm, 0.2 mL/min, UV and ESIMS detection, 340 nm and 
negative ion mode, respectively) using a linear gradient of 30 to 70% of 0.1% (v/v) 
formic  acid  in  MeCN  and  0.1%  (v/v)  formic  acid  in  H2O  over  50  min.  For  the 
hydrolysate of 3 for method A, both S- and R-Amp were detected by reversed-phase 
HPLC at tR = 9.8 and 10.0 min, respectively, in the ratio of 4.1:1. For the hydrolysate 
of 3 for method B, both S- and R-Amp were detected by reversed-phase HPLC at tR = 
9.8 and 10.0 min, respectively, in the ratio of 1:2.2. The retention times (tR min; S/R 
ratio) of the Amp derivatized standards were as follows: L-FDLA-S-Amp (9.8, 6.7:1) 
and D-FDLA-S-Amp (10.0, 1:5.9). For the hydrolysate of the reduction product of 3 
(method  A),  the  assignment  of  the  reduced  Ibu  unit  was  determined  by LC-MS 
analysis due to overlap in the HPLC trace. The retention time (tR min, 4S to 4R ratio, 
base  peak m/z) of  the reduced  natural  product hydrolysate  matched L-FDLA-(3RS, 
4S)-Adhpa (19.7, 13.8:1, 454.1), while D-FDLA-(3RS, 4S)-Adhpa eluted at 20.6 min. 
  Synthesis  of  (2S)-2-amino-4-methylpentan-3-one  (Amp)  and  (3R/S,  4S)-4-
amino-2,2-dimethyl-3-hydroxy-pentanoic  acid  (Adhpa)  for  assignment  of 
desmethoxylyngbyastatin 3 (3). According  to a procedure modified from Theberge 
43and  Zercher  (2003),  carbonyl  diimidazole  (CDI,  981  mg,  5.87  mmol,  1.02  eq.) 
dissolved in 20 mL anhydrous THF was added to a stirred, room temperature solution 
of 1.09 g (5.75 mmol, 1 eq.) Boc-L-Ala in 10 mL anhydrous THF, contained in a 100 
mL  round-bottom  flask.  To  a  separate  250  mL  round-bottom  flask  containing  a 
solution of monobenzyl malonate (1.41 g, 6.9 mmol, 1.2 eq.) in 20 mL of anhydrous 
THF was added 3.45 mL (3.45 mmol) of a 1 M hexanes solution of dibutylmagnesium 
at 0 ºC. The acyl imidazole solution was transferred to this 250 mL flask containing 
the magnesium salt and the combined solutions were allowed to stir for 2 h in the ice-
bath before being left to stir for 24 h at room temperature. The reaction was quenched 
by the addition of 40 mL sat. aq. NH4Cl and extracted three times with 20 mL EtOAc. 
The combined organic layers were dried with Na2SO4, filtered, and concentrated. The 
crude  residue was chromatographed on silica  with 20% EtOAc in hexanes to yield 
1.11 g (60 %) of (4S)-N-Boc-4-amino-3-oxo-pentanoic benzyl ester as a colorless oil, 
confirmed by ESIMS+ (m/z 344 [M + Na]+) and comparison of 1H NMR data with the 
literature (Williams et al., 2003). The latter product (1.00 g, 3.11 mmol, 1 eq.) was 
dissolved in anhydrous THF (10 mL) in a 100 mL round-bottom flask before CH3I 
(1.76 mL, 28.0 mmol, 9 eq.) was added, followed immediately by NaH (dry, 95%, 79 
mg, 3.11 mmol, 1 eq.). After stirring at room temperature for 1 h, additional CH3I (9 
eq.)  and  NaH  (1  eq.)  were  added  and  the  solution  was  stirred  for  24  h.  The 
concentrated  reaction  mixture  was  partitioned  between EtOAc/H2O  and dried over 
Na2SO4  to  give  730  mg  crude  (4S)-N-Boc-4-amino-2,2-dimethyl-3-oxopentanoic 
benzyl ester, as established by ESIMS+ ([M+Na]+ m/z 371.9) and 1H NMR. 
A solution of the latter crude product (50 mg, 0.143 mmol) in 2.5 mL anhydrous 
MeOH was  added  dropwise  to  NaBH4  (21.6  mg,  0.572  mmol,  4  eq.)  in  2.5  mL 
anhydrous MeOH at 0 °C. After stirring for 30 min, the solution was acidified with 1N 
HCl until pH 6. The solution was then partitioned between EtOAc and brine, and the 
organic layer concentrated to dryness to yield 27 mg (0.078 mmol, 55%) of (3R/S, 4S)-
N-Boc-4-amino-2,2-dimethyl-3-hydroxy-pentanoic benzyl ester. The benzyl protecting 
44group was removed by hydrogenation over 5% Pd/C in 2 mL anhydrous EtOH at room 
temperature  for  18  h.  The  mixture  was  filtered,  concentrated  in  vacuo,  and 
resuspended in 1 mL CH2Cl2-TFA (1:1) with stirring  for 2 h. The acid was removed 
under a  stream  of nitrogen to afford 10.5 mg  (0.065 mmol, 83%) of (3R/S, 4S)-4-
amino-2,2-dimethyl-3-hydroxy-pentanoic  acid  (Adhpa). Alternatively, 20 mg  (0.057 
mmol)  of  (4S)-N-Boc-4-amino-2,2-dimethyl-3-oxopentanoic  benzyl  ester  was 
deprotected  as  described  above  to  afford  4.2  mg  (0.037  mmol,  65%)  of  the 
decarboxylated product (2S)-2-amino-4-methylpentan-3-one (Amp).
 P r e p a r a t i o n   a n d   C h i r a l   L C - M S   o f   2 - h y d r o x y - 3 - m e t h y l p e n t a n o i c   a c i d  
(HMPA) for (3). Diazotization of L-Ile (100 mg, 0.75 mmol) dissolved in 50 mL of 
0.2 N perchloric acid (0 °C) was carried out by the dropwise addition of a cold (0 °C) 
20 mL solution of sodium nitrite (1.4 g, 20 mmol) with rapid stirring. The solution was 
stirred at room temperature until the evolution of N2 subsided (~60 min). The solution 
was then brought to boiling  for 3 min, cooled to room  temperature, saturated with 
NaCl, and extracted with 20 mL EtOAc. The extract was dried with anhydrous Na2SO4 
and concentrated under vacuum to afford (2S, 3S)-HMPA as an oil. The three other 
stereoisomers (2S,3R)-HMPA, (2R,3R)-HMPA and (2R,2S)-HMPA were  synthesized 
in a  similar manner from L-allo-Ile,  D-Ile and  D-allo-Ile, respectively. A portion of 
each standard was analyzed using  chiral LC-MS. The  retention time  of the natural 
product hydrolysate matched that for (2S,3S)-HMPA (7.5 min; Chirobiotic TAG, 4.6 x 
250 mm; MeOH-10 mM NH4OAc 3:2 at pH 5.50; flow rate, 0.4 mL/min; detection by 
ESIMS in negative ion mode). The retention times of the remaining HMPA standards 
were as follows: (2S, 3R)-HMPA (6.5 min), (2R,3R)-HMPA (9.2 min), (2R,2S)-HMPA 
(8.1 min).
  Cell Viability Assays. Mouse  neuroblastoma  neuro-2a  or  HeLa  cells (ATCC, 
Manassas, VA) were cultured in RPMI-1640 media with 2 mM L-glutamine, pH 7.4 
(Mediatech  Inc.,  Manassas,  VA)  supplemented  with  10%  fetal  bovine  serum 
(HyClone,  Logan,  UT),  1  mM sodium  pyruvate  (Mediatech),  and  1%  penicillin/
45streptomycin (Mediatech) at 37 ºC in a humidified chamber containing 5% CO2. Cells 
were seeded into 96-well plates (neuro-2a: 20,000 cells per well; HeLa: 3,000 cells per 
well) in 90 µL of medium 4 h before treatment. Purified compounds were added to 
cells at final concentrations ranging from 10 nM to 10 µM (neuro-2a cells) or 2 µM 
(HeLa cells), each added in a 10 µL aliquot generated by serial dilution in serum-free 
medium on the day of the experiment, from stock solutions of 200 µM  (1 and 2, both 
cell lines) or 2 mM (3 and dolastatin 12,  neuro-2a cells only)  compound in 100% 
DMSO  (neuro-2a  cells)  or  100%  EtOH  (HeLa  cells).  Each  96-well  plate  also 
contained untreated and vehicle-treated control cells. Neuro-2a cells were also treated 
with 30 µg/mL of the parent 25% MeOH-EtOAC fraction as a positive control. Cell 
viability  was  determined  after  48  h  treatment  using  a  standard  3-(4,5-
dimethylthiazol-2-yl)-2,5,diphenyly tetrazolium bromide (MTT) assay. Briefly, MTT 
reagent (0.5 mg/mL  in  PBS;  Sigma, St.  Louis,  MO) was  added  to  each well  and 
incubated for 2 h at 37°C. The  medium was then  aspirated from all wells and the 
purple formazan product solubilized with DMSO. The optical density of each well was 
determined  at  550  nm  using  a  BioTek  Synergy HT microplate  reader  with  Gen5 
software (Bio-Tek, Winooski, VT). The cytotoxicity of each purified compound was 
assessed in  at least three  independent cultures with  the  viability of vehicle-treated 
control cells defined as 100% in all experiments. 
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48Table S-2.1. List of and growth mediums used to culture Red Sea cyanobacteria.
Media Constituents
RSM 1.5 g NaNO3, 75 mg MgSO4, 40 mg K2HPO4ŋ3H2O, 20 mg Na2CO3ŋH2O, 6 mg citric 
acid, 6 mg ferric ammonium citrate, 1 mg Na2-EDTA, 1 mL Trace Metals, 1 mL DN
Vitamin Mix and 998 mL Instant Ocean (41 g/L), pH 8.4
DN Vitamin 
Mix
0.2 g thiamine HCl, 0.1 g biotin, 0.1 g calcium pantothenate, 10 mg para-aminobenzoic 
acid, 1 mg cyanocobalamin, 1 mg folic acid, 1 mg myo-inositol, 1 mg nicotinic acid and 
1 liter DI water
Soil Extract 5.0 g dry soil loam (mix of sand, silt and clay particles) and 200 mL DI water. Pasteurize 
over two consecutive days for 3 hours at 98 °C. Alternatively, autoclave for 1 hour at 121 
°C, 15 psi., and filter particulates.
Trace Metals 520 mg Na2-EDTA, 178 mg FeSO4ŋ7H2O, 23.2 mg Co(NO3)2ŋ6H2O, 14.8 mg       
ZnSO4ŋ7H2O, 10 mg MnCl2, 6.2 mg H3BO3, 3.6 mg NaMoO4ŋ2H2O, 2.7 mg       
NiSO4ŋ6H2O, 1.7 mg CuCl2ŋ2H2O and 100 mL DI water
49Table S-2.2. NMR Spectroscopic Data for Grassypeptolide D (1) in CDCl3 (400 
MHz).
unit position δC, mult. δH, mult. (J in Hz) COSY HMBC ROESY
Maba 1 172.4, C
2 45.6, CH 2.50, dq (7.0, 6.8) H-3, H3-5 3, 5 H-3, H3-4, H3-5
3 48.5, CH 4.22, m H-2, H3-4,
NH (A)
H-2, H3-4, H3-5
4 19.9, CH3 1.19, d (6.7) H-3 1, 2, 3 H-2, H-3, H3-5
5 14.4, CH3 1.12, d (7.0) H-2 2, 3 H-3, H3-4, H-55
NH 7.70, br  H-3 6
Thr 6 169.3, C
7 59.1, CH 4.45, dd (6.8, 6.1) H-8, NH (B) 10 H3-9, NH (B)
8 69.1, CH 4.02, m H-7, H3-9 H3-9, NH (B)
9 19.7, CH3 1.22, d (6.4) H-8 7, 8 H-7, H-8
OH 4.00, br
NH 6.9, d (7.3) H-7 10 H-7, H-8, H-11, H-12b
N-Me-Leu 10 170.3, C
11 57.5, CH 4.70, br H-12a/b H-12a, H-12b, H3-15, 
H-18, NH (B)
12a 37.2, CH2 1.97, m H-11, H-12b, 
H-13
H-11, H3-14
12b 1.67, m H-12a, H-13 H-11, H3-15, NH (B)
13 25.3, CH 1.58, m H-12a, H-12b, 
H3-14, H3-15
14 23.2, CH3 0.98, d (6.4) H-13 12, 13, 15 H-12a, H-19b
15 22.8, CH3 0.94, d (6.5) H-13 12, 14 H-11, H-12b, H3-16
16 33.2, CH3 3.20, s 11, 17 H3-15, H-18
Aba-thn-ca 17 170.4, C
18 78.1, CH 5.29, m H-19a, H-19b 17, 20 H-11, H3-16, H-19a
19a 33.3, CH2 3.60, m H-18 17, 18 H-18
19b 3.26, m H-18 20 H3-14
20 178.0, C
21 54.2, CH 4.55, m H-22b, NH (D) 20 H-22a
22a 25.2, CH2 2.11, m H3-23 H-21, H3-23
22b 1.86, m H-21 H3-23, NH (D)
23 11.6, CH3 0.96, t (6.9) H-22a 21 H-21, H-22a, H-22b, 
NH (D)
NH 7.10, d (7.7) H-21 24 H-22b, H3-23
N-Me-Phe-thn-ca 24 173.7, C
25 84.0, C
26a 43.1, CH2 3.74, d (-11.5) H-26b 24, 28 H-26b, H3-27
26b 3.17 d (-11.3) H-26a 24, 25, 27 H-26a, H3-27
27 24.3, CH3 1.35, s 24, 25, 26 H-26a, H-26b, 
H-33/35
50Table S-2.2 (continued). NMR Spectroscopic Data for Grassypeptolide D (1) in 
CDCl3 (400 MHz).
unit position δC, mult. δH, mult. (J in Hz) COSY HMBC ROESY
N-Me-Phe-thn-ca 28 173.9, C
29 58.9, CH 5.39, dd (10.7, 6.4) H-30a, H-30b 28 H-30a, H-33/35
30a 36.0, CH2 3.24, m H-29 29, 31, 
32/36
30b 3.16, m H-29 31, 32/36 H-32/36
31 135.5, C
32/36 129.2, CH 7.33, m 31, 33/35 H-30b
33/35 128.5, CH 7.22, m 34 H3-27, H-29
34 127.6, CH 7.20, m
37 30.7, CH3 3.21, s 29, 38 H-39, H-41a, H-41b
Pro 38 172.7, C
39 57.5, CH 4.84, dd (8.8,5.1) H-40a, H-40b H3-37, H-41a, H-42b
40a 27.5, CH2 2.22, m H-39
40b 1.93, m H-39
41a 24.9, CH2 1.99, m H3-37, H-39, H-42a
41b 1.63, m 40 H3-37
42a 47.8, CH2 3.97, m H-42a H-41a, H-44
42b 3.53, m H-42b 43 H-40b, H-44
N-Me-Val 43 168.6, C
44 60.0, CH 4.98, d (11.0) H-45 43, 45 H-42a, H-42b, H3-46, 
H3-47
45 27.4, CH 2.32, m H-44, H3-46, 
H3-47
H3-48
46 19.6, CH3 0.98, d (6.4) H-45 44, 45, 47 H-44, H-45
47 18.0, CH3 0.88, d (6.6) H-45 44, 45, 46 H-44, H3-48
48 30.0, CH3 3.12, s 44, 49 H-45, H3-47, H-50, 
H-55
Pla 49 170.2, C
50 72.4, CH 5.33, dd (9.9, 3.2) H-51a H3-48
51a 36.9, CH2 3.09, dd (-14.5, 9.9) H-50 52, 53/57
51b 3.04, dd (-14.4, 3.2) 53/57
52 134.9, C
53/57 129.1, CH 7.22, m 55
54/56 129.5, CH 7.24, m 53/57
55 127.6, CH 7.27, m 54/56 H3-5, H3-48
51Table S-2.3.  NMR  Spectroscopic  Data  for  Grassypeptolide  E  (2)  in  CDCl3  (700 
MHz).
unit position δC, mult. δH, mult. (J in Hz) COSY HMBC ROESY
Maba 1 172.9, C
2 45.5, CH 2.51, qd (7.0, 4.5) H-3, H3-5 1, 5 H-3, H3-4, H3-5, 
H-14
3 47.0, CH 4.23, m H-2, H3-4,
NH (A)
H-2, H3-4, NH 
(A)
4 19.3, CH3 1.10, d (7.0) H-3 2, 3 H-3, H-5
5 14.4, CH3 1.16, d (7.0) H-2 1, 2, 3 H-4
NH 6.45, d (9.9) H-3 6 H-7
Thr 6 170.5, C
7 57.0, CH 3.36, dd (6.9, 3.3) NH (B) H-11, NH (A)
8 67.9, CH 3.30, m H3-9 6 H-9, NH (A), 
NH (B)
9 19.4, CH3 0.87, d (6.5) H-8 7, 8 H-8
OH
NH 6.9, d (6.9) H-7 10 H-8, H-11
N-Me-Leu 10 170.0, C
11 54.6, CH 5.15, t (7.7) H-12a/b 10, 12, 13, 16 H-7, H-12a/b, 
NH (B)
12a/b 37.1, CH2 1.78, m  H-11, H-13 10, 11, 13, 14, 
15
H-11, H3-14, 
H3-15, H3-16
13 25.3, CH 1.52, m H3-14, H3-15 11, 12, 14, 15 H3-14, H3-15, 
H3-16
14 23.2, CH3 0.98, d (6.6) H-13 12, 13, 15 H-2, H-12a/b, 
H-13
15 22.4, CH3 0.93, d (6.7) H-13 12, 13, 14 H-12a.b, H-13
16 30.7, CH3 3.49, s 11, 17 H-12a/b, H-13
Aba-thn-ca 17 169.3, C
18 75.9, CH 5.07, m H-19a, H-19b 17, 20 H-19a, H-19b
19a 35.5, CH2 4.15, br dd H-18, H-19b 17, 18 H-18, H-19a, 
H-42a
19b 3.44, dd (-11.2, 8.5) H-18, H-19a 20 H-18, H-19b
20 175.0, C
21 53.2, CH 4.71, ddd (9.0, 4.0, 2.7) H-22a, H-22b, 
NH (D)
H-22a, H-22b, 
NH (D)
22a 28.5, CH2 1.95, dqd (-11.5, 7.4, 4.0) H-21, H-22b, 
H3-23
20, 21, 23 H-21, H-22b, 
H3-23
22b 1.48, m  H-21, H-22a, 
H3-23
20, 21, 23 H-21, H-22a, 
H3-23
23 10.0, CH3 0.74, t (7.4) H-22a, H-22b 21, 22 H-22a, H-22b
NH 7.5, d (9.0) H-21 20 H-21
N-Me-Phe-thn-ca 24 168.9, C
25 84.0, C
26a 41.5, CH2 3.29, d (-11.6) H-26b 24, 25, 27, 28
26b 3.18, d (-11.7) H-26a 24, 25, 27 H3-27
27 23.9, CH3 1.38, s 25, 26, 28 H-26b
52Table S-2.3 (continued). NMR Spectroscopic Data for Grassypeptolide E (2) in CDCl3 
(700 MHz).
unit position δC, mult. δH, mult. (J in Hz) COSY HMBC ROESY
N-Me-Phe-thn-ca 28 173.9, C
29 55.8, CH 5.87, dd (12.2, 3.0) H-30a, H-30b 30, 37, 38 H-30b, H-32/36, 
H-33/35, H-34
30a 36.1, CH2 3.55, br  H-29, H-30b 29, 31, 32/36 H-30b, H3-37
30b 3.28, m H-29, H-30a 28, 31, 32/36 H-29, H-30a, H3-37
31 137.7, C
32/36 129.6, CH 7.18, m H-33/35 33/35, 34 H-29
33/35 129.3, CH 7.03, br  H-32/36, H-34 31, 32/36 H-29
34 127.3, CH 7.08, m H-33/35 32/36 H-29
37 30.2, CH3 3.17, s 29, 38 H-30a, H-30b, H-39, 
H-40b, H-41a/b
Pro 38 171.2, C
39 58.8, CH 5.10, br H-40a, H-40b 40, 41, 42, 43 H3-37, H-40a, H-44
40a 31.2, CH2 2.30, m H-39, H-40b, 
H-41a/b
39 H-39, H-40b
40b 2.10, m H-39, H-40a, 
H-41a/b
38, 39 H3-37, H-40a, H-42a, 
H-42b
41a/b 21.7, CH2 2.01, m H-40a, H-40b, 
H-42a, H-42b
H3-37, H-42a, H-42b, 
H3-46
42a 46.9, CH2 3.80, m H-41a/b, H-42b 40 H-19, H-40b, H-41a/b
42b 3.69, m H-41a/b, H-42a 41 H-40a, H-40b, H-41a/
b, H3-48
N-Me-Val 43 168.5, C
44 58.1, CH 5.01, d (10.8) H-45 43, 45, 47, 48, 
49
H-39, H-45, H3-46, 
H3-47
45 28.1, CH 2.35, m H-44, H3-46, 
H3-47
44, 46, 47 H-44, H3-46, H3-47, 
H3-48
46 19.5, CH3 0.95, d (6.7) H-45 44, 45, 47 H-41a/b, H-44, H-45
47 18.6, CH3 0.85, d (6.7) H-45 44, 45, 46 H-44, H-45
48 30.3, CH3 3.20, s 44, 49 H-45, H-42b
Pla 49 171.4, C
50 72.4, CH 5.33, dd (9.7, 3.8) H-51a, H-51b 1, 51, 52 H-51a, H-51b
51a 36.9, CH2 3.16, m H-50, H-51b 52, 53/57 H-50, H-51b
51b 3.01, m H-50, H-51a 49, 50, 52, 
53/57
H-50, H-51a
52 136.1, C
53/57 129.1, CH 7.12, m H-54/56 54/56, 55
54/56 129.5, CH 7.31, m H-53/57, H-55 52, 53/57
55 127.4, CH 7.24, m H-54/56 54/56
53Table S-2.4. NMR Spectroscopic Data for Ibu-epidesmethoxylyngbyastatin 3 (3) in 
CDCl3 (400 MHz).
unit position δC, mult. δH, mult. (J in Hz) COSY HMBC ROESY HSQC-
TOCSY
Amha 1 173.2, C
2 43.4, CH 2.89, ob H-3, H3-7 1 H3-7 7
3 52.8, CH 3.96, br H-2, H-4b,
NH (A)
H3-7
4a 24.4, CH2 1.53, m H3-7
4b 1.27, ob H-3 H3-7, NH (A) 3, 4
5a 20.0, CH2 1.44, m H3-6 3, 4, 6
5b 1.32, m
6 13.9, CH3 0.86, t (7.0) H-5a 4, 5 3, 4, 5
7 13.4, CH3 1.21, d (6.9) H-2 1, 2, 3 H-2, H-3, H-4a/b,
H-47
2, 3
NH 7.84, br H-3 H-4b
N-Me-Ala 8 169.6, C
9 53.3, CH 5.10,m H3-10 8 H-10 10
10 14.0, CH3 1.37, d (6.9) H-9 8, 9 H-9 9
11 31.1, CH3 2.76, s 12 H3-17, H3-18
Ibu 12 173.6, C
13 54.4, C
14 208.4, C
15 51.2, CH 4.83, br H3-16, NH (B) 16, 19 H3-16, H3-18
16 19.3, CH3 1.18, d (6.8) H-15 H-15 15
17 23.5, CH3 1.33, s 12, 13, 14, 
18
H3-11, H-23/27
18 21.6, CH3 1.26, s 12, 13, 14, 
17
H3-11, H-15
NH 6.86, br H-15 19
N-Me-Phe 19 170.5, C
20 61.2, CH 4.98, br H-21a, H-21b 19 H-23/27, H-30 21
21a 35.9, CH2 3.32, m H-20, H-21b 20 H-23/27, H-30 20
21b 2.92, br m H-20, H-21a 19 H-23/27, H-30 20
22 136.5, C
23/27 128.7, CH 7.23, m 25 H3-17, H-20, H-21a, 
H-21b, H3-28, H3-33
24/26, 25
24/26 129.0, CH 7.29, m 22, 23/27 23/27, 25
25 127.3. CH 7.21, m
28 30.5, CH3 2.98, s 20 H-23/27
54Table S-2.4 (continued). NMR Spectroscopic Data for Ibu-epidemethoxy-
lyngbyastatin 3 (3) in CDCl3 (400 MHz).
unit position δC, mult. δH, mult. (J in Hz) COSY HMBC ROESY HSQC-
TOCSY
N-Me-Val 29 169.9, C
30 58.0, CH 4.77, d (10.7) H-31 29, 31, 33 H-20, H-21a, H-21b, 
H3-32, H3-33
31, 32, 33
31 27.0, CH 2.22, br H-30, H3-32,
H3-33
H3-32, H3-33, H3-34 30, 32, 33
32 18.6, CH3 0.69, br H-31 30, 31, 33 H-30, H-31, H3-33, 
H3-34
30, 31, 33
33 18.5, CH3 0.36, br H-31 30, 31, 32 H-23/27, H-30, H-31, 
H3-32, H3-34
30, 31, 32
34 29.3, CH3 2.97, s 30, 35 H-31, H3-32, H3-33, 
H-36a, H-36b
Gly 35 169.2, C
36a 41.0, CH2 4.45, br m H-36b, NH (C) 35 H3-34, H-36b
36b 3.72, br m H-36a H3-34, H-36a
NH 7.10, ob H-36a H-38
N-Me-Leu 37 170.5, C
38 55.0, CH 5.26, br dd (7.6, 
6.7)
H-39a, H-39b 37, 39 H-39a, H3-41,
NH (C)
39a 37.3, CH2 1.77, m H-38, H-39b,
H-40
40 H-38, H3-41 38, 42
39b 1.56, ob H-38, H-39a 38, 40 H-38, H3-43 38, 42
40 24.7, CH 1.45, br m H-39a, H3-41,
H3-42
39, 42 39
41 23.0, CH3 0.93, d (6.6) H-40 39, 40, 42 H-39a, H-39b 38, 42
42 22.1, CH3 0.87, d (7.0) H-40 38
43 29.6, CH3 2.84, s H-39b, H-45a, H-45b
Gly 44 169.7, C
45a 42.0, CH2 4.38, br m H-45b, NH (D)
45b 3.75, br m H-45a
NH 6.96, br H-45a
Hmpa 46 170.2, C
47 77.5, CH 5.28, br d (5.6) H-48 1, 46, 48 H3-7, H-48, H3-50 48, 49, 50, 
51
48 37.2, CH 2.03, br m H-47, H3-51 H-47, H3-50
49a 24.4, CH2 1.59, ob H-49b, H3-50 H3-50
49b 1.49, m H-49a, H3-50 H3-51 48
50 11.5, CH3 0.88, t (5.6) H-49a, H-49b 48, 49 H-47, H-48, H-49a 48, 49
51 15.0, CH3 0.90, d (7.7) H-48 47, 48 H-49b 47, 48
ob = obscured
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76Abstract
  Cultivation of the marine cyanobacterium Moorea producens, collected from the 
Nabq  Mangroves  in  the  northern  tip of  the  Red Sea  (Gulf  of Aqaba), led  to  the 
isolation  of  the  potent  cytotoxins  apratoxin  A and  lyngbyabellin  B.  Furthermore, 
meticulous examination of the cytotoxic fractions revealed a new naturally occurring 
apratoxin analogue, apratoxin H (1), and a oxidized analogue, apratoxin A sulfoxide 
(2).  The  three-dimensional  structures of  compounds  1  and  2  were  determined  by 
chemical  degradation,  MS,  NMR,  and CD spectroscopy. Apratoxin H (1)  contains 
pipecolic acid in place of the proline residue present in apratoxin A, expanding  the 
naturally occurring  analogues that display amino  acid  substitutions within the  final 
module  of  the  apratoxin  biosynthetic  pathway.  Apratoxin  A  sulfoxide  (2)  was 
considered  as  a  possible  isolation  artifact,  however  experimental  oxidations  of 
apratoxin A did not generate apratoxin A sulfoxide. Although the structural differences 
between  compounds  1  and  2  relative  to  the  previously  reported  apratoxins  are 
minimal, their cytotoxicity to human NCI-H460 lung cancer cells (IC50 = 3.4 and 89.9 
nM, respectively) provides further insight into the structure–activity relationships of 
the  apratoxin  family.  Finally,  phylogenetic  analysis  of  the  apratoxin-producing 
cyanobacterial  strains  belonging  to  the  genus  Moorea,  coupled  with  the  recently 
annotated  apratoxin  biosynthetic  pathway,  reveals  that  apratoxin  production  and 
structural diversity may be regulated by key environmental  factors specific to their 
geographical niche.
77Introduction
  Marine  cyanobacteria  are  capable  of  producing  series  of  closely related  and 
highly bioactive  secondary metabolites,  often  of  mixed  biosynthetic  origin,  with 
unique  cancer cell  toxicity profiles. A number of these  compounds have served  as 
therapeutic lead compounds in cancer clinical trials (Simmons et al., 2005). Notably, 
Adcetris®  (SGN-35,  brentuximab  vedotin),  a  synthetic  dolastatin  10  analogue 
(monomethyl  auristatin  E)  conjugated  to  an  anti-CD30  monoclonal  antibody 
(Francisco et al., 2003), has been granted accelerated approval by the U.S. Food and 
Drug  Administration  for  treatment  of  Hodgkin  lymphoma  (HL)  and  systemic 
anaplastic large cell lymphoma (ALCL; “Seattle Genetics,” 2013).
  Recently,  the  depsipeptide  scaffold  of  the  apratoxin  series  of  secondary 
metabolites, produced by several tropical marine cyanobacterial species of the Moorea 
genus (formerly classified as Lyngbya bouillonii, L. majuscula and L. sordida), has 
become an attractive platform for synthetic efforts aimed at developing  more potent 
and selective analogues, given their subnanomolar activity to several cancer cell lines 
and unique mechanism of action (Chen et al., 2011; Y. Liu et al., 2009;  Ma  et al., 
2006). Importantly, apratoxin A is the  first antitumor agent identified  to inhibit the 
cellular  secretory  pathway  by  preventing  the  N-glycosylation  and  subsequent 
cotranslational translocation of several cancer-associated receptors (including receptor 
tyrosine kinases, RTKs) and secreted proteins (e.g. growth factors and cytokines) from 
the cytoplasm to the endoplasmic reticulum (ER), leading to their rapid proteasomal 
degradation (Y.  Liu  et al., 2009).  In  agreement  with  this  proposed mechanism  of 
action,  Luesch  and  colleagues  (2011)  subsequently synthesized  an  apratoxin A/E 
hybrid  analogue  with greater potency and efficacy. This synthetic  hybrid  not only 
depleted  cellular  levels  of  the  tyrosine  kinase  receptors  VEGFR-2  (vascular 
endothelial  growth  factor  receptor)  and  PDGFR-β  (platelet-derived  growth  factor 
receptor, β polypeptide) in mouse colorectal carcinomas (HCT116 xenograft), but also 
78displayed  a  marked  reduction  in  toxicity  compared  to  apratoxin  A.  Apratoxin  A 
suppression  of  cotranslational  translocation  is  somewhat  specific  in  that  it 
downregulates a relatively small subset of associated cell-surface proteins (66 of 476 
identified) and RTKs in  U2OS  osteosarcoma cells (Liu  et al., 2009).  However, its 
selectivity may be further enhanced through the identification of additional apratoxin 
analogues and medicinal chemistry studies.
  Our  focus  on  microorganisms from  unique  marine  environments  lead  to  the 
identification of a new Moorea producens strain (RS05) that shares 98.9% sequence 
homology (SSU 16S rRNA gene) with the reported apratoxin-producing strains from 
Guam  and Palau. Furthermore, preliminary data  showed that this Red Sea Moorea 
producens  RS05  strain  produced  several  compounds  within  the  apratoxin  family. 
Thus, monophyletic cultures of Moorea producens RS05 were established and grown 
over the span of two years, which yielded a new apratoxin analogue along with the 
known compounds apratoxin A and lyngbyabellin  B.  Here we  report the isolation, 
structure determination and biological activity of  apratoxin H (1), and apratoxin A 
sulfoxide (2).
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80Results and Discussion
  In 2007, A dark brown filamentous “Lyngbya” cyanobacterium was collected by 
hand from the shallows of the Nabq Mangrove in the Gulf of Aqaba near Sharm el-
Sheikh,  Egypt.  Microscopically,  this  cyanobacterium  contained  long,  unbranched   
filaments with wide  discoid  cells  that were  contained  within  thick  polysaccharide 
sheaths, which is consistent with the  description of Moorea producens sp. nov. (N. 
Engene et al., 2012). A unialgal culture, established through repetitive isolation and 
subculturing of individual trichomes, as previously described (Thornburg et al., 2011), 
was maintained in laboratory culture and used to propagate multiple large cultures (30 
× 1.5 L) over the span of two years. A crude organic extract of the Red Sea Moorea 
producens  RS05  was  subjected  to  bioassay-guided  fractionation  via  normal  phase 
vacuum liquid chromatography (NP-VLC) using a stepped solvent gradient of hexanes 
to  EtOAc  to  MeOH.  The  fractions  eluting  with  100%  EtOAc  and  25%  EtOAc–
hexanes were  highly toxic  to brine  shrimp (0.1 µg/mL  resulted  in  100% kill) and 
yielded  two minor  components (1,  3.5 mg  and  2, 0.9  mg),  as well  as the  known 
cytotoxic  macrolide  lyngbyabellin B (4.6 mg) and the highly cytotoxic  lipopeptide 
apratoxin A (41.0 mg) as the major component, following  C18 solid-phase extraction 
and exhaustive RP-HPLC.
  The  1H  and  13C  NMR  spectra  for 1  and  2 were  very similar to apratoxin  A 
(Hendrik  Luesch  et al., 2001)  from  a  Moorea sp. (previously reported as Lyngbya 
majuscula and Lyngbya bouillonii) collected from Apra Harbor, Guam. In particular, 
the  1H NMR spectrum  showed two mutually coupled aromatic proton doublets (δH 
7.17, 6.82), indicating  the presence of a para-disubstituted benzene, one NH doublet 
(δH 6.05), a putative  methoxy group (δH 3.79), two N-methyl substituents (δH  2.71, 
2.79) and a 9H methyl singlet (δH 0.89) characteristic of a tert-butyl group. However, 
HRTOFMS  data  suggested  a  molecular  formula  of  C46H71N5O8S  ([M +  H]+  m/z 
854.5074) for 1 and C45H69N5O9S ([M + H]+ m/z 856.4897) for 2, which putatively 
81differed  from  apratoxin  A  by  a  methylene  and  an  oxygen  atom,  respectively. 
Furthermore, the HRMS data did not correspond to any of the known apratoxins (A–
G; Figure 3.1), suggesting  the isolation of two new apratoxin A analogues from the 
Red Sea Moorea producens strain. Analysis of the 2D NMR spectra (HSQC, HMBC, 
COSY, ROESY) for compounds 1 and 2 showed that 2 shared the same sequence of 
subunits  as  apratoxin  A,  while  1  possessed  identical  spin  systems  and  planar 
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Figure 3.1. Apratoxins A–G.connectivities  for  the  PKS  moiety and  four  out of  the  five  amino  acid  units  of 
apratoxin A: N-Me-alanine (N-Me-Ala), modified cysteine (moCys), N-Me-isoleucine 
(N-Me-Ile) and O-methyl tyrosine (O-Me-Tyr). The HMBC and COSY experiments 
identified four contiguous methylene units within the  final spin system of 1 (Table 
3.1), attributable to the replacement of the proline residue in apratoxin A by pipecolic 
acid (Pip) in this new analogue designated apratoxin H (1).
  Although compound 2 shares the planar connectivity of apratoxin A, examination 
of the 1D and 2D NMR data for 2 (Supporting Information, Table S-3.1) showed a 
significant downfield shift for the 13C resonance of the methylene in the thiazoline (δ 
57.0, C-31) relative to both 1 (δ 37.6, C-32) and apratoxin A (δ 37.6, C-31; Luesch et 
al., 2001), suggesting  a  heteroatom  substitution or modification of the  neighboring 
sulfur  atom.  The  chemical  shift  of  the  equivalent C-2  carbon  in  an  oxazoline  is 
typically between 72.6 and  74.1  ppm  (Ireland et al., 1982;  Portmann et al., 2008). 
Thus, it is more likely that 2 contains an oxidized sulfur atom  within the modified 
cysteine  /  thiazoline  group,  which is consistent with  an  increase  of  16  mass units 
relative to apratoxin A. Therefore, we have assigned 2 as apratoxin A sulfoxide.
  To  further  examine  these  closely related  apratoxin  analogues  ESIMS3  studies 
were performed. Analysis of the fragmentation patterns observed for compounds 1 and 
2 relative to apratoxin A (Figure 3.2) shows that a pseudo c ion (m/z 725), resulting 
from ring opening  at the ester linkage and loss of Pip/Pro, is present in compound 1 
and apratoxin A. The subsequent loss of the polyketide subunit to leave a fragment of 
m/z 571 in compound 1 and apratoxin A, is followed by detection of a series of b ions 
due to loss of N-Me-Ile (m/z 444) and N-Me-Ala (m/z 359), which is consistent with 
previously reported cyclic peptide fragmentations that exhibit mostly b ions (W. Liu et 
al., 2009). Compound 2 yielded a minor fragmentation pattern that was identical to 
that of both  1  and apratoxin A,  suggesting  that compound 2  may share  the  same 
sequence as compound 1 and apratoxin A. However, the pseudo c ion in apratoxin A 
and  1  (Figure  3.2)  was  not  observed  for  compound  2.  Instead,  two  major 
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Table 3.1. NMR Spectroscopic Data for Apratoxin H (1) in CDCl3 (500 MHz).
unit position δC, mult. δH, mult. (J in Hz)a COSY HMBC ROESY
Pip 1 172.2, C –
2 54.4, CH 4.60, dd (7.0, 3.6) H-3a, H-3b 1, 3, 4, 6 H-3a, H-3b
3a 25.7, CH2 1.82, m H-2, H-3b H-2
3b 2.03, m H-2, H-3a 1, 5 H-2, H3-42/43/44
4a 19.2, CH2 1.36, m H-4b H-4b
4b 1.62, m H-4a 1, 5 H-4a
5a 24.3, CH2 1.56, m H-5a, H-6b H-5b
5b 1.82, m H-5b, H-6b 6 (w)c H-5a, H-6a
6a 43.1, CH2 3.50, m  H-5a, H-5b, 
H-6b
4 (w)c, 5 (w)c H-5b
6b 4.35, m H-6a 4, 5 H-8
N-Me-Ile 7 169.7, C –
8 54.4, CH 5.48, d (11.5) H-9 7, 9 H-6a, H3-12, H3-13
9 31.8, CH 2.29, m H-8, H-10b, 
H3-12
11 H-10b, H3-12, 
H3-13
10a 24.6, CH2 0.99, m H-9, H3-11 8, 11, 12 H-10b, H-9
10b 1.33, m H-9, H3-11 H-10a, H3-13
11 9.0, CH3 0.91, ob H-10b
12 14.5, CH3 0.92, ob H-9 8 H-8, H-9
13 30.4, CH3 2.71, s 8, 14 H-8, H-9, H-10b, 
H-15, H-19, OH
N-Me-Ala 14 169.6b, C –
15 60.8, CH 3.31, br m H3-16 H3-13, H3-17
16 14.0, CH3 1.25, d (6.7) H-15 14, 15 H3-17
17 36.7, CH3 2.79, s 15, 18 H-15, H3-16, H-19, 
H-22/26
O-Me-Tyr 18 170.5, C –
19 50.6, CH 5.06, ddd (10.9, 9.5, 
   4.8)
H-20a, 
H-20b, NH
18, 20, 21 H3-17, H-20a, NH
20a 37.3, CH2 2.88, dd (-12.4, 4.8) H-19, H-20b 18, 19, 21, 
22/26
H-20b, H-22/26
20b 3.14, dd (-12.4, 4.8) H-19, H-20a 18, 19, 21, 
22/26
H-20a, H-22/26
21 128.3, C –
22/26 130.6, CH 7.17, d (8.5) H-23/25 22/26, 23/25, 
24
H3-17, H-19, H-20a, 
H-20b, H-23/25
23/25 113.9, CH 6.82, d (8.6) H-22/26 21, 23/25, 24 H-22/26, H3-27
24 158.7, C –
27 55.3, CH3 3.79, s 24 H-23/25
NH 6.05, d (9.4) H-19 28 H-19, H3-3385
Table 3.1 (continued). NMR Spectroscopic Data for Apratoxin H (1) in CDCl3 (500 
MHz).
unit position δC, mult. δH, mult. (J in Hz)a COSY HMBC ROESY
moCys 28 169.6b, C –
29 130.5, C –
30 136.4, CH 6.36, br d (9.6) H-31, H3-33 28, 32, 33 H-31, H-32a, H-35
31 72.6, CH 5.23, ddd (9.4, 9.1, 
   4.5)
H-30, H-32a, 
H-32b
29, 30 H-30, H-32b, H3-33
32a 37.6, CH2 3.13, dd (-10.9, 4.7) H-31, H-32b 29, 31, 34 H-30, H-32b
32b 3.47, dd (-10.9, 8.7) H-31, H-32a 30, 31, 34 H-31, H-32a
33 13.4, CH3 1.97, s H-30 28, 29, 30, 
31d, 32
H-31, NH
polyketide 34 177.1, C –
35 48.8, CH 2.65, ob H-36, H3-45 34, 36, 45 H-30, H-36, H-37b, 
H3-45
36 71.7, CH 3.56, dddd (10.9, 10.6, 
   10.4, 3.0)
H-35, H-37a, 
H-37b, OH
H-35, H3-45, H3-46
37a 38.5, CH2 1.11, ddd (-13.8, 10.9,
   3.0)
H-36, H-37b, 
H-38
38 H-37b, H-38
37b 1.46, ddd (-13.7, 11.1, 
   4.0)
H-36, H-37a 35, 36, 38, 46 H-35, H-37a, H-38, 
H-40
38 24.5, CH 2.11, br m H-37a, H-39a, 
H3-46
H-37a, H-37b, 
H-39b, H3-46, OH
39a 37.8, CH2 1.26, ob H-38, H-39b, 
H-40
38 H-39b, H-40, 
H3-42/43/44
39b 1.79, m H-39a, H-40 37, 38, 40 H-38, H-39a, H-40, 
H3-42/43/44
40 77.4, CH 4.90, dd (12.7, 2.2) H-39a, H-39b 1, 39, 
42/43/44
H-37b, H-39a, 
H-39b, H3-42/43/44
41 34.9, C –
42/43/44 3 × 26.1, CH3 3 × 0.89, s 40, 41, 
42/43/44
H-3b, H-39a, 
H-39b, H-40
45 16.7, CH3 1.06, d (6.9) H-35 34, 35, 36 H-35, H-36
46 19.9, CH3 1.01, d (6.7) H-38 36d, 37, 38,   
39
H-36, H-38
OH – 4.40, d (10.9) H-36 36 H3-13, H-38
a J values obtained from 1H spectrum recorded at 700 MHz. b These carbons have the same chemical 
shift. c(w) indicates a weak correlation. d Four-bond HMBC correlation. ob = obscured.fragmentation pathways were observed, resulting from ring opening and fragmentation 
of  the  thiazoline  (Figure  3.3 A and  B;  Supporting  Information, Figure  S-3.18). A 
difference of 48 mass units (SO) between the two b ion series, coupled with an IR 
absorption  at  1031  cm-1 (S=O  stretching  vibration),  confirmed  the  presence  of  a 
sulfoxide  group  in  2.  For  most  cyclic  peptides,  fragmentation  occurs  following 
protonation of a peptide bond to open the macrocycle and give a linear form of the 
molecule with an acylium ion representing  the  C-terminus (Ngoka & Gross, 1999). 
However, in compound 2 it appears that oxidation of the thiazoline sulfur atom may 
86
O H
N
N
N
O
O
O
O
N
O
O
S
N
OH
O H
N
N
N
O
OH
O
S
N
H
O H
N
N
N
O
O
O
S
N
O+
H
O H
O+
O H
N
N
O
O
S
N
H
O+
O H
N
O
S
N
H
O+
Apratoxin A       
                1
                2
C-terminus "N"-terminus
n=1 [M + H]+ m/z 840.5
n=2 [M + H]+ m/z 854.5
n=1 [M + H]+ m/z 856.5
m/z 725.5
m/z 725.4
not observed
A       
1
2
A       
1
2
m/z 571.4
m/z 571.3
m/z 587.3
A       
1
2
m/z 444.2
m/z 444.1
m/z 460.2
A       
1
2
m/z 359.3
m/z 359.2
m/z 375.1
n
– Pro/Pip
– PK subunit
– N-Me-Ile
– N-Me-Ala
Figure 3.2. Schematic showing the fragmentation pattern of compounds 1 and 2 
relative to the major MS3 fragmentation pattern observed for apratoxin A.lead to an increase in ring strain and weakening of the carbon sulfur bond at C-33 due 
to the electron withdrawing properties of the oxygen atom.
  The  presence  of  a  thiazoline  sulfoxide  moiety  in  a  natural  product  is 
unprecedented in the  literature. However, several  prenylated quinones containing  a 
rare  1,1-dioxo-1,4-thiazine  ring  (Figure  3.4, Ascidiathiazone  A and  B)  have  been 
reported from marine ascidians (Pearce et al., 2007). Additionally, there are numerous 
reports of methionine sulfoxide or sulfone residues of putative biosynthetic origin in 
natural  products such  as leinamycin  from  a  Streptomyces  sp.  (Hara  et al.,  1989), 
dendroamide  C  from  the  epilithic  cyanobacterium  Stigonema  dendroideum Fremy 
(Ogino  et al., 1996),  tenuecyclamide  D isolated from  a  terrestrial  cyanobacterium 
Nostoc spongiaeforme var. tenue (Banker & Carmeli, 1998), waiakeamide from the 
Indonesian  sponge  Ircinia  dendroides  (Mau  et  al.,  1996),  haligramide  B  from  a 
Haliclona nigra  sponge  collected  in  Papua  New Guinea  (Rashid et al., 2000) and 
carriebowmide  from  the  marine cyanobacterium  “Lyngbya”  polychroa  (Figure  3.4; 
Gunasekera et al., 2008). Interestingly, Rashid et al. (2000) performed the oxidative 
conversion  of  haligramide  A  to  waiakeamide  in  order  to  compare  the  overall 
stereostructures of the two compounds, which suggests that waiakeamide may in fact 
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Figure 3.3. Assignment of MS3 fragmentation data for compound apratoxin A 
sulfoxide (2).
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31be an artifact rather than a natural product. However, Sera et al. (2003) later reported 
the  isolation of a  waiakeamide  derivative containing  a methionine-sulfoxide moiety 
along  with  a  methionine-sulfone  unit.  Notably,  the  selective  oxidation of  the  two 
methionine units within the haligramides was not observed by Rashid et al. (2000), 
suggesting  that  the  waiakeamide  sulfone  analogue  is  not  an  artifact.  In  contrast, 
Baumann  and  colleagues  (2007)  report  that  the  cyclic  octapeptide  planktocyclin 
undergoes oxidation of its methionine residue upon acidification of the HPLC eluents 
and during long term storage under atmospheric oxygen. Thus, it is possible that the 
sulfur  atom  of  methionine-containing  natural  products  undergoes  oxidation  under 
normal isolation and storage conditions.
  To examine the possibility that apratoxin A was oxidized to compound 2 during 
the isolation process, apratoxin A was treated with 30% aqueous hydrogen peroxide 
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Figure  3.4.  Marine  natural  products  of  putative  biosynthetic  origin  containing 
oxidized sulfur atoms.
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Leinamycinwith and without acetic acid according to the methods of Rashid et al. (2000; Figure 
3.5). Analysis of the reaction products of apratoxin A by RP18 HPLC-MS revealed the 
presence of apratoxin A and 3 (m/z [M + H]+ 906.4; [M + Na]+ 928.4; [M – H + 2Na]+ 
950.4; 1:1:1) in the ratio of 2.9:1 and 1.7:1 for treatments with and without acetic acid, 
respectively. A 1,1-dioxo-  or  1-oxo  thiazoline  (2)  was not detected  in  any of  the 
HPLC-MS  profiles,  suggesting  that the  sulfur  atom  within  the  thiazoline  is  fully 
oxidized  to  cysteic  acid  under  these  reaction  conditions.  Noteworthy  is  that  the 
haligramides contain a thiazole ring within their core structure that does not appear to 
undergo oxidation following  treatment with acetic  acid and 30% aqueous hydrogen 
peroxide for 6 h (Rashid et al., 2000). Although apratoxin A was unable to be oxidized 
to compound 2 under these reaction conditions, it is still possible that 2 was formed 
during  the  isolation  process  given  that  chlorinated  solvents  (CH2Cl2–MeOH,  2:1) 
become  weakly acidic  over  time.  In  fact,  E-dehydroapratoxin A (Figure  3.6)  is a 
derivative  that  is  presumed  to  form  from  the  acid-catalyzed  decomposition  of 
apratoxin A in CDCl3 (Luesch et al., 2002). However, E-dehydroapratoxin A was not 
detected within the fraction containing  compound 2. Alternatively, apratoxin A could 
undergo  posttranslational  modification  within  the  cyanobacterium  or  through  the 
actions of associated  heterotrophic  bacteria. The selective oxidation of a thiazoline 
moiety is intriguing and there is no evidence that 2 is an isolation artifact, particularly 
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Figure 3.5. Oxidation of apratoxin A.
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30 min., rtin  the  absence  of  any doubling  of  NMR  chemical  shifts  that  would  suggest  the 
presence  of  diastereomers  generated  by  non-enzymatic  oxidation.  Further 
investigation  of  the  function  of  some  of  the  uncharacterized  proteins  within 
biosynthetic pathway of the apratoxins (Grindberg  et al., 2011) may shed light onto 
their function and the possible biosynthetic origin of compound 2.
  The absolute configuration of the amino acid units within apratoxin H (1) and the 
sulfoxide analogue (2) were determined by RP18 HPLC-MS of the ozonolysis and acid 
hydrolysis products of 1 and 2 derivatized with N-α-(5-fluoro-2,4-dinitrophenyl-)-L-
leucinamide (Marfey’s reagent). Marfey’s analysis indicated the presence of N-Me-L-
Ala, D-Cya for an S configuration at the α-carbon, N-Me-L-Ile, O-Me-L-Tyr for 1 and 
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Figure 3.6. Semisynthetic  apratoxin analogue E-dehydroapratoxin A (Luesch et al., 
2002) along with the synthetic analogues of apratoxin A, apratoxin A/E hybrid (Chen 
et al., 2011) and oxoapratoxin A (Ma et al., 2006).2.  Additionally,  L-Pip  was  present  in  the  hydrolysate  of  1,  while  2  contained  a 
corresponding L -Pro  residue.  The  relative  configuration  of  the  polyketide  moiety 
(C33–C45) of apratoxin H (1) was determined to be the same as in apratoxin A based 
on little  to no  variation  in  the  13C  NMR  chemical  shifts (Figure 3.7 A), which  is 
consistent with the closely matching 1H NMR shifts and coupling constants [Table 3.1 
and (Luesch et al., 2001)]. Interestingly, the oxidized analogue (2) showed minor 13C 
chemical shift variations (< 1 ppm) relative to apratoxin A for the C35 chiral center 
and CH3-44 within the polyketide portion of the molecule (Figure 3.7 B), suggesting 
that oxidation of the sulfur atom alters the conformation of the thiazoline and adjacent 
carbon skeleton relative to  apratoxin A. However, these  chemical shift differences, 
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Figure  3.7.  Differential  13C  NMR  chemical  shifts  of  the  polyketide  moiety  in 
apratoxin A versus compounds 1 (A) and 2 (B).coupled with similar proton-proton coupling constants [Supporting Information, Table 
S-3.1 and (Luesch et al., 2001)] do not suggest a change in configuration at the C-34 
and C-35 chiral centers. The overall stereostructure of apratoxin H (1) and apratoxin 
A were further compared by circular dichroism (CD), which produced nearly identical 
negative and positive Cotton effects (CEs) near 236 and 210 nm, respectively (Figure 
3.8). However, the oxidized analogue (2) displayed a negative CE (ca. 236 nm) nearly 
3–fold smaller than apratoxin A and H (1). This effect is likely caused by a slight 
change in the overall conformation of the structure due to the oxidation of the sulfur 
atom within the thiazoline moiety.
Figure 3.8. CD spectra of apratoxin A, H (1) and apratoxin A sulfoxide (2).
  Apratoxin H (1) showed significant cytotoxicity to human NCI-H460 lung cancer 
cells (IC50 3.4 nM), which is comparable to the results obtained for apratoxin A in this 
study (IC50  2.5  nM;  Supporting  Information,  Figure  S-3.1).  The  small  difference 
(~1.4-fold) in cytotoxicity between 1 and apratoxin A is consistent with the results 
obtained for the Pro to N-Me-Ala substitution present in apratoxin F (Tidgewell et al., 
2010), indicating  that this region of the molecule is not critical for activity (Figure 
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Apratoxin A sulfoxide (2)3.9). However, a Pro to N-Me-Ala substitution in combination with an N-Me-Ile to N-
Me-Val  exchange  (apratoxin  G)  at  the  neighboring  position  results  in  a  7–fold 
reduction  in activity (Tidgewell  et al., 2010). Interestingly, a  subsequent medicinal 
chemistry study focused on substitutions within the peptide portion of the apratoxin A 
scaffold reports a 62–fold decrease in activity against HCT116 colorectal carcinoma 
cells  for  an  N-Me-Ile  to  N-Me-Ala  substitution  (AA4,  Figure  3.9).  In  contrast, 
incorporation of N-Me-Val at AA4 does not affect cytotoxicity (Chen et al., 2011), 
suggesting  that a more  bulky hydrophobic group (i.e. Ile or Val) is required at this 
position (Figure 3.9).
  The  thiazoline  S-oxidation  product (2) showed  a  nearly 36–fold  reduction  in 
cytotoxicity  against  human  NCI-H460  lung  cancer  cells  (IC50  89.9  nM),  while  a 
synthetic  oxazoline  analogue  of  apratoxin A  (Figure  3.6)  was  only 4.4–fold  less 
cytotoxic  to  HeLa  cervical  carcinoma  cells  than  apratoxin  A  (Ma  et  al.,  2006). 
Together,  these  results  suggest  that  apratoxin  cytotoxicity  is  sensitive  to  certain 
modifications  of the  moCys thiazoline  unit (C27–C32). Remarkably,  the  synthetic 
apratoxin A/E hybrid (Figure 3.6), which lacks the  allylic methyl group (C-32) and 
α,β-unsaturation  (∆  28),  shows  a  5.2–fold  increase  in  potency  against  HCT116 
colorectal  carcinoma  cells  and  less  nonspecific,  off-target  effects.  The  latter  is 
evidenced by greater in vivo tumor selectivity and a significant reduction of toxicity, 
which  may stem  from  the  inability to  form  conjugates  with  cellular  nucleophiles 
following  reduction of the  ∆  28 double bond (Chen  et al., 2011). Interestingly, the 
C-34 epimer of the  apratoxin A/E  hybrid (Figure 3.6) was equipotent (Chen et al., 
2011), which suggests that the conformational flexibility observed in the upper portion 
of the polyketide moiety in compound 2 does not affect the activity. Thus, it is likely 
that a loss of pi bond characteristics in the thiazoline ring through resonance between 
the imino unsaturation and the sulfoxide group may play a more critical role in the loss 
of activity for this analogue. Similarly, replacement of the proline residue (AA5) in 
apratoxin A with the  less rigid amino acid substituents present in apratoxin F and 
93compound 1 should afford greater conformational flexibility within the AA5 / tert-
butyl region of the apratoxin scaffold, which does not seemingly affect their activity 
(Figure 3.9). However, in the apratoxin A/E hybrid, a change in the C-2 configuration 
of  proline  resulted  in  a  226–fold  loss  of  cytotoxicity,  suggesting  that  the  overall 
stereostructure  within  this region of the molecule is critical  for potent cytotoxicity 
(Chen et al., 2011). Thus, medicinal chemistry efforts focused on further modifications 
of  the  thiazoline  and  proline  ring  systems  flanking  the  polyketide  portion  of  the 
apratoxin scaffold may fine tune apratoxin selectivity and potency and greatly enhance 
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Figure 3.9. Structure-activity relationships (SAR) profile of the apratoxins modified 
from  Tidgewell  et al.  (2010)  to  include  cytotoxicity data  for  1  and  2  relative  to 
apratoxin A, and the reported analogues. Individual units within the core structure of 
apratoxin  A  are  highlighted  to  show  whether  modifications  significantly  reduce 
activity (red), or show potency comparable with, or superior to, that of apratoxin A 
(green). * = indicates an indirect comparison across different cell lines. † = cytotoxicity 
relative to oxoapratoxin A.the  SAR  with  respect to  the  overall  geometry required  for  this  highly cytotoxic 
molecule.
  Apratoxins F, G and H (1) are the only naturally occurring apratoxin analogues 
containing  amino  acid  substitutions,  which  may  stem  from  relaxed  substrate 
specificity within the adenylation domains of their respective biosynthetic enzymes. 
Coincidentally, the enzyme responsible for conversion of L-lysine to L-pipecolate in 
the  biosynthesis  of  the  immunosuppressants  rapamycin  and  FK506  bears  a  close 
resemblance  to  ornithine  cyclodeaminases,  which  convert  L-ornithine  to  L-proline 
(Gatto et al.,  2006). The  ability of  the  final  module  of  the  apratoxin  biosynthetic 
pathway to activate and incorporate L-lysine and L-pipecolate is therefore plausible. 
However, the incorporation of N-Me-Ala at this terminal position in apratoxin F and G 
likely results from  changes  to  several  of  the  critical  binding  pocket  residues  that 
mediate  substrate  specificity or  the  presence  of  multiple,  cryptic  adenylation  (A) 
domains  (Challis  et  al.,  2000).  Consistent  with  these  observations,  the  recently 
annotated apratoxin  biosynthetic  gene cluster  from an apratoxin-producing  Moorea 
bouillonii  cyanobacterium  revealed that the final module contained two A-domains 
and a methyl transferase (MT; Grindberg  et al., 2011). The presence of a MT in this 
module explains the incorporation of an N-methyl group in apratoxin F and G, but not 
the final alanine residue. Furthermore, this MT is likely not functional in the apratoxin 
A pathway due to the specificity for proline of the neighboring A-domain. Although 
the functionality of the second domain could not be predicted accurately due to the 
absence of the highly conserved active site residue lysine (Grindberg et al., 2011), it is 
likely that such  a  deletion  accounts  for  the  relaxed  substrate  specificity observed 
within this domain.
  In  an  effort  to  characterize  the  evolutionary  relationship  of  the  apratoxin-
producing  strains  of  Moorea  sp.,  which  have  been  misidentified  historically  as 
Lyngbya bouillonii, Lyngbya majuscula and Lyngbya sordida (Engene et al., 2012), a 
phylogenetic  analysis  was  performed  utilizing  the  16S  rRNA gene  (Figure  3.10). 
95Noteworthy is that Apratoxins A–C were isolated from collections of Moorea sp. made 
from Guam and Palau (Luesch et al., 2002; Luesch et al., 2001), while collections of 
Moorea sp. inhabiting Papua New Guinea (Gutiérrez et al., 2008) and Palmyra Atoll 
(Tidgewell  et  al.,  2010)  have  afforded  apratoxins A–D  and  apratoxins  F  and  G, 
respectively (Figure  3.10).  Collectively,  these  strains,  coupled  with  our apratoxin-
producing  Red Sea Moorea sp., share  98.9% sequence  homology within their SSU 
16S  rRNA  gene,  suggesting  that  these  organisms  are  closely  related  species. 
Furthermore, this distinct cluster of Moorea spp. seemingly share a nearly identical 
biosynthetic  pathway for  the  production  of apratoxins,  which  is  likely due  to  the 
presence of putative transposases flanking  the boundaries of this biosynthetic cluster 
(Grindberg  et  al.,  2011),  leading  to  its  mobility  and  horizontal  gene  transfer. 
Remarkably, however, the apratoxins have only been reported from M. bouillonii, and 
M. producens, suggesting that the successful horizontal gene transfer of this relatively 
large (57.4 kb) biosynthetic gene cluster has either not occurred outside of this clade,   
or has thus far evaded detection. Additionally, transposase genes were not detected 
between  any of  the  genes  within  the  biosynthetic  cluster (Grindberg  et al., 2011). 
Thus, many of the apratoxin analogues have  likely resulted  from the activation  of 
several  cryptic  genes  within  the  apratoxin  biosynthetic  pathway,  which  are  likely 
regulated by environmental and epigenetic cues present within each organism’s unique 
niche. Furthermore, temporal changes in the production of secondary metabolites are 
often observed for many marine microorganisms and invertebrates as a  response to 
biotic interactions,  or  to preserve  primary biological  functions,  both of which vary 
seasonally (Esquenazi et al., 2011; Humair et al., 2009; López-Legentil et al., 2006). 
Luesch and co-workers (2008) reported the differential production of apratoxin A and 
a new analogue, apratoxin E, based on the depth from which a Guamanian Moorea 
bouillonii cyanobacterium was collected, and the presence or absence of the closely 
associated  red  alpheid  shrimp,  Alpheus  frontalis.  In  agreement  with  these 
observations, the Red Sea Moorea producens strain was grown in BG-11 medium that 
96had  been  modified  to  closely  resemble  the  relatively  extreme  environmental 
conditions of the cyanobacterium’s natural environment (pH 8.4 and salinity 41‰), 
which may have contributed to the production of the previously unreported apratoxin 
analogue, apratoxin H (1). Given the recent insights into the biosynthetic pathway of 
the apratoxins (Grindberg  et al., 2011), it is remarkable that relatively few apratoxin 
analogues  have  been reported  from  research groups  that have  focused intently on 
apratoxin-producing  strains of cyanobacteria. This may be due to different isolation 
schemes employed where these relatively minor analogues may be missed due to low 
abundance and/or complexity of the metabolite profile. Notably, additional apratoxin 
analogues  were  detected  in  our  extracts  of  the  cultured  Moorea  producens  RS05 
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Figure 3.10. Phylogenetic relationship of the apratoxin-producing cyanobacteria with 
other marine filamentous cyanobacteria based on SSU (16S) rRNA gene sequences. 
Labels on the terminal nodes indicate the taxa, strain, GenBank accession numbers in 
parenthesis, and collection sites for relevant strains. Reference (R) or type strains (T) 
are included within each cyanobacterial group. The support values at important nodes 
are  indicated  as  bootstrap  and  posterior  probability  for  the  maximum-likelihood 
(PhyML) and Bayesian inference (MrBayes) methods (* = bootstrap of > 98% and a 
posterior probability of 1.0).  Support values < 60 are  not indicated.  The  scale  bar 
indicates 0.04 expected nucleotide substitutions per site. cyanobacterium. However, these minor components were not able to be  purified in 
sufficient quantity. Thus, a more meticulous examination of extract components from 
this  and  other  apratoxin-producing  cyanobacteria  collected  with  temporal  and/or 
environmental  variations  in  mind  may reveal  additional,  more  diverse  apratoxin 
analogues.
98Experimental
  General  Experimental  Procedures.  Optical  rotations  were  measured  on  a 
JASCO P-1010 polarimeter. UV spectra and CD measurements were recorded using a 
JASCO J-815 spectropolarimeter. IR spectra  were  recorded on a Thermo Scientific 
Nicolet IR100 FT-IR Spectrometer. NMR data were acquired in CDCl3 referenced to 
residual CHCl3 chemical shifts (δC 77.2, δH 7.26) on a Bruker Avance III 700 MHz 
spectrometer equipped with a 5mm 13C cryogenic probe for compound 2. NMR data 
for 1 were acquired in CDCl3 on a Bruker Avance III 500 MHz spectrometer equipped 
with a 5 mm TXI probe. High-resolution mass spectrometry was performed in positive 
ion mode on an AB SCIEX Triple TOF 5600 mass spectrometer. LC-ESIMS3 data 
were  obtained  on  an  AB  SCIEX  3200  Q  TRAP mass  spectrometer.  HPLC  was 
performed using a Shimadzu dual LC-20AD solvent delivery system with a Shimadzu 
SPD-M20A UV/VIS photodiode array detector.
  Collection, Isolation and  Culture of the Red  Sea Moorea  producens  strain 
RS05. A dark brown filamentous assemblage of cyanobacteria was collected by hand 
using snorkel from the Nabq Mangroves (1 – 5 ft) in the Gulf of Aqaba near Sharm el-
Sheikh,  Egypt (N  27° 21.146'  E  33°  54.472')  on  May 31,  2007  (collection  code 
Nabq-4). Cyanobacterial isolation, morphological characterization and culturing  was 
performed as described previously (Thornburg et al., 2011).
  DNA Extraction, Amplification of Cyanobacterial 16S rRNA. Genomic DNA 
was  extracted  and  amplified  by  polymerase  chain  reactions  (PCR)  as  previously 
described  (Thornburg  et  al.,  2011).  The  16S  rRNA  partial  gene  sequences  were 
inspected visually and assembled using CAP3 (Huang & Madan, 1999). The resulting 
contig was analyzed for chimeric sequences using Pintail (Ashelford et al., 2005) and 
compared  to  sequences  in  the  Ribosomal  Database  Project  database  (http://
rdp.cme.msu.edu)  and  GenBank  (http://www.ncbi.nlm.nih.gov).  The  consensus 
sequence was deposited in GenBank under accession number JX470179.
99  Phylogenetic Analysis.  The  evolutionary relationship of the  Red  Sea Moorea 
producens strain with other groups of cyanobacteria was determined as described in 
Chapter Two of this thesis.
  Extraction and Isolation of Compounds 1, 2, Apratoxin A and Lyngbyabellin 
B. Culture collections of Moorea producens RS05 (30 × 1.5 L cultures) grown over a 
span of two years yielded 1.32 g  organic extract (CH2Cl2-MeOH, 2:1). The organic 
extract was subjected to bioassay-guided fractionation via NP VLC using  a stepped 
solvent gradient of hexanes to EtOAc to MeOH to produce nine fractions (A – I). The 
fractions eluting  with 20% EtOAc – hexanes (fraction F) and 100% EtOAc (fraction 
G) showed potent toxicity to brine shrimp and were  further separated C18 reversed-
phase (RP18) solid phase extraction (SPE) using a stepped solvent gradient from 60% 
MeOH-H2O  to  100%  MeOH,  followed  by  100%  CH2Cl2.  Isocratic  RP-HPLC 
(column: Synergi Fusion-RP, 10 x 250 mm, 90% MeOH-H2O, 3.5 mL/min) of the SPE 
fractions eluting in 80% MeOH-H2O for fraction F and G yielded lyngbyabellin B (4.6 
mg, tR = 5.9 min.) and three impure compounds from each fraction with matching UV 
profiles and retention times. Corresponding peaks were combined from each fraction 
and targeted for further purification by RP HPLC (Synergi Max, 4.6 x 250 mm) with 
80% MeOH-H2O (0.8 mL/min), yielding 2 (0.9 mg, tR = 14.1 min.), or 90% MeOH-
H2O (0.7 mL/min), yielding apratoxin A (41.0 mg, tR = 9.3 min.) and 1 (3.5 mg, tR = 
10.8 min). LC-MS  profiling  (Synergi  Fusion-RP,  2 x  100 mm, 0.2  mL/min, linear 
gradient of 65 to 100% MeCN in 0.1% (v/v) aqueous TFA) of fraction F also showed 
an  [M +  H]+  m/z  665/667/669  (100:75:20)  ion  cluster  and  [M +  H]+  m/z  826.2, 
suggesting a trace amount of hectochlorin and apratoxin B/C, respectively.
  Apratoxin H  (1):  white,  amorphous  solid;  [α]30D  –207 (c  0.10,  MeOH);  UV 
(MeOH) λmax (log ε) 195 (4.85), 226 (4.45), 284 (3.23); FTIR (neat) νmax 3428 (br), 
2962, 2934, 2874, 1738, 1626, 1512, 1456, 1385, 1280, 1247, 1180, 1074 cm-1; 1H and 
13C  NMR  data,  see  Table  3.1;  HRTOFMS  m/z  876.5041  [M  +  Na]+  (calcd  for 
100C46H71N5O8SNa,  876.4921),  m/z  854.5074  [M  +  H]+  (calcd  for  C46H72N5O8S, 
854.5102).
  Apratoxin A sulfoxide (2): white, amorphous solid; [α]30D –94 (c 0.10, MeOH); 
UV (MeOH) λmax (log  ε) 193 (4.67), 226 (4.26), 284 (3.14); FTIR (neat) νmax   3402 
(br), 2964, 2932, 2872, 1740, 1626, 1512, 1453, 1384, 1277, 1247, 1178, 1072, 1031 
cm-1;  1H and 13C NMR data, see Supporting Information (Table S-3.1); HRTOFMS m/
z 856.4897 [M + H]+ (calcd for C45H70N5O9S, 856.4894).
  Apratoxin A: white, amorphous solid; [α]30D –198 (c 0.10, MeOH); UV (MeOH) 
λmax (log ε) 193 (4.97), 226 (4.41), 269 (3.92); FTIR (neat) νmax 3422 (br), 2965, 2933, 
2876, 1742, 1625, 1512, 1456, 1385, 1277, 1248, 1180, 1074 cm-1; 1H and 13C NMR 
data,  see  Supporting  Information  (Figures  S-3.14  and  S-3.15);  HRTOFMS  m/z 
862.4666 [M + Na]+ (calcd for C45H69N5O8SNa, 862.4764), m/z 840.4927 [M + H]+ 
(calcd for C45H70N5O8S, 840.4945).
  Lyngbyabellin B:  white, amorphous solid;  [α]30D  –135  (c  0.10, MeOH);  UV 
(MeOH) λmax (log ε) 196 (4.48), 240 (3.98); HRTOFMS m/z 679.1775 [M + H]+ (calcd 
for C28H41Cl2N4O7S2, 679.1794).
  Absolute Configuration of Apratoxin H (1) and Apratoxin A sulfoxide (2). 
The amino acid standards relevant to compounds 1 and 2 were obtained commercially 
and  prepared as 50 mM solutions in  H2O. Each standard was then derivatized  for 
Marfey’s  analysis  by  adding  1  M  NaHCO3 ( 1 0  µL)  and  N-α-(5-fluoro-2,4-
dinitrophenyl-)-L-leucinamide (L-FDLA or D-FDLA, 1% w/v in acetone, 50 µL) to 25 
µL of each standard solution. The mixture was heated at 40 °C for 1 h with continuous 
stirring, cooled to  room temperature, acidified with  2N HCl  (5 µL),  evaporated to 
dryness and resuspended in 1:1 MeCN-H2O (250 µL).
  Approximately 0.4 mg  of 1 and 0.2 mg of 2 were dissolved separately in 3 mL 
CH2Cl2 (-78  °C).  Ozone was then bubbled through  each solution  for 15 min. The 
solution was dried under a stream of N2 gas, followed by an oxidative workup of the 
residue (0.6 mL of H2O2-HCOOH 1:2 at 70 °C for 20 min). The oxidation product was 
101concentrated  under vacuum and hydrolyzed with 6N HCl  (1 mL) in an Ace high-
pressure  tube,  1200W  microwave  for  50  s  and  immediately  cooled  to  0  °C  and 
evaporated  to  dryness.  The  hydrolyzed  products  were  resuspended  in  50  µL 
MeCN:H2O (1:10) and derivatized for Marfey’s analysis in a similar manner to the 
derivatized  chromatographic  standards.  The  Marfey’s  products  of  1  and  2  were 
resuspended in 1:1 MeCN-H2O (100 µL) and analyzed by LC-MS  (Kinetex  XB-C18 
110A, 4.6 x 100 mm, 2.6 µm, 1.5 mL/min, UV and ESIMS detection, 340 nm and 
negative  ion  mode,  respectively)  using  a  linear  gradient  of  30  to  70%  MeCN 
(containing 0.1% [v/v] formic acid) and 0.1% (v/v) formic acid in H2O over 15 min. 
The  retention  time  (tR  min, base  peak  m/z) of the residues in the  hydrolysate  of 1 
matched standards for N-Me-L-Ala  (5.29,  396.2), D-Cya  (2.12,  462.1),  N-Me-L-Ile 
(7.88, 438.2), L-Pip (7.10, 422.3) and O-Me-L-Tyr (7.20, 488.3). The retention times 
for the residues in the hydrolysate of 2 were consistent with the results for 1, with the 
exception  of  an  L-Pro  (4.54,  408.2)  standard  rather  than  L-Pip  matching  the 
corresponding residue in the hydrolysate of 2. The retention times (tR min, base peak 
m/z) of the other amino acid standards analyzed were: N-Me-D-Ala (5.49, 396.2), L-
Cya (2.22, 462.1), N-Me-D-Ile (9.48, 438.2), N-Me-L-allo-Ile (8.03, 438.2), N-Me-D-
allo-Ile (9.58, 438.2), D-Pip (6.56, 422.3), D-Pro (5.92, 408.2) and O-Me-D-Tyr (8.78, 
488.3).
  Biological Assays. Cytotoxicity of the  organic extract and crude fractions was 
evaluated against brine shrimp (Artemia salina) as previously described (Carballo et 
al., 2002; McLaughlin et al., 1998) with some modifications. Samples were added to 
24-well plates containing newly hatched (24 h) brine shrimp (10 to 15 per well) in 
artificial seawater at final concentrations ranging from 1 to 100 ppm. Brine shrimp 
toxicity was determined after a 24 h incubation period (28 °C) by counting the number 
of dead shrimp verses total number in each well.
  Cytotoxicity of the purified compounds was evaluated in human NCI-H460 lung 
cancer cells (ATCC, Manassas, VA) as previously described (Thornburg et al., 2011), 
102with minor modifications. Cells were seeded into 96-well plates (6,000 cells per well) 
in 50 µL of medium 12 h before treatment. Approximately 2 h before treatment, test 
samples were  generated  from  a  stock solution (6 mg/mL, 100%  DMSO)  that was 
serially diluted in serum-free medium. Following aspiration of seed growth medium, 
test samples (50 µL) were added to seeded cells at final concentrations ranging from 
0.00595 nM to 17.85 µM. Each 96-well plate also contained untreated and vehicle-
treated  control  cells.  Cell  viability  was  determined  after  48  h  treatment  using  a 
standard 3-(4,5-dimethylthiazol-2-yl)-2,5,diphenyly tetrazolium bromide (MTT) assay 
as previously described (Thornburg  et al., 2011). The cytotoxicity of  each  purified 
compound was assessed in at least three  independent cultures with the  viability of 
vehicle-treated control cells defined as 100% in all experiments. Dose response curves 
were  plotted  using  GraphPad  Prism®  (v5.0)  and  IC50  values  were  derived  from 
nonlinear regression analysis.
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Figure S-3.1. Dose-response curves of apratoxin A, apratoxin H (1) and the oxidized 
apratoxin A analogue (2) in the human NCI-H460 lung  cancer cell line (n = 3). Cell 
viability was assessed after 48 hours using a colorimetric MTT cell viability assay and 
is reported as the percentage of viable cells relative to the vehicle control.
106Table S-3.1. NMR Spectroscopic Data for Apratoxin A sulfoxide (2) in CDCl3 (700 
MHz).
unit position δC, mult. δH, mult. (J in Hz)a COSY HMBC ROESY
Pro 1 172.6, C
2 59.8, CH 4.22, br t (7.4) H-3a, H-3b 1, 3 H-3a, H-3b, H-4b
3a 29.5, CH2 1.90, m H-2, H-3b 1, 4 H-2
3b 2.26, m H-2, H-3a 1, 4, 5 H-2
4a 25.7, CH2 1.92, m H-5a, H-5b H-5b
4b 2.06, m H-5a, H-5b 2, 3 H-2, H-5b
5a 48.0, CH2 3.69, m H-4a, H-4b, 
H-5b
3, 4 H-5b, H-7
5b 4.18, m H-4a, H-4b, 
H-5a
3, 4 H-4a, H-4b, H-5a, 
H-7
N-Me-Ile 6 170.5, C
7 57.3, CH 5.23, d (11.5) H-8 6, 8 H-5a, H-5b, H-8, 
H3-12
8 32.2, CH 2.18, m H-7 H3-11 11 H-7, H3-11, H3-12
9a 25.0, CH2 0.99, m H-9b 10, 11 H-9b
9b 1.36, m H-9a, H3-10 H-9a, H3-10
10 9.6, CH3 0.95, d (7.5) H-9b 8, 9 H-9b
11 14.5, CH3 0.97, d (7.3) H-8 7, 8, 9 H-8
12 30.5, CH3 2.66, s 7, 13 H-7, H-8, H-14, 
H-29, OH
N-Me-Ala 13 170.2, C
14 60.8, CH 3.31, m H3-15 13, 15 H3-12, H3-15, H3-16
15 14.1, CH3 1.23, d (6.6) H-14 13, 14 H-14, H3-16
16 36.9, CH3 2.82, s 14, 17 H-14, H-18, H3-15, 
OH
O-Me-Tyr 17 170.5, C
18 50.8, CH 5.05, m H-19a, H-19b, 
NH
17, 19 H3-16, H-19a, H-19b, 
H-21/25, NH
19a 37.2, CH2 2.88, dd (-12.5, 4.5) H-18, H-19b 17, 18, 20, 
21/25
H-18, H-19b
19b 3.14, m H-18, H-19a 17, 18, 20, 
21/25
H-18, H-19a, NH
20 128.4, C
21/25 130.8, CH 7.17, d (8.5) H-22/24 19, 21/25, 
22/24, 23
H-18, H3-26
22/24 114.1, CH 6.80, d (8.5) H-21/25 20, 22/24, 
23
H3-26
23 158.9, C
26 55.5, CH3 3.79, s 23 H-21/25, H-22/24
NH 6.05, d (9.5) H-18 27 H-18, H-19b, H3-32
107Table S-3.1 (continued).  NMR Spectroscopic Data for Apratoxin A sulfoxide(2) in 
CDCl3 (700 MHz).
unit position δC, mult. δH, mult. (J in Hz)a COSY HMBC ROESY
moCys 27 169.5, C
28 133.8, C
29 135.0 5.90, d (9.9) H-30, H3-32 27, 30, 31, 
32
H3-12, H-30, H-31a, 
H-32
30 71.8, CH 5.70, m H-29, H-31a, 
H-31b
28, 29, 31, 
33 
H-29, H-31a, H-31b
31a 57.0, CH2 2.78, dd (-13.9, 5.7) H-30, H-31b 29, 30, 33 H-29, H-30, H-31b
31b 3.32, dd (-14.0, 5.9) H-31a 29, 33 H-30, H-31a
32 13.6, CH3 2.0, s H-29 27, 28, 29 H-29, H-30, NH
polyketide 33 177.2, C
34 48.7, CH 2.84, dq (10.5, 7.0) H-35, H3-44 33, 35, 44 H-35, H-36b, H3-44, 
OH
35 70.8, CH 3.89, dddd (11.1, 
   10.8, 10.5, 3.5)
H-34, H-36a, 
H-36b, OH
H-34, H-36a H3-44, 
H3-45, OH
36a 37.9, CH2 1.24, m H-35, H-36b, 
H-37
38 H-35, H-36b
36b 1.61, m H-35, H-36a, 
H-37
34, 36, 45 H-34, H-36a, H-39, 
OH
37 24.7, CH 2.12, m H-36a, H-36b, 
H-38b, H3-45
H-39, H3-45
38a 37.6, CH2 1.31, ob H-38b, H-39 37 H-38b, H-39
38b 1.82, m H-37, H-38a 36 H-38a, H-39
39 77.7, CH 4.98, dd (12.6, 2.2) H-38a 1, 40, 
41/42/43
H-36b, H-37, H-38a, 
H-38b, H3-41/42/43
40 35.1, C
41/42/43 3 × 26.3, CH3 3 × 0.89, s 39, 40, 
41/42/43
H-39
44 15.7, CH3 1.35, d (7.0) H-34 33, 34, 35 H-34, H-35
45 20.0, CH3 1.01, d (6.5) H-37  37, 38 H-35, H-37
OH 4.65, d (11.5) H-35 35 H3-12, H3-16, H-34, 
H-35, H-36b, H-37
 ob = obscured.
108 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
109
F
i
g
u
r
e
 
S
-
3
.
2
.
 
1
H
 
N
M
R
 
s
p
e
c
t
r
u
m
 
f
o
r
 
a
p
r
a
t
o
x
i
n
 
H
 
(
1
)
 
i
n
 
C
D
C
l
3
 
(
7
0
0
 
M
H
z
)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
110
F
i
g
u
r
e
 
S
-
3
.
3
.
 
1
3
C
 
N
M
R
 
s
p
e
c
t
r
u
m
 
f
o
r
 
a
p
r
a
t
o
x
i
n
 
H
 
(
1
)
 
i
n
 
C
D
C
l
3
 
(
1
2
5
 
M
H
z
)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
111
F
i
g
u
r
e
 
S
-
3
.
4
.
 
D
Q
F
 
C
O
S
Y
 
s
p
e
c
t
r
u
m
 
f
o
r
 
a
p
r
a
t
o
x
i
n
 
H
 
(
1
)
 
i
n
 
C
D
C
l
3
 
(
5
0
0
 
M
H
z
)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
112
F
i
g
u
r
e
 
S
-
3
.
5
.
 
M
u
l
t
i
p
l
i
c
i
t
y
-
e
d
i
t
e
d
 
H
S
Q
C
 
s
p
e
c
t
r
u
m
 
f
o
r
 
a
p
r
a
t
o
x
i
n
 
H
 
(
1
)
 
i
n
 
C
D
C
l
3
 
(
5
0
0
 
M
H
z
)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
113
F
i
g
u
r
e
 
S
-
3
.
6
.
 
H
M
B
C
 
s
p
e
c
t
r
u
m
 
f
o
r
 
a
p
r
a
t
o
x
i
n
 
H
 
(
1
)
 
i
n
 
C
D
C
l
3
 
(
5
0
0
 
M
H
z
)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
114
F
i
g
u
r
e
 
S
-
3
.
7
.
 
R
O
E
S
Y
 
s
p
e
c
t
r
u
m
 
f
o
r
 
a
p
r
a
t
o
x
i
n
 
H
 
(
1
)
 
i
n
 
C
D
C
l
3
 
(
5
0
0
 
M
H
z
)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
115
F
i
g
u
r
e
 
S
-
3
.
8
.
 
1
H
 
N
M
R
 
s
p
e
c
t
r
u
m
 
f
o
r
 
a
p
r
a
t
o
x
i
n
 
A
 
s
u
l
f
o
x
i
d
e
 
(
2
)
 
i
n
 
C
D
C
l
3
 
(
7
0
0
 
M
H
z
)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
116
F
i
g
u
r
e
 
S
-
3
.
9
.
 
1
3
C
 
N
M
R
 
s
p
e
c
t
r
u
m
 
f
o
r
 
a
p
r
a
t
o
x
i
n
 
A
 
s
u
l
f
o
x
i
d
e
 
(
2
)
 
i
n
 
C
D
C
l
3
 
(
1
7
5
 
M
H
z
)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
117
F
i
g
u
r
e
 
S
-
3
.
1
0
.
 
C
O
S
Y
 
s
p
e
c
t
r
u
m
 
f
o
r
 
a
p
r
a
t
o
x
i
n
 
A
 
s
u
l
f
o
x
i
d
e
 
(
2
)
 
i
n
 
C
D
C
l
3
 
(
7
0
0
 
M
H
z
)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
118
F
i
g
u
r
e
 
S
-
3
.
1
1
.
 
M
u
l
t
i
p
l
i
c
i
t
y
-
e
d
i
t
e
d
 
H
S
Q
C
 
s
p
e
c
t
r
u
m
 
f
o
r
 
a
p
r
a
t
o
x
i
n
 
A
 
s
u
l
f
o
x
i
d
e
 
(
2
)
 
i
n
 
C
D
C
l
3
 
(
7
0
0
 
M
H
z
)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
119
F
i
g
u
r
e
 
S
-
3
.
1
2
.
 
H
M
B
C
 
s
p
e
c
t
r
u
m
 
f
o
r
 
a
p
r
a
t
o
x
i
n
 
A
 
s
u
l
f
o
x
i
d
e
 
(
2
)
 
i
n
 
C
D
C
l
3
 
(
7
0
0
 
M
H
z
)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
120
F
i
g
u
r
e
 
S
-
3
.
1
3
.
 
R
O
E
S
Y
 
s
p
e
c
t
r
u
m
 
f
o
r
 
a
p
r
a
t
o
x
i
n
 
A
 
s
u
l
f
o
x
i
d
e
 
(
2
)
 
i
n
 
C
D
C
l
3
 
(
7
0
0
 
M
H
z
)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
121
F
i
g
u
r
e
 
S
-
3
.
1
4
.
 
1
H
 
N
M
R
 
s
p
e
c
t
r
u
m
 
f
o
r
 
a
p
r
a
t
o
x
i
n
 
A
 
i
n
 
C
D
C
l
3
 
(
7
0
0
 
M
H
z
)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
122
F
i
g
u
r
e
 
S
-
3
.
1
5
.
 
1
3
C
 
N
M
R
 
s
p
e
c
t
r
u
m
 
f
o
r
 
a
p
r
a
t
o
x
i
n
 
A
 
i
n
 
C
D
C
l
3
 
(
1
7
5
 
M
H
z
)
.H
N
N
N
O
O
O
O
N
O
O
S
N
O
H
O
D
E
F
A
C
B
-
H
2
O
 
b
5
F
A
 
(
F
E
D
C
B
)
 
a
4
F
E
 
(
E
D
C
B
)
 
b
4
C
D
 
(
C
B
A
F
)
 
b
3
F
E
 
(
E
D
C
)
 
b
3
B
C
 
(
B
A
F
)
 
b
2
F
E
 
(
E
D
)
 
b
4
F
A
 
(
F
E
D
C
)
 
b
3
F
A
 
(
F
E
D
)
 
b
0
4
F
A
 
b
0
3
F
A
 
b
2
B
A
 
(
A
F
)
 
123
F
i
g
u
r
e
 
S
-
3
.
1
6
.
 
A
n
n
o
t
a
t
e
d
 
M
S
/
M
S
 
s
p
e
c
t
r
u
m
 
o
f
 
a
p
r
a
t
o
x
i
n
 
A
 
[
c
o
l
l
i
s
i
o
n
 
e
n
e
r
g
y
 
(
C
E
)
,
 
2
5
;
 
d
e
c
l
u
s
t
e
r
i
n
g
 
p
o
t
e
n
t
i
a
l
 
(
D
P
)
,
 
3
3
;
 
e
n
t
r
a
n
c
e
 
p
o
t
e
n
t
i
a
l
 
(
E
P
)
,
 
1
0
;
 
T
 
=
 
4
0
0
 
°
C
]
.-
H
2
O
 
b
5
F
A
 
(
F
E
D
C
B
)
 
a
4
F
E
 
(
E
D
C
B
)
 
b
4
C
D
 
(
C
B
A
F
)
 
b
3
F
E
 
(
E
D
C
)
 
b
3
B
C
 
(
B
A
F
)
 
b
2
F
E
 
(
E
D
)
 
b
2
B
A
 
(
A
F
)
 
b
4
F
A
 
(
F
E
D
C
)
 
b
3
F
A
 
(
F
E
D
)
 
b
0
4
F
A
 
H
N
N
N
O
O
O
O
N
O
O
S
N
O
H
O
D
E
F
A
C
B
124
F
i
g
u
r
e
 
S
-
3
.
1
7
.
 
A
n
n
o
t
a
t
e
d
 
M
S
/
M
S
 
s
p
e
c
t
r
u
m
 
o
f
 
a
p
r
a
t
o
x
i
n
 
H
 
(
1
)
 
[
c
o
l
l
i
s
i
o
n
 
e
n
e
r
g
y
 
(
C
E
)
,
 
2
5
;
 
d
e
c
l
u
s
t
e
r
i
n
g
 
p
o
t
e
n
t
i
a
l
 
(
D
P
)
,
 
3
3
;
 
e
n
t
r
a
n
c
e
 
p
o
t
e
n
t
i
a
l
 
(
E
P
)
,
 
1
0
;
 
T
 
=
 
4
0
0
 
°
C
]
.-
H
2
O
 
b
4
B
A
 
(
E
2
,
3
D
C
B
)
 
b
’
4
B
A
 
(
E
3
D
C
B
)
 
b
5
D
C
 
(
C
B
A
F
E
1
)
 
b
4
C
B
 
(
B
A
F
E
1
)
 
b
3
B
A
 
(
E
2
,
3
D
C
)
 
b
’
3
B
A
 
(
E
3
D
C
)
 
b
2
B
A
 
(
E
2
,
3
D
)
 
b
’
2
B
A
 
(
E
3
D
)
 
b
3
B
A
 
(
A
F
E
1
)
 
a
4
F
E
 
(
E
1
-
3
D
C
B
)
 
b
3
F
E
 
(
E
1
-
3
D
C
)
 
H
N
N
N
O
O
O
O
N
O
O
S
N
O
H
R
i
n
g
 
o
p
e
n
i
n
g
 
/
 
I
n
i
t
i
a
l
 
f
r
a
g
m
e
n
t
a
t
i
o
n
O
D
E
3
F
A
C
B
O
R
i
n
g
 
o
p
e
n
i
n
g
 
/
 
I
n
i
t
i
a
l
 
f
r
a
g
m
e
n
t
a
t
i
o
n
E
1
E
2
125
F
i
g
u
r
e
 
S
-
3
.
1
8
.
 
A
n
n
o
t
a
t
e
d
 
M
S
/
M
S
 
s
p
e
c
t
r
u
m
 
o
f
 
a
p
r
a
t
o
x
i
n
 
A
 
s
u
l
f
o
x
i
d
e
 
(
2
)
 
[
c
o
l
l
i
s
i
o
n
 
e
n
e
r
g
y
 
(
C
E
)
,
 
2
5
;
 
d
e
c
l
u
s
t
e
r
i
n
g
 
p
o
t
e
n
t
i
a
l
 
(
D
P
)
,
 
3
3
;
 
e
n
t
r
a
n
c
e
 
p
o
t
e
n
t
i
a
l
 
(
E
P
)
,
 
1
0
;
 
T
 
=
 
4
0
0
 
°
C
]
. References
Ashelford, K. E., Chuzhanova, N. A., Fry, J. C., Jones, A. J., & Weightman, A. J. 
(2005). At Least 1 in 20 16S rRNA Sequence Records Currently Held in Public 
Repositories Is Estimated To Contain Substantial Anomalies. Appl. Environ. 
Microbiol., 71(12), 7724-7736.
Banker, R., & Carmeli, S. (1998). Tenuecyclamides A−D, Cyclic Hexapeptides from 
the  Cyanobacterium  Nostoc spongiaeforme var. tenue. J. Nat. Prod., 61(10), 
1248-1251.
Baumann, H. I., Keller, S., Wolter, F. E., Nicholson, G. J., Jung, G., Süssmuth, R. D., 
&  Jüttner,  F.  (2007).  Planktocyclin,  a  Cyclooctapeptide  Protease  Inhibitor 
Produced by the  Freshwater Cyanobacterium Planktothrix  rubescens. J. Nat. 
Prod., 70(10), 1611-1615.
Carballo,  J.,  Hernandez-Inda,  Z.,  Perez,  P.,  &  Garcia-Gravalos,  M.  (2002).  A 
comparison between two brine shrimp assays to detect in vitro cytotoxicity in 
marine natural products. BMC Biotechnol., 2(1), 17.
Challis, G. L., Ravel, J., & Townsend, C. A. (2000). Predictive, structure-based model 
of  amino  acid  recognition  by  nonribosomal  peptide  synthetase  adenylation 
domains. Chem. Biol., 7(3), 211-224.
Chen,  Q.  Y.,  Liu,  Y.,  &  Luesch,  H.  (2011).  Systematic  Chemical  Mutagenesis 
Identifies  a  Potent  Novel  Apratoxin  A/E  Hybrid  with  Improved  in  Vivo 
Antitumor Activity. ACS Med. Chem. Lett., 2(11), 861-865.
Engene, N., Rottacker, E. C., Kaštovský, J., Byrum, T., Choi, H., Ellisman, M. H., 
Komárek, J., & Gerwick, W. H. (2012). Moorea producens gen. nov., sp. nov. 
and  Moorea  bouillonii  comb.  nov.,  tropical  marine  cyanobacteria  rich  in 
bioactive  secondary  metabolites.  Int.  J.  Syst.  Evol.  Microbiol.,  62(Pt  5), 
1171-1178.
Esquenazi, E., Jones, A. C., Byrum, T., Dorrestein, P. C., & Gerwick, W. H. (2011). 
Temporal  dynamics of natural product biosynthesis in marine cyanobacteria. 
Proc. Natl. Acad. Sci., 108(13), 5226-5231.
Francisco, J. A., Cerveny, C. G., Meyer, D. L., Mixan, B. J., Klussman, K., Chace, D. 
F.,  Rejniak,  S.  X.,  Gordon,  K. A.,  DeBlanc,  R.,  Toki,  B.  E.,  Law,  C.  L., 
Doronina, S. O., Siegall, C. B., Senter, P. D., & Wahl, A. F. (2003). cAC10-
vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and 
selective antitumor activity. Blood, 102(4), 1458-1465.
Gatto, G. J., Boyne, M. T., Kelleher, N. L., & Walsh, C. T. (2006). Biosynthesis of 
Pipecolic Acid by RapL, a Lysine Cyclodeaminase Encoded in the Rapamycin 
Gene Cluster. J. Am. Chem. Soc., 128(11), 3838-3847.
126Grindberg,  R. V.,  Ishoey,  T.,  Brinza, D.,  Esquenazi,  E.,  Coates,  R. C.,  Liu, W.-t., 
Gerwick,  L.,  Dorrestein,  P.  C.,  Pevzner,  P., Lasken,  R.,  &  Gerwick, W.  H. 
(2011). Single  Cell  Genome  Amplification Accelerates Identification of  the 
Apratoxin  Biosynthetic  Pathway  from  a  Complex  Microbial  Assemblage. 
PLoS ONE, 6(4), e18565.
Gunasekera, S. P., Ritson-Williams, R., & Paul, V. J. (2008). Carriebowmide, a New 
Cyclodepsipeptide  from  the  Marine  Cyanobacterium  Lyngbya polychroa. J. 
Nat. Prod., 71(12), 2060-2063.
Gutiérrez, M., Suyama, T. L., Engene, N., Wingerd, J. S., Matainaho, T., & Gerwick, 
W. H. (2008). Apratoxin D, a Potent Cytotoxic Cyclodepsipeptide from Papua 
New Guinea Collections of the Marine Cyanobacteria Lyngbya majuscula and 
Lyngbya sordida. J. Nat. Prod., 71(6), 1099-1103.
Hara, M., Asano, K., Kawamoto, I., Takiguchi, T., Katsumata, S., Takahashi, K., & 
Nakano,  H.  (1989).  Leinamycin,  a  new  antitumor  antibiotic  from 
Streptomyces;  producing  organism,  fermentation  and  isolation.  J.  Antibiot., 
42(12), 1768-1774.
Huang,  X.,  &  Madan,  A.  (1999).  CAP3:  A  DNA  Sequence  Assembly Program. 
Genome Res., 9(9), 868-877.
Humair,  B.,  Gonzalez,  N.,  Mossialos,  D.,  Reimmann,  C.,  &  Haas,  D.  (2009). 
Temperature-responsive  sensing  regulates  biocontrol  factor  expression  in 
Pseudomonas fluorescens CHA0. ISME J, 3(8), 955-965.
Ireland, C. M., Durso, A. R., Newman, R. A., & Hacker, M. P. (1982). Antineoplastic 
cyclic peptides from the marine tunicate Lissoclinum patella. J. Org. Chem., 
47(10), 1807-1811.
Liu, W. T., Ng, J., Meluzzi, D., Bandeira, N., Gutierrez, M., Simmons, T. L., Schultz, 
A. W., Linington, R. G., Moore,  B. S., Gerwick, W. H.,  Pevzner, P. A., & 
Dorrestein, P. C. (2009). Interpretation of Tandem Mass Spectra Obtained from 
Cyclic Nonribosomal Peptides. Anal. Chem., 81(11), 4200-4209.
Liu,  Y.,  Law,  B.  K.,  &  Luesch,  H.  (2009).  Apratoxin  A Reversibly  Inhibits  the 
Secretory  Pathway  by  Preventing  Cotranslational  Translocation.  Mol. 
Pharmacol., 76(1), 91-104.
López-Legentil,  S.,  Bontemps-Subielos,  N.,  Turon,  X.,  &  Banaigs,  B.  (2006). 
Temporal  Variation  in  the  Production  of  Four  Secondary Metabolites  in  a 
Colonial Ascidian. J. Chem. Ecol., 32(9), 2079-2084.
Luesch, H., Yoshida, W. Y., Moore, R. E., & Paul, V. J. (2002). New apratoxins of 
marine cyanobacterial origin from guam and palau. Bioorg. Med. Chem., 10(6), 
1973-1978.
Luesch, H., Yoshida, W. Y., Moore, R. E., Paul, V. J., & Corbett, T. H. (2001). Total 
Structure Determination of Apratoxin A, a  Potent Novel Cytotoxin from the 
127Marine  Cyanobacterium  Lyngbya  majuscula.  J.  Am.  Chem.  Soc.,  123(23), 
5418-5423.
Ma,  D.,  Zou,  B.,  Cai,  G.,  Hu,  X.,  &  Liu,  J.  O.  (2006).  Total  Synthesis  of  the 
Cyclodepsipeptide Apratoxin A and Its Analogues and Assessment of Their 
Biological Activities. Chem. Euro. J., 12(29), 7615-7626.
Matthew, S., Schupp, P. J., & Luesch, H. (2008). Apratoxin E, a Cytotoxic Peptolide 
from  a  Guamanian  Collection  of  the  Marine  Cyanobacterium  Lyngbya 
bouillonii. J. Nat. Prod., 71(6), 1113-1116.
Mau, C. M. S., Nakao, Y., Yoshida, W. Y., Scheuer, P. J., & Kelly-Borges, M. (1996). 
Waiakeamide, a Cyclic Hexapeptide from the Sponge Ircinia dendroides. The 
J. Org. Chem., 61(18), 6302-6304.
McLaughlin, J. L., Rogers, L. L., & Anderson, J. E. (1998). The Use of Biological 
Assays to Evaluate Botanicals. Drug Inf. J., 32(2), 513-524.
Ngoka, L., & Gross, M. (1999). A nomenclature  system  for labeling  cyclic peptide 
fragments. J. Am. Soc. Mass. Spectrom., 10(4), 360-363.
Ogino, J., Moore, R. E., Patterson, G. M. L., & Smith, C. D. (1996). Dendroamides, 
New  Cyclic  Hexapeptides  from  a  Blue-Green  Alga.  Multidrug-Resistance 
Reversing Activity of Dendroamide A. J. Nat. Prod., 59(6), 581-586.
Pearce, A. N., Chia, E. W., Berridge, M. V., Clark, G. R., Harper, J. L., Larsen, L., 
Maas, E. W., Page, M. J., Perry, N. B., Webb, V. L., & Copp, B. R. (2007). 
Anti-inflammatory  Thiazine  Alkaloids  Isolated  from  the  New  Zealand 
Ascidian Aplidium sp.:     Inhibitors of the Neutrophil Respiratory Burst in a 
Model of Gouty Arthritis. J. Nat. Prod., 70(6), 936-940.
Portmann, C., Blom, J. F., Kaiser, M., Brun, R., Jüttner, F., & Gademann, K. (2008). 
Isolation  of  Aerucyclamides  C  and  D  and  Structure  Revision  of 
Microcyclamide  7806A:  Heterocyclic  Ribosomal  Peptides from  Microcystis 
aeruginosa PCC 7806 and Their Antiparasite Evaluation. J. Nat. Prod., 71(11), 
1891-1896.
Rashid, M. A., Gustafson, K. R., Boswell, J. L., & Boyd, M. R. (2000). Haligramides 
A  and  B,  Two  New  Cytotoxic  Hexapeptides  from  the  Marine  Sponge 
Haliclona nigra. J. Nat. Prod., 63(7), 956-959.
Seattle Genetics. (2013). CD30-Directed Adcetris® (brentuximab vedotin).  Retrieved 
January 21, 2013, from www.seattlegenetics.com/adcetris
Sera, Y., Adachi, K., Fujii, K., & Shizuri, Y. (2003). A New Antifouling Hexapeptide 
from a Palauan Sponge, Haliclona sp. J. Nat. Prod., 66(5), 719-721.
Simmons, T. L., Andrianasolo, E., McPhail, K., Flatt, P., & Gerwick, W. H. (2005). 
Marine natural products as anticancer drugs. Mol. Cancer Ther., 4(2), 333-342.
Thornburg, C. C., Thimmaiah, M., Shaala, L. A., Hau, A. M., Malmo, J. M., Ishmael, 
J.  E.,  Youssef,  D.  T. A.,  &  McPhail,  K.  L.  (2011).  Cyclic  Depsipeptides, 
128Grassypeptolides D and E and Ibu-epidemethoxylyngbyastatin 3, from a Red 
Sea Leptolyngbya Cyanobacterium. J. Nat. Prod., 74(8), 1677-1685.
Tidgewell, K., Engene, N., Byrum, T., Media, J., Doi, T., Valeriote, F. A., & Gerwick, 
W. H. (2010). Evolved Diversification of a Modular Natural Product Pathway: 
Apratoxins F and G, Two  Cytotoxic  Cyclic  Depsipeptides  from  a  Palmyra 
Collection of Lyngbya bouillonii. ChemBioChem, 11(10), 1458-1466.
129Chapter Four
Leptochelin, a Cytotoxic Metal Ion Chelator from a 
Leptolyngbya Cyanobacterium
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130Abstract
  The cyclic depsipeptide leptochelin, isolated from a cyanobacterium of the genus 
Leptolyngbya, is a marine natural product with a uniquely modified chemical scaffold. 
The planar structure was established by a combination of NMR spectroscopy and mass 
spectrometry, including  1H-15N and 13C INADEQUATE 2D NMR data obtained from 
natural abundance and 13C-enriched samples, respectively. The absolute configuration 
has yet to be established due to a combination of unusual and diverse structural units 
including  2,4-diamino-3-hydroxy-2-methylpentanoic  acid  (DHMPA),  3-(2-chloro-1-
hydroxyethyl)-2-methyloxirane-2-carboxylic  acid,  glyceric  acid,  3-chlorosalicylic 
acid,  2-methylcysteine  and  bromo-phenylalanine.  Importantly,  a  Zn-leptochelin 
complex, which displays a significant increase in potency, provides evidence for the 
metal-binding  capability and  coordination  of several  key functional  groups within 
leptochelin.  Leptochelin  showed  selective  cytotoxicity  to  human  NCI-H460  lung 
cancer cells (IC50 = 153 nM) compared to HeLa cervical carcinoma cells (IC50 = > 1 
µM), and the metal-bound form was also significantly more potent against both cell 
lines, suggesting a unique metal-dependent mechanism.
131Introduction
  The enormous chemical diversity and biochemical specificity of natural product 
structures  have  long  been  recognized  as  superior  to  synthetic  and  combinatorial 
compounds  (Koehn  &  Carter,  2005).  Accordingly,  the  capacity  of  marine 
cyanobacteria to produce structurally diverse, highly bioactive secondary metabolites 
with  a  broad  spectrum  of  biological  activities  makes  them  a  logical  source  for 
obtaining chemically diverse natural products (Nunnery et al., 2010; Tidgewell et al., 
2010). More specifically, marine cyanobacterial natural products contain a high degree 
of  N-  and  C-methylation,  α/β-hydroxy acids,  ketide  extended  and  β-amino  acids, 
heterocycles,  and  halogen  atoms,  which  stem  from  the  convergence  of  multiple 
biosynthetic  pathways  (Sattely  et  al.,  2008).  The  production  of  such  a  diverse, 
multifunctional array of secondary metabolites, although energetically costly, provides 
a selective advantage to microorganisms living in dense communities and/or nutrient 
limited  environments  (Cronin,  2001).  However,  the  primary  function  of  many 
cyanobacterial metabolites remains largely unknown (Leao et al., 2012). 
  A number  of  distinct functional  groups within  a  given  metabolite  may  offer 
insight  into  its  primary  function.  For  example,  N-acyl  homoserine  lactones,  and 
variations thereof, are typically used as chemical signals within bacterial communities, 
while  metabolites  containing  catecholate,  carboxylate  or  hydroxamate  functional 
groups  dominate  marine  siderophores (Wright et al.,  2012).  Siderophores are  low 
molecular weight metabolites that facilitate iron uptake due to their high affinity for 
ferric  iron  (Fe3+),  an  essential  growth  factor  for phytoplankton,  cyanobacteria  and 
heterotrophic bacteria (Vraspir & Butler, 2009). In mammalian cells, the rate-limiting 
enzyme  in  DNA  synthesis,  iron-dependent  ribonucleotide  reductase  (RNR),  is 
activated by the generation and transfer of tyrosyl radicals between its two subunits 
(RNR1 and  RNR2), which occurs through reactions of  molecular oxygen with the 
diferric iron center of the RNR2 subunit (Richardson et al., 2009). An increase in RNR 
132activity in  neoplastic  cells  suggests  that iron  chelators may be  used  for  selective 
inhibition of tumor cell  growth (Shao et al., 2006).  Indeed,  several  iron chelators, 
originally developed for the treatment of iron overload due to transfusion-dependent 
anemias  (Payne  et  al.,  2008),  have  been  explored  as  potential  antitumor  agents. 
Desferrioxamine  B  (1,  DFO,  Desferal®)  is  a  siderophore  from  the  bacterium 
Streptomyces pilosus (Bickel et al., 1960) that has shown anti-proliferative activity in 
various  cancer  cells  (Richardson  et  al.,  2009).  However,  DFO  exhibits  poor 
bioavailability and failed to show anticancer activity in several clinical trials (Yu et al., 
2006).  Alternatively,  several  thiosemicarbazone-based  iron  chelators,  including 
Triapine® (2), Dp44mT (3) and derivatives thereof, have shown promise as anticancer 
agents  given  their  ability to  bind  intracellular  iron  and  generate  reactive  oxygen 
species (ROS), leading to either inactivation of RNR or apoptosis (Li et al., 2001; Liu 
et al., 1992; Lukmantara et al., 2013; Yuan et al., 2004).
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  Like iron, other trace metals such as cobalt (Co), nickel (Ni), copper (Cu) and 
zinc (Zn) are essential cofactors for enzymes and proteins in marine microorganisms 
(Wright et al., 2012). However, depending on their chemical speciation, trace metals 
that are vital for growth can also have toxic effects on various metabolic processes. 
Thus,  to  balance  their  positive  and negative  effects,  the  specificity and  degree  of 
complexation  of  a  trace  metal  with  a  given  chelator  is  critical  (Vraspir &  Butler, 
1332009).  For  example,  a  number  of  azole-containing  cyclic  peptides  from  marine 
cyanobacteria,  such  as  the  patellamides  (4,  Morris,  Jaspars  et  al.,  2001)  and 
grassypeptolides (5, Kwan et al., 2010; Figure 4.1), adopt unique conformations that 
allow them to preferentially bind Cu2+ and Zn2+ ions within their central cavities. The 
binding  of such redox-active metals may protect copper-sensitive organisms, as the 
complexed form of copper is less toxic (Vraspir & Butler, 2009), or it may serve as an 
activating  mechanism  to  confer  biological  activity on  the  complexing  metabolite 
(Kwan  &  Luesch,  2010). A prime  example  is  that  of  the  chemotherapeutic  agent 
bleomycin (6, Bleonoxane® = ~60% bleomycin A2 and ~30% bleomycin B2; Figure 
4.2),  from  the  terrestrial  actinomycete  Streptomyces  verticillus  (Umezawa  et  al., 
1966). The pyrimidine moiety of bleomycin (Figure 4.2), together with the bithiazole 
tail, binds DNA, while the metal-binding domain binds Fe(II) or Cu(I) and molecular 
oxygen  to  enable  sequence  selective  DNA binding  and  cleavage  (Chen  & Stubbe, 
2005).
  A potential  target of  Zn2+  chelators  are  metal-dependent histone  deacetylases 
(HDACs), which play a role in the global repression of gene transcription, including a 
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Figure 4.1. Structures of patellamides A and C with the thiazole (T), amine (A) and 
oxazole (O) nitrogens or TAO metal binding domains shown in red. The structurally 
similar grassypeptolides (5) are also capable of binding Cu2+ and Zn2+ ions.number  of  key  oncogenes  and  tumor  suppressor  genes  (de  Ruijter  et  al.,  2003; 
Haberland et al., 2009). Thus, inhibition of HDAC activity has broad implications for 
the reversal of aberrant acetylation levels associated with a variety of disease states, 
and several HDAC inhibitors have been evaluated clinically (Guan & Fang, 2010). A 
key feature of the more potent HDAC inhibitors is the presence of a functional group 
capable of binding the catalytic Zn(II) ion of HDAC. Perhaps the most potent inhibitor 
of  HDAC  enzymes  known  is  largazole  (7),  which  was  isolated  from  a  marine 
cyanobacterium Symploca sp. (Taori et al., 2008). Largazole shares a similar structure 
and mechanism of action to the HDAC inhibitor romidepsin (8, Istodax®), which was 
recently approved for the  treatment of  cutaneous T-cell lymphoma  (Guan &  Fang, 
2010). Notably, both structures are modified in vivo to yield a free thiol group capable 
of  binding  the  active  site  Zn(II)  ion  of  HDACs  (Figure  4.3;  Cole  et al.,  2011). 
However, the rigid thiazoline-thiazole ring system within the macrocycle of largazole 
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Figure 4.2. Structure of bleomycins (6) and derivates that comprise Bleonoxane®. The 
metal-binding region is in green with the coordinating nitrogen atoms shown in black. 
(Chen & Stubbe, 2005).provides an  ideal  conformation  for binding  the  opening  of the  HDAC  active  site, 
which may account for the observed specificity for class I isoforms (Hong & Luesch, 
2012).
  Based on the  diversity of functional groups capable of binding  trace metals, a 
large  number  of  marine  metabolites  are  proposed  to  function  as  metal  ligands. 
However, relatively few siderophore structures and metal chelators have been isolated 
from marine bacteria (Vraspir & Butler, 2009; Wright et al., 2012). In the course of 
investigating the biosynthetic capacity of laboratory-cultured cyanobacteria from the 
Red Sea, we have directly isolated a highly modified, halogenated depsipeptide (9) 
complexed with  Zn2+  from  a  Leptolyngbya  cyanobacterium,  as well as the  known 
brominated macrolide phormidolide (10, Williamson et al., 2002). Notably, the metal-
free compound was isolated previously by the Gerwick group (ca. 2001; Vulpanovici 
2003)  from  a  phormidolide-producing  Indonesian  Leptolyngbya  strain  that  shares 
99.9%  sequence  homology  with  our  Red  Sea  isolate.  Although  extensive  NMR 
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Figure 4.3. Structures of the potent HDAC inhibitors largazole (7) and romidepsin (8, 
Istodax®). The thioester linkage of largazole is hydrolyzed, while the disulfide bond of 
romidepsin is reduced in vivo to allow thiol-binding of the active site Zn2+ of HDACs. 
Identical portions of each structure are highlighted in red.spectroscopic data were obtained for this compound, including a 13C INADEQUATE 
NMR spectrum for a 13C-labeled sample, the planar structure was not fully assigned, 
and an acknowledged incorrect structure was presented (Vulpanovici, 2003). Here we 
report the resolved planar structure and biological activity of leptochelin (9) and the 
Zn2+  complexed  form,  the  latter  of  which  shows  a  2  to  4.5–fold  increase  in 
cytotoxicity against human NCI-H460 lung  cancer cells (IC50 = 73 nM) and HeLa 
cervical carcinoma cells (IC50 = 239 nM), respectively.
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137Results and Discussion
  A mat-forming marine cyanobacterium was obtained by hand using scuba from a 
hard coral substrate in the Red Sea. A glycerol-preserved portion of this collection was 
prepared for transport and later reanimated in our laboratory with enrichment medium 
as previously described (Thornburg  et al., 2011) to yield several live cyanobacterial 
isolates. One of these monoclonal isolates, Leptolyngbya sp. RS02, was cultured over 
the span of four years, and an organic extract of the culture material was subjected to 
bioassay-guided fractionation via normal phase vacuum liquid chromatography (NP 
VLC) using a stepped solvent gradient of hexanes to EtOAc to MeOH. The fractions 
eluting with 100% EtOAc (G) and 25% MeOH–EtOAc (H) were moderately toxic to 
brine  shrimp  (10  mg/mL  reduced  cell  viability  by  70  and  43%,  respectively). 
Therefore,  the  G  fraction  was  separated  by C18  reversed-phase  (RP)  solid-phase 
extraction (SPE) and RP-HPLC to yield the known inactive metabolite phormidolide 
(10, 16.0 mg) as the major component and a putative phormidolide analogue (0.1 mg) 
that was highly cytotoxic to mouse Neuro-2a neuroblastoma cells (30 µg/mL reduced 
cell  viability by 80%). In  our attempt to  isolate more  of  this active  phormidolide 
analogue from the less cytotoxic H fraction, an additional unrelated metabolite (9, 1.1 
mg) that was highly cytotoxic to human NCI-H460 lung cancer cells (IC50 = 73 nM) 
was discovered. 1H and 13C NMR data for the latter compound matched an extensively 
characterized  (NMR  and  MS),  yet  unresolved,  structure  from  a  phormidolide-
producing Indonesian Leptolyngbya sp. (Vulpanovici, 2003). However, a difference in 
mass, coupled with a distinct isotope pattern (Figure 4.4), suggested that our Red Sea 
Leptolyngbya compound was a zinc complexed form  of  the unresolved compound, 
which we have now named leptochelin (9) for its chelating properties. Notably, since 
the  original isolation of 9 (ca. 2001), several attempts to re-isolate  this structurally 
intriguing compound have been futile. This is likely due to the compound’s ability to 
form  metal  complexes,  which  alter  the  compound’s  behavior  with  respect  to  the 
138original isolation scheme. Thus, to directly compare the two compounds by MS and 
NMR more effectively, approximately 6.0 mg of uncomplexed compound 9 (stored at 
OSU)  was  supplied  by Dr.  W.  H.  Gerwick,  Scripps  institution  of  Oceanography, 
University of California, San Diego, and is gratefully acknowledged.
  Newly acquired HRTOFMS data for 9 showed a pseudomolecular ion [M + Na]+ 
at  m/z 895.0786  (∆  0.3  mDa)  and  a  complex  isotope  pattern  consistent  with  the 
presence of several heteroatoms (Figure 4.4). Analysis of this isotope pattern, coupled 
with  1H and 13C NMR data, established a molecular formula of C35H39N4O11SCl2Br, 
and implied 17 degrees of unsaturation. The atomic composition of the Zn-leptochelin 
molecular ion was established as C35H37N4O11SCl2BrZnNa from HRTOFMS data ([M 
– 2H + Zn + Na]+ m/z 956.9924, ∆ 0.0 mDa). Although the original NMR dataset 
(acquired  ~2002)  for  9 was quite  extensive, and obtained  on nearly 10–fold more 
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Figure 4.4.  HRTOFMS  spectra  showing  the  distinct isotope  patterns observed  for 
unbound/free leptochelin (9) and the Zn(II) adduct.
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Table 4.1. NMR Spectroscopic Data for Leptochelin (9) and Zn-Leptochelin in 
CDCl3.
No.
Leptochelin Leptochelin Zn-Leptochelin Zn-Leptochelin
No. δH, mult. (J in Hz)a δC or δN, mult.a δH, mult. (J in Hz) δC, mult.
1 178.9, C 179.0, C
2 85.4, C 84.3, C
3a 3.42, d (-11.7) 41.8, CH2 3.44, d (-11.7) 42.1, CH2
3b 3.59, d (-11.7) 3.59, d (-11.7)
4 1.45, s 22.9, CH3 1.47, s 22.6, CH3
N(1) 285.1b, N
5 176.8, C 176.3, C
6 61.5, C 61.6, C
7 3.67, d (8.1) 64.4, CH 3.72, d (8.2) 64.3, CH
8 3.92, m 75.4, CH 4.00, br m 75.0, CH
9a 3.72, m 37.8, CH2 3.79, dd (2.7, 8.6) 38.2, CH2
9b 3.88, m 3.93, dd (1.0, 10.2)
10 1.56, s 21.1, CH3 1.543, s 20.9, CH3
11 186.5, C 185.0, C
12 62.7, C 61.7, C
13 3.84, br 77.9, CH 3.86, d (2.7) 78.0, CH
14 4.51, m 50.2, CH 4.53, pd (7.6, 3.0) 50.3, CH
15 1.53, s 31.1, CH3 1.541, s 30.8, CH3
16 1.18, d (7.1) 15.4, CH3 1.16, d (7.6) 15.5, CH3
NH(2a) 1.52, obs 39.7c, NH2 1.63, obs
NH(2b) 3.29, obs 3.56, br d (-11.6)
OH-13 4.59, d (1.5) 4.64, br s
NH(3) 10.09, d (7.7) 121.0c, NH 10.16, d (7.7)
17 175.2, C 175.3, C
18 4.42, m 57.8, CH 4.41, ddd (3.6, 7.0, 11.0) 58.1, CH
19a 2.92, dd (2.4, 11.7) 37.1, CH2 2.93, dd (2.4, 11.7) 37.1, CH2
19b 3.26, dd (3.4, 14.4) 3.25, dd (3.5, 14.2)
20 135.7, C 135.7, C
21/25 7.22, d (8.2) 130.9, CH 7.24, d (8.3) 130.9, CH
22/24 7.46, d (8.2) 131.9, CH 7.47, d (8.3) 131.9, CH
23 121.0, C 121.0, C
NH(4) 8.07, d (7.0) 125.0c, NH 8.27, d (7.0)
26 173.0, C 172.9, C
27 4.509, m 67.4, CH 4.57, br dd (8.5, 9.5) 67.2, CH
28a 4.34, m 69.4, CH2 4.34, br dd (8.4, 8.4) 69.1, CH2
28b 4.44, m 4.46, br dd (8.8, 9.6)
29 171.0, C 170.5, C
30 117.9, C 118.5, C
31 165.0, C 165.6, C
32 111.2, C 109.8, C
33 7.58, dd (1.9, 7.8) 137.5, CH 7.59, dd (1.7, 7.4) 137.7, CH
34 6.30, t (7.8) 112.8, CH 6.30, t (7.8) 112.8, CH
35 7.62, dd (1.9, 7.8) 130.2, CH 7.62, dd (1.7, 8.1) 130.5, CH
OH-31
  NMR data recorded at 600 MHz for leptochelin (9) and 700 MHz for Zn-leptochelin.
  a Data for 1H and 13C obtained from Vulpanovici (2003).
  bAssigned from 15N-GHMBC (500 MHz). cAssigned from 15N-HSQC (600 MHz). obs = 
  obscured.compound,  the  1H  and  13C  NMR  spectra  for  Zn-leptochelin  exhibited  fewer 
overlapped signals compared to those  for unbound 9 (see Supporting  Information), 
which  is possibly due  to  a  more  rigid  conformation  provided  by the  bound  zinc 
species. Thus,  the  planar  structure  of  leptochelin  (9)  was  established  through  the 
combined  analysis  of  the  two  NMR  datasets  for  unbound  leptochelin  and  Zn-
leptochelin. Several distinct features were deduced from the 1H, 13C and multiplicity-
edited HSQC NMR spectra for Zn-leptochelin that suggested it was derived from a 
mixed  nonribosomal  peptide  synthetase  (NRPS)  and  polyketide  synthase  (PKS) 
biosynthetic  pathway (Table  4.1). These  included  the  presence  of  two  substituted 
aromatic spin systems (δH 6.3–7.62), two NH doublets (δH  8.27 and δH  10.16), two 
putative  α-H  multiplets  (δH  4.41  and  4.53),  four  methylenes  (δH  2.93–4.46),  six 
putative  ester/amide  carbonyl  13C  signals  (δC  170.5–185.0),  four  oxymethines  (δC 
64.3–78.0) and four methyl groups (δC 30.8, 22.6, 20.9, 15.5). Interpretation of COSY 
and  HMBC  correlations  (Supporting  Information,  Tables  S-4.1  and  S-4.2)  further 
defined the two aromatic spin systems as a para-substituted bromo-phenylalanine (4-
Br-Phe), indicated by two mutually coupled 2H doublets (δH 7.47 and 7.24), and a 3-
chloro-2-hydroxybenzoic  acid  (3-chlorosalicylic  acid,  3-CSA)  moiety.  An  HMBC 
correlation  to  the  benzoic  acid  carbonyl  resonance  (δC-29 170.5)  from  a  midfield 
methine multiplet (δH  4.57), in turn coupled to a midfield methylene  13C resonance 
(δC-28 69.1) and a second deshielded quaternary 13C signal (δC-26 172.9), was consistent 
with a 2,3-dihydroxypropanoic acid (Dhpa) residue connected to the chlorosalicylic 
acid moiety (Table A-4.2). The Dhpa carboxylate (C-26) was connected to the amino 
terminus  of  the  4-Br-Phe  residue  in  an  amide  linkage  on  the  basis  of an HMBC 
correlation from NH-4 (δH  8.27) to carbonyl C-26, thereby establishing  a portion of 
leptochelin (9) as –CSA–Dhpa–BrPhe–.
	
 Perhaps one of the most challenging features in the structural elucidation of the 
leptochelin  depsipeptide  (9)  was  the  presence  of  an  exceptionally high  number  of 
quaternary carbons, thereby limiting the amount of information obtained from typical 
1412D NMR  experiments (e.g. COSY, HMBC,  ROESY,  etc.) that could establish key 
1H-1H or  1H-13C connections for 9. Thus, a  13C-enriched sample of leptochelin (9), 
obtained by culturing the Indonesian Leptolyngbya sp. in medium supplemented with 
[U-13C] glucose (Vulpanovici, 2003) during the course of biosynthetic investigations 
of  phormidolide,  was subsequently used  to  acquire  an  INADEQUATE  experiment 
(Bax  et al., 1981). Analysis of the 13C-13C connectivities in this experiment allowed 
the  stepwise tracing  of adjacent carbon atoms in leptochelin (9). More specifically, 
connectivities  of  C-1  to  C-4,  C-5  to  C-10  and  C-11  to  C-16  visible  in  the 
INADEQUATE  spectrum  for  free  leptochelin  supported  several  key HMBC  and 
COSY  correlations  for  both  free  and  Zn-bound  leptochelin,  and  clarified  several 
ambiguous connections within the finally assigned unusual  fragments (Figure  4.5). 
From  the  data  acquired  for  Zn-leptochelin,  an  AB  spin  system  of  an  isolated 
methylene (δH-3 3.44/3.59) showed HMBC correlations to signals for the C-1 carbonyl 
(δC  179.0)  and  C-5  sp2-hybridized  quaternary  carbon  (δC  176.3),  establishing  a 
continuous connection from C-1 to C-10. Within this fragment, HMBC correlations 
from a methyl singlet (δH-4 1.47) to a midfield resonance for a quaternary carbon (δC-2 
84.3), the C-3 methylene and C-1 carbonyl  13C resonances, was consistent with the 
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Figure  4.5.  Selected  13C-13C  (INADEQUATE)  and  1H-15N  HMBC  correlations 
establishing  key fragments containing the 2,4-diamino-3-hydroxy-2-methylpentanoic 
acid unit (A) and the 4-methyl thiazoline/2-methyloxirane-containing fragment (B) in 
leptochelin (9).presence  of  an  α-methyl  thiazoline.  Further  indication  of  heterocyclization  at this 
position was evidenced by the downfield shift of the 15N resonance for N-1 (δN 285.1) 
relative to the two amide nitrogens (δN-3 121 and δN-4 125; Martin & Hadden, 2000) in 
the  15N  experiments  acquired  on  free  leptochelin.  Finally,  the  adjacent  2-
methyloxirane within the C-5 to C-10 portion of this fragment was proposed based on 
the  requirement for an additional unsaturation from  the molecular formula and  13C 
chemical shift data consistent with the attachment of an epoxide oxygen to C-6 (δC 
61.6) and C-7 (δC 64.3). For the C-11 to C-16 fragment (Figure 4.5), careful inspection 
of the HMBC and HSQC data, revealed two obscured 1H signals (δH 3.56 and 1.63) 
that  shared  a  mutual  COSY  correlation.  The  presence  of  a  primary  amine  was 
confirmed by an 15N-HSQC experiment acquired on unbound leptochelin (δH 3.29 and 
1.53 / δN 39.7; Supporting Information, Table S-4.1). Furthermore, HMBC correlations 
from the free amine 1H signal at δH 3.56 to deshielded quaternary carbon (δC-11 185.0), 
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Figure 4.6. Selected 2D NMR correlations connecting the macrocyclic backbone of 
leptochelin (9).midfield quaternary carbon (δC-12 61.7) and oxymethine (δC-13 78.0) resonances were 
consistent with a 1H-15N-gHMBC spectrum for free leptochelin. The latter showed a 
correlation  from  oxymethine  H-13  (δ 3.84)  to  the  shielded  free  amine  resonance, 
placing  the free amine moiety on C-12 geminal to CH3-15. Several key HMBC and 
ROESY  (supported  by  COSY  and  INADEQUATE)  correlations  established  the 
macrocyclic  backbone  and  led  to  the  proposed planar  structure  for  leptochelin  (9, 
Figure  4.6).  Notably,  an  HMBC  correlation  from  H-8  (δ  4.00)  to  a  deshielded 
quaternary  13C  resonance  (δC-11  185.0),  and  ROE  cross  peaks  observed  in  Zn-
leptochelin  between  the  H3-4  (δH  1.47),  H-27  (δH  4.57)  and  H2-28  (δH  4.34/4.46) 
established  the  two  ester  linkages  in  the  molecule.  Given  the  number  of  highly 
modified groups within this molecule, X-ray crystallographic analysis is likely the best 
method to determine the absolute configuration of the nine chiral centers, as well as 
the coordinating geometry for the bound zinc ion. However, attempts to obtain crystals 
of 9 large enough for X-ray crystallographic analysis have thus far failed. Despite this 
setback, there are several key differences in the  13C NMR chemical  shifts between 
unbound  9  and  the  zinc  bound  species  that indicate  possible  metal  binding  sites 
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Figure  4.7.  Differential  13C  NMR  chemical  shifts  for  leptochelin  (9)  and  Zn-
leptochelin (∆ = δC 9 ‒ δC Zn-9).(Figure  4.7).  Notable  are  the  13C  shift  variations  observed  at  the  C-2  thiazoline 
stereocenter, the free amine-substituted C-12 and neighboring carbonyl carbon C-11. 
In addition, the NH2 1H signals (δH  1.63/3.56) for Zn-leptochelin were shifted slightly 
downfield compared to those  for unbound 9 (δH  1.52/3.29). Overall, these chemical 
shift differences suggest that each  of  these  functional  groups  may coordinate  the 
binding of Zn2+ in leptochelin (9). Most intriguing is the 13C shift variation observed at 
C-32 (∆ 1.4 ppm), the chlorine-bearing aromatic carbon vicinal to the phenolic carbon 
(C-31) of  the  benzoic acid  moiety. Although the C-31  shift chemical  difference  is 
relatively minimal (< 0.5 ppm),  it is conceivable  that the C-31 ‒OH and the  C-32 
chlorine substituent may also coordinate Zn2+ in a manner similar to that of catechol-
containing siderophores. However, it is also possible that only the hydroxyl oxygen 
participates in the binding of Zn2+; in doing so, the change in electron delocalization 
around the aromatic ring  causes shielding  of C-32. Importantly, all of the  1H NMR 
signals observed in the spectrum for unbound 9 were also present in the spectrum for 
Zn-leptochelin  (Table  4.1),  suggesting  that  deprotonation  is  not  required  for  the 
binding of the zinc. Thus, the loss of two protons observed in the HRESIMS spectrum 
of Zn-leptochelin likely occurs during  the ionization process. However, it should be 
noted that the C-31 ‒OH 1H signal was not observed in either of the 1H NMR spectra. 
Nonetheless, the binding  of zinc by leptochelin is quite remarkable, considering  that 
the zinc ion remains bound throughout the chromatographic methods employed in our 
isolation  scheme.  This  is  further  supported  by  the  observation  of  two  clearly 
distinguishable  chromatographic  peaks  representing  both  leptochelin  and  Zn-
leptochelin A, as well as differences observed in their respective optical rotations, UV 
absorbances  and  CD  spectra  (Supporting  Information,  Figure  S-4.2),  which  is 
consistent  with  reported  literature  values  for  the  metal-bound  patellamides  and 
lissoclinamides (Morris, Jaspars, et al., 2001; Morris, Milne, et al., 2001).
  Leptochelin  (9)  possesses  a  diverse  array of  modified  structural  features  that 
likely stem from the interplay of a mixed NRPS/PKS biosynthetic pathway containing 
145multiple optional  domains and/or tailoring  enzymes.  Furthermore, 3-chlorosalicylic 
acid is probably derived from benzoic acid via the shikimate pathway (Dewick, 2009), 
which  undergoes  halogenation  at  some  point  during  or  post  assembly.  Another 
intriguing  structural element is the 4-methylthiazoline fused to the 2-methyloxirane-
containing  unit. Notably, a  methylated  thiazoline  was  not proposed  in the original 
structure (Vulpanovici, 2003). In fact, α-methyl  thiazolines have  only recently been 
reported  from  marine  cyanobacteria,  such  as in largazole  (Taori  et al., 2008),  the 
hoiamides  (Choi  et  al.,  2010),  and  grassypeptolides  D  and  E  from  our  group 
(Thornburg  et al., 2011). Remarkably, this is the second Red Sea  Leptolyngbya sp. 
identified  to  produce  methylated  thiazolines.  Thus,  to  gain  some  insight into  the 
taxonomic  relationship  of  our  different  α-methyl  thiazoline-producing  strains,  a 
phylogenetic  analysis  based  on  the  SSU  (16S)  rRNA  gene  sequences  from  the 
grassypeptolide-producing  Red  Sea  Leptolyngbya  sp.  RS03  (GenBank  acc.  no. 
JF518829), the leptochelin-producing Red Sea Leptolyngbya sp. RS02 (GenBank acc. 
no.  JX481735)  and  the  leptochelin-producing  Indonesian  Leptolyngbya  sp.  was 
performed. The analysis revealed a distinct cluster of Leptolyngbya spp. with a shared 
evolutionary history  (Figure  4.8).  Morphologically,  the  two  leptochelin-producing 
strains were identical to one another, which is supported by their identical 16S rRNA 
gene sequences. Noteworthy is that these two strains group closely with the marine 
Leptolyngbya reference strain Leptolyngbya ectocarpi ATCC 29409, which exhibits a 
thin  bright-red  mat  compared  to  the  thick  deep-purple  mats  of  the  leptochelin-
producing Leptolyngbya spp (see Appendix). Interestingly, a systematic classification 
of the grassypeptolide-producing strain, which exhibits small purple tufts that adhere 
to  the  bottom  of  the  culture  flask,  indicated  that  this  organism  is  Leptolyngbya 
ectocarpi  (Gomont)  Anagnostidis  et  Komárek  (Komárek  &  Anagnostidis,  2005; 
Thornburg  et al., 2011). However, this latter strain is evolutionarily distant from the 
reference  strain  compared  to  the  leptochelin-producers.  These  morphological 
146differences,  coupled  with  the  16S  rRNA  data,  further  support  the  need  for  the 
inclusion of phylogenetics into the taxonomic classification of cyanobacteria. 
  The less conserved internal transcribed spacer (ITS) region linking the 16S and 
23S  ribosomal  genes  has  been  used  to  probe  the  subgeneric  relationship  of 
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Figure 4.8. Phylogenetic relationship of the leptochelin-producing cyanobacteria with 
other marine filamentous cyanobacteria based on SSU (16S) rRNA gene sequences. 
Labels on the terminal nodes indicate the taxa, strain, GenBank accession numbers in 
parenthesis, and collection sites for relevant strains. Reference (R) or type strains (T) 
are included within each cyanobacterial group. The support values at important nodes 
are  indicated  as  bootstrap  and  posterior  probability  for  the  maximum-likelihood 
(PhyML) and Bayesian inference (MrBayes) methods (* = bootstrap of > 98% and a 
posterior probability of 1.0).  Support values < 60 are  not indicated.  The  scale  bar 
indicates 0.03 expected nucleotide substitutions per site.
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– / 0.73cyanobacteria  (Boyer et al.,  2001;  Otsuka  et al.,  1999).  Given that the  seemingly 
identical  leptochelin-producing  strains  of  Leptolyngbya  sp.  were  isolated  from 
geographically distant collection sites, yet maintained in the same culture laboratory, 
additional  housekeeping  genes  were  investigated  to  gain  further  insight into  their 
relatedness. These  included the  less conserved 16S–23S  ITS  region, as well as the 
RNA polymerase gamma subunit (rpoC1) gene. Although the sequence data for the 
16S–23S  ITS  region  did  show  several  base  pair  substitutions  (99.9%  sequence 
identity) between the two leptochelin-producing Leptolyngbya spp., we cannot rule out 
the  possibility  of  the  existence  of  multiple  rRNA  operons  within  these  strains. 
However, it should be noted that only one band of identical length was obtained for 
the 16S  plus ITS region for each isolate using several different primer sets. This is 
consistent with  the  presence  of  only a  single  rRNA operon  or  multiple  identical 
operons (Boyer et al., 2001).  Furthermore, the  rpoC1  gene sequence  was identical 
between the two strains. Thus, it is likely that these two Leptolyngbya spp. are the 
same  strain  isolated  from  geographically  distant  locations,  which  is  plausible 
considering that the ocean currents connecting the Indian Ocean to the Red Sea may 
serve as a biological corridor. This “transport” phenomenon may also be reflected in 
the  similarities  observed  between  our  apratoxin  H-producing  Red  Sea  Moorea 
producens strain RS05 (GenBank acc. no. JX470179) and the apratoxins F and G-
producing  Palmyra  Atoll  Moorea  bouillonii  strain  PAL08-16  (GenBank  acc.  no. 
GU111927), which share 99.5% sequence identity between their respective (SSU) 16S 
rRNA  genes.  Notably,  the  two  apratoxin-producing  strains  were  maintained  in 
different culture collections.
  Leptochelin (9) displayed potent cytotoxicity to human NCI-H460 lung  cancer 
cells (IC50 = 153 nM). In contrast, it was nearly 7–fold less cytotoxic to HeLa cervical 
carcinoma cells (IC50 = > 1.0 µM), suggesting  some level of cancer cell selectivity 
(Supporting  Information,  Figure  S-4.1).  Remarkably,  the  zinc  bound  form  of 
leptochelin resulted in a 2 to 4.5–fold reduction, respectively in IC50 values across for 
148the two cell lines. Thus, it is tempting to speculate that leptochelin may demonstrate a 
cell-specific, metal-dependent mechanism (e.g. inhibition of a specific metalloenzyme 
via  selective  chelation  of  its metal  cofactor),  and  a  non-specific  metal-dependent 
mechanism  of action, whereby an exogenously bound  zinc  ion  confers activity on 
leptochelin (e.g. through the generation of intracellular ROS via a redox mechanism). 
Importantly, ROS can activate several signaling cascades in mammalian cells, and thus 
either contribute to cellular proliferation or induce antiproliferative effects depending 
upon the cell type and concentration of individual reactive species (Storz, 2005). As 
such,  altering  the  redox  status of  cancer  cells has  become  an  attractive  target for 
anticancer  therapeutics.  For  example,  ATN-224  (choline  tetrathiomolybdate) 
selectively  chelates  the  copper  ion  in  superoxide  dismutase  1  (SOD1),  a  Cu/Zn-
dependent enzyme that regulates ROS in cells by converting superoxide anions (O2-) 
into  H2O2  and  O2  (P.  Huang  et  al.,  2000).  This  leads  to  an  inhibition  of  cell 
proliferation and angiogenesis in endothelial cells (Juarez et al., 2006). Noteworthy is 
that SOD1 is overexpressed in a number of human lung adenocarcinomas, including 
human lung cancer epithelial H460 cells (Somwar et al., 2011). Thus, possible SOD1 
inhibition by leptochelin would be predicted to lead to an increase in the steady-state 
levels of superoxide anion in the cell, which has been shown to decrease cell migration 
and invasion in H460 cells (Luanpitpong et al., 2010). Furthermore, the generation of 
mitochondrial-derived  ROS  is  an  early  and  necessary  event  for  the  initiation  of 
bortezomib-induced apoptotic signaling  in  H460 cells (Ling  et al., 2003). Lastly, it 
should be noted that the presence of both iron and copper bound species of leptochelin 
were identified during preliminary LC-MS profiling, but have not yet been obtained in 
pure  form.  Thus,  further  characterization  of  the  metal  binding  capabilities  of 
leptochelin with respect to selectivity and affinity may provide valuable information 
for  its  potential  cellular  target.  In  addition,  the  differential  activity  observed  for 
leptochelin,  coupled  with  the  numerous  potential  targets  of  metal  chelators, 
149necessitates  further  investigation  as  to  the  mechanism  of  action  and  cancer 
chemotherapeutic potential of leptochelin (9).
150Experimental
  General  Experimental  Procedures.  Optical  rotations  were  measured  on  a 
JASCO P-1010 polarimeter. UV spectra and CD measurements were recorded using a 
JASCO J-815 spectropolarimeter. IR spectra  were  recorded on a Thermo Scientific 
Nicolet IR100 FT-IR Spectrometer. NMR data for leptochelin were acquired in CDCl3 
referenced to residual CHCl3 chemical shifts (δC 77.2, δH 7.26) on a Bruker DRX 600 
MHz  spectrometer  (5mm  TXI  probe)  and  a  Bruker  DPX  400  MHz  spectrometer     
(Vulpanovici, 2003). 15N spectra were referenced to a 100 mM solution of formamide 
in CDCl3 (HCONH2 = 0 ppm). NMR data for Zn-leptochelin A were acquired in CDCl3 
on a Bruker Avance III 700 MHz spectrometer equipped with a 5mm  13C cryogenic 
probe and a  Bruker Avance  III 500 MHz spectrometer equipped with a  5 mm TXI 
probe. HRESIMS for each compound was performed in positive ion mode on an AB 
SCIEX Triple TOF 5600 mass spectrometer. Individual isotope patterns were analyzed 
using  the  Formula  Finder  tool  in  PeakView®,  a  stand-alone  software  package 
developed specifically for the AB SCIEX TripleTOF 5600 system. LC-ESIMS  data 
were  obtained  on  an  AB  SCIEX  3200  Q  TRAP mass  spectrometer.  HPLC  was 
performed using a Shimadzu dual LC-20AD solvent delivery system with a Shimadzu 
SPD-M20A UV/VIS photodiode array detector. 
  Collection,  Isolation  and  Culture  of  the  Red  Sea  Leptolyngbya s p .   strain 
RS02. A cyanobacterial  mat of apparent mixed assemblage  was  collected by hand 
using  scuba from a hard coral surface  (24–30 ft) in the Red Sea on May 26, 2007 
(collection  code  EHu-05-26-07-4).  Cyanobacterial  isolation,  morphological 
characterization and culturing  was performed as described previously (Thornburg  et 
al., 2011). For collection, isolation and culture of the Indonesian Leptolyngbya sp. see 
Vulpanovici (2003).
  DNA Extraction and Amplification of Cyanobacterial genes. Genomic DNA 
was extracted and 16S rRNA genes amplified by polymerase chain reactions (PCR) as 
151previously described  (Thornburg  et al.,  2011). The 16S–23S  ITS  region  was PCR 
amplified using the primers described in Boyer et al. (2001), and the RNA polymerase 
gamma-subunit (rpoC1) genes with the degenerate primers described in Engene et al. 
(2010):  LrpoC1-F  (5′-CYTGYTTNCCYTCDATDATRTC-3′)  and  LrpoC1-R  (5′-
YTNAARCCNGARATGGAYGG-3′). The 16S rRNA partial gene sequences and their 
respective ITS regions were inspected visually and assembled using CAP3 (X. Huang 
&  Madan, 1999).  The  resulting  contig  was analyzed for chimeric  sequences using 
Pintail (Ashelford et al., 2005) and compared to sequences in the Ribosomal Database 
Project  database  (http://rdp.cme.msu.edu)  and  GenBank  (http://
www.ncbi.nlm.nih.gov).  The  16S  rRNA  consensus  sequence  was  deposited  in 
GenBank under accession number JX481735.
 P h y l o g e n e t i c   A n a l y s i s .  T h e  e v o l u t i o n a r y  r e l a t i o n s h i p  o f  t h e  R e d  S e a  
Leptolyngbya strain with other groups of cyanobacteria was determined as described 
in Chapter Two of this thesis.
  Extraction and Isolation of Zn-leptochelin. Cultures of Leptolyngbya sp. RS02 
(10 × 1.5 L cultures grown for 6 months) were harvested by filtration on glass-fiber 
filters  and  extracted  in  organic  solvent  (CH2Cl2-MeOH,  2:1)  to  afford  2.05  g  of 
extract. The  organic  extract was  subjected to  bioassay-guided fractionation via NP 
VLC using a stepped solvent gradient of hexanes to EtOAc to MeOH to produce six 
fractions (A, C, E, G, H and I). The fraction eluting with 25% MeOH–EtOAC (H) was 
moderately toxic to brine shrimp and further separated by RP18 SPE using  a stepped 
solvent gradient of MeOH–H2O from 50% MeOH–H2O to 100% MeOH, followed by 
100% CH2Cl2. The RP18 SPE   fraction eluting  in 85% MeOH was subjected to RP-
HPLC using a combined isocratic and gradient profile (column: Synergi Polar-RP, 10 
x 250 mm, 75% MeOH-H2O for 30 min., increasing to 100% MeOH for 30 min., 3.0 
mL/min) to yield Zn-leptochelin A (1.1 mg, tR = 46.8 min.). LC-MS profiling (Synergi 
Fusion-RP,  2  x  100  mm,  0.2 mL/min, 70%  MeOH in 0.1% (v/v) aqueous FA)  of 
fraction H also showed an ion cluster for [M – 4H + Fe +Na]+ at m/z 947/949/951/953 
152suggesting the presence of Fe-leptochelin. Furthermore, a cluster spanning m/z 955 to 
965 [M – 2H + X +Na]+ suggested the presence of two overlapping  ion clusters for 
Zn2+ and Cu2+ bound species. However, only the Zn-bound form was isolated in our   
HPLC protocol. For the isolation of leptochelin (9) see Vulpanovici (2003).
  Leptochelin  (9):  white,  amorphous  solid;  [α]30D  –84.4  (c  0.10,  CHCl3);  UV 
(MeOH) λmax (log ε) 197 (4.77), 213 (4.57), 255 (4.14), 318 (3.55), 352 (3.37); FTIR 
(neat) νmax 3333 (br), 3241, 3004, 2921, 2849, 1678, 1611, 1529, 1466, 1379, 1243, 
1151, 1074, 1011 cm-1; 1H and 13C NMR data, see Table 4.1; HRTOFMS [M + Na]+ m/
z 895.0786 (calcd for C35H39N4O11SCl2BrNa, 895.0789).
  Zn-Leptochelin: clear, yellow glass; [α]30D –210.5 (c 0.10, CHCl3); UV (MeOH) 
λmax (log ε) 196 (4.81), 225 (4.56), 258 (4.16), 356 (3.77); FTIR (neat) νmax  3338 (br), 
2925, 1682, 1606, 1543, 1521, 1512, 1453, 1383, 1244, 1247, 1152, 1072, 1026 cm-1; 
1H and 13C NMR data, see Table 4.1; HRTOFMS [M – 2H + Zn + Na]+ m/z 956.9924 
(calcd for C35H37N4O11SCl2BrZnNa, 956.9924).
  Biological Assays. Cytotoxicity of the  organic extract and crude fractions was 
evaluated against brine shrimp (Artemia salina) as previously described (Carballo et 
al., 2002; McLaughlin et al., 1998) with some modifications. Samples were added to 
24-well plates containing newly hatched (24 h) brine shrimp (10 to 15 per well) in 
artificial seawater at final concentrations ranging from 1 to 100 ppm. Brine shrimp 
toxicity was determined after a 24 h incubation period (28 °C) by counting the number 
of dead shrimp verses total number in each well.
  Cytotoxicity of the purified compounds was evaluated in human NCI-H460 lung 
cancer  and  HeLa  cervical  carcinoma  cells  (ATCC,  Manassas,  VA)  as  previously 
described (Thornburg et al., 2011), with minor modifications. Cells were seeded into 
96-well  plates (5,000  cells per  well) in 50  µL of  medium  16  h  before  treatment. 
Approximately 2 h before treatment, test samples were generated from a stock solution 
(6 mg/mL, 100% DMSO) that was serially diluted in serum-free medium. Following 
aspiration of seed growth medium, test samples (50 µL) were added to seeded cells at 
153final  concentrations  ranging  from  0.01  nM to  10.0  µM.  Each  96-well  plate  also 
contained untreated  and vehicle-treated control  cells.  Cell  viability was determined 
after  48  h  treatment  using  a  standard  3-(4,5-dimethylthiazol-2-yl)-2,5,diphenyly 
tetrazolium  bromide (MTT) assay as previously described (Thornburg  et al., 2011). 
The cytotoxicity of each purified compound was assessed in at least three independent 
cultures  with  the  viability of  vehicle-treated  control  cells  defined  as  100%  in  all 
experiments. Dose response curves were  plotted using  GraphPad Prism® (v5.0) and 
IC50 values were derived from nonlinear regression analysis.
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155Supporting Information
156Figure  S-4.1.  The  dose  response  curves  for  leptochelin  (9)  and  Zn-leptochelin in 
human NCI-H460 (n = 3) and HeLa cervical carcinoma cell lines (n = 3). Cell viability 
was assessed  after 48  hours using  a  colorimetric  MTT cell  viability assay and  is 
reported as the percentage of viable cells relative to the vehicle control.
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157Figure S-4.2. CD (A) and UV (B) spectra for leptochelin (9, blue) and Zn-leptochelin 
(red).
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A
BTable S-4.1. NMR Spectroscopic Data for Leptochelin (9) in CDCl3.
No. δCa or δN, mult. δH, mult. (J in Hz)a HSQC-TOCSYa HMBCa 15N-HMBC INADEQUATEa
1 178.9, C 2
2 85.4, C 1, 3, 4
3a 41.8, CH2 3.42, d (-11.7) 2, 4, 5 N(1) 2
3b 3.59, d (-11.7) 1, 2, 4
4 22.9, CH3 1.45, s 1, 2, 3 N(1) 2
N(1) 285.1b, N
5 176.8, C 6
6 61.5, C 5, 7, 10
7 64.4, CH 3.67, d (8.1) 8, 9 6, 8, 9, 10 6, 8
8 75.4, CH 3.92, m 7, 9 7, 9, 11 7, 9
9a 37.8, CH2 3.72, m 7, 8, 9 7, 8 8
9b 3.88, m 7, 8, 11
10 21.1, CH3 1.56, s 5, 6, 7 6
11 186.5, C 12
12 62.7, C 11, 13, 15
13 77.9, CH 3.84, br 14, 16, NH(3) 15 NH(2), NH(3) 12, 14
14 50.2, CH 4.51, m 13, 16, NH(3) 12, 13, 16 13, 16
15 31.1, CH3 1.53, s 11, 12, 13 12
16 15.4, CH3 1.18, d (7.1) 13, 14, NH(3) 13, 14 NH(4) 14
NH(2a) 39.7c, NH2 1.52, obs
NH(2b) 3.29, obs 11, 12, 13, 14
OH-13 4.59, d (1.5)
NH(3) 121.0c, NH 10.09, d (7.7) 14, 16, 17
17 175.2, C 18
18 57.8, CH 4.42, m 19, NH(4) 17, 19, 26 17, 19
19a 37.1, CH2 2.92, dd (2.4, 11.7) 18 17, 18, 20, 21/25 NH(4) 18, 20
19b 3.26, dd (3.4, 14.4) 18, 20, 21/25 NH(4)
20 135.7, C 19, 21/25
21/25 130.9, CH 7.22, d (8.2) 19, 22/24, 23 20
22/24 131.9, CH 7.46, d (8.2) 20, 21/25, 23 23
23 121.0, C 22/24
NH(4) 125.0c, NH 8.07, d (7.0) 18, 19, 26
26 173.0, C 27
27 67.4, CH 4.509, m 26, 28, 29 26, 28
28a 69.4, CH2 4.34, m 26, 27, 29 27
28b 4.44, m 26, 27, 29
29 171.0, C
30 117.9, C 35
31 165.0, C 32
32 111.2, C 31
33 137.5, CH 7.58, dd (1.9, 7.8) 34 30, 31, 35 34
34 112.8, CH 6.30, t (7.8) 33, 35 30, 32 33, 35
35 130.2, CH 7.62, dd (1.9, 7.8) 34, 35 29, 31, 33 30, 34
OH-31
aAll data, with the exception of 15N data, from Vulpanovici (2003) with the numbering scheme modified 
to match that of Zn-leptochelin. 1H and 13C NMR data recorded at 600 MHz and 150 MHz, 
respectively. bAssigned from 15N-gHMBC (500 MHz). cAssigned from 15N-HSQC (600 MHz) acquired 
by K. McPhail, 2002.
159Table S-4.2. NMR Spectroscopic Data for Zn-Leptochelin Complex in CDCl3.
No. δC, mult. δH, mult. (J in Hz) COSY HMBC ROESY
1 179.0, C
2 84.3, C
3a 42.1, CH2 3.44, d (-11.7) H-3b 2, 4, 5 H3-4
3b 3.59, d (-11.7) H-3a 1, 2, 4
4 22.6, CH3 1.47, s 1, 2, 3 H-3a, H-27, H-28b
N(1)
5 176.3
6 61.6, C
7 64.3, CH 3.72, d (8.2) H-8 6, 8, 9, 10 H3-10
8 75.0, CH 4.0, br m H-8, H-9a, H-9b 7, 9, 11 H3-10, H3-16
9a 38.2, CH2 3.79, dd (2.7, 8.6) H-8, H-9b 7, 8
9b 3.93, dd (1.0, 10.2) H-8, H-9a 7, 8, 11
10 20.9, CH3 1.543, s 5, 6, 7 H-7
11 185.0, C
12 61.7, C
13 78.0, CH 3.86, d (2.7) H-14 15 H-14, H3-15, H3-16
14 50.3, CH 4.53, pd (7.6, 3.0) H-13, H3-16, NH(3) 12, 13, 16 H-13, H3-16, NH(3)
15 30.8, CH3 1.541, s 11, 12, 13 H-13
16 15.5, CH3 1.16, d (7.6) H-14 13, 14 H-8, H-13, H-14, NH(3)
NH(2a) 1.63, ob NH(2b) aNH(2b)
NH(2b) 3.56, br d (-11.6) NH(2a) 11, 13 aNH(2a), NH(3)
OH-13 4.64, br s
NH(3) 10.16, d (7.7) H-14 14, 16, 17 H-14, H3-16, H-19a, 
NH(2a), NH (2b), NH(4) 
17 175.3, C
18 58.1, CH 4.41, ddd (3.6, 7.0, 11.0) H-19a, H-19b, NH(4) 19 H-19a, H-19b, H-21/25
19a 37.1, CH2 2.93, dd (2.4, 11.7) H-18, H-19b 17, 18, 20, 21/25 H-18, H-19b, H-21/25, 
NH(3), NH(4)
19b 3.25, dd (3.5, 14.2) H-18, H-19a 18, 20, 21/25 H-18, H-19a, H-21/25
20 135.7, C
21/25 130.9, CH 7.24, d (8.3) H-22, H-24 19, 22/24, 23 H-18, H-19a, H-19b, 
NH(4)
22/24 131.9, CH 7.47, d (8.3) H-21, H-25 20, 21/25, 23
23 121.0, C
NH(4) 8.27, d (7.0) H-18 18, 19, 26 H-19a, H-21/25, H-27, 
H-28a, H-28b, NH(3)
26 172.9, C
27 67.2, CH 4.57, br dd (8.5, 9.5) H-28a, H-28b 26, 28, 29 H3-4, NH(4)
28a 69.1, CH2 4.34, br dd (8.4, 8.4) H-27, H-28b 26, 27, 29 NH(4)
28b 4.46, br dd (8.8, 9.6) H-27, H-28a 26, 27, 29 H3-4, NH(4)
29 170.5, C
30 118.5, C
31 165.6, C
32 109.8, C
33 137.7, CH 7.59, dd (1.7, 7.4) H-34 30, 31, 35 H-34
34 112.8, CH 6.30, t (7.8) H-33, H-35 30, 32 H-33, H-35
35 130.5, CH 7.62, dd (1.7, 8.1) H-34 29, 31, 33 H-34
OH-31
1H and 13C NMR data recorded at 700 MHz and 175 MHz, respectively. aCOSY artifact observed in 
ROESY spectrum. ob = obscured.
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181Abstract
  Hydrothermal vents are among  the most extreme and dynamic environments on 
Earth. They are characterized by physical  extremes of temperature (2–350  ºC) and 
pressure, steep chemical, pH and temperature gradients, and a complete absence  of 
light. Despite these harsh conditions, the biological, chemical and physical diversity of 
hydrothermal  vents  parallels  the  highly  productive  terrestrial  and  shallow  water 
marine environments, which have been rich sources of biologically active compounds. 
Thus, in collaboration with the NOAA Vents program at Oregon State University and 
Pacific Marine Environmental  Laboratory (PMEL) we have begun investigating  the 
chemical diversity of prokaryotic and eukaryotic organisms that exist in the immediate 
vicinity of hydrothermal vent flows from Axial Seamount on the Juan de Fuca Ridge. 
In  particular,  a  diverse  collection  of  deep-vent  invertebrates  including  Ridgeia 
piscesae tubeworms, Paralvinella palmiformis palm worms and Lepetodrilus fucensis 
limpets,  as well as microbial  mats at diffuse vent flows and a  blue  protozoan  mat 
identified as a folliculinid ciliate (Folliculinopsis sp.) have been collected for natural 
products investigations during the 2009–2012 New Millennium Observatory (NeMO) 
annual  expeditions.  Bioassay-guided  fractionation  following  microtiter  plate-based 
antimicrobial  assays  against both  Staphylococcus aureus and  Escherichia  coli w a s  
used in conjunction with  LC-MS/MS  and NMR profiling  to identify anti-infective 
natural  product leads from  extract libraries of these  collections, as well as several 
laboratory-cultured deep-vent actinomycetes. 
182Introduction
  The deep ocean may be defined technically as depths beyond the euphotic zone 
(upper 200-300 m; Van Dover et al., 2002) where the sea bottom, in darkness, receives 
less than 1% of organic matter from photosynthetic primary production, oxygen levels 
and temperatures (down to 2 °C) plummet, and hydrostatic pressures rise to greater 
than 1,000 atmospheres in the deep trenches (10 m water = 1 atmosphere; Walsh et al., 
1981). However, in  the realm  of natural  products chemistry, many logically report 
depths beyond  those  readily accessible  by SCUBA  as  “deep”.  Thus,  in  a  recent, 
comprehensive deep-sea review, Skropeta considered the range of ocean environments 
below 50 m  (~164  ft), which host a  variety of marine  invertebrates and  microbes 
adapted  to  physical  extremes  in  environmental  conditions  (Skropeta,  2008).  The 
introduction to  the  latter review provides an informative  overview of  the  deep-sea 
environment and the effects of the extreme, although very stable, conditions on the 
gene regulation, macromolecules, and the metabolism of deep-sea organisms.
  Once thought to comprise a very low diversity of organisms evolved to occupy a 
physiologically challenging  niche  that precluded  the  intense  competition  of  many 
shallow water ecosystems, deep-sea benthic communities are now recognized to be 
highly diverse, although not abundant. In the  1960’s, focused efforts to sample the 
deep ocean  floor resulted  in unexpected findings of  high faunal  diversity, even in 
individual benthic dredge and epi-benthic sled samples from less than 100 to greater 
than 5,000 m (Sanders & Hessler, 1969). Nevertheless this high diversity, which is on 
the same order as that found in shallow tropical seas and has been attributed to the 
seasonal  and  geological stability of the  deep-sea  environment,  occurs  in relatively 
sparse pockets of slow-growing benthic organisms that are likely limited in density by 
food scarcity. Therefore, the exceptionally dense and diverse communities within the 
immediate vicinity of hydrothermal vents were in stark contrast to the surrounding sea 
bottom when first observed: in 1977, scientists aboard the manned deep submergence 
183vehicle (DSV) Alvin dove in the Galapagos Rift valley (ca. 2,500 m) to investigate 
recently photographed  communities  of  large  suspension-feeding  benthic  organisms 
surrounding  active  hydrothermal  vents  (Lonsdale,  1977).  Hydrothermal  vents, 
considered one of the most extreme environments on Earth, are formed when water 
heated in the earth’s crust by magma is forced explosively to the surface through rock 
fissures in volcanic regions. At deep-sea vent sites, in addition to physical extremes of 
temperature (up to 400 ºC) and pressure and a complete absence of light, there are also 
extremely steep chemical, pH and temperature gradients between vent fluids and the 
surrounding seawater (Burgess et al., 2007). Remarkably, the growth rates of the deep 
vent  communities  proved  comparable  to  organisms  from  shallow  tropical 
environments (Childress & Fisher, 1992), and ultimately, the presence of extremely 
high  concentrations of  chemosynthetic  microorganisms led  to a  new paradigm  for 
primary production  in  the  absence  of  sunlight  (Corliss  et  al.,  1979;  Jannasch  & 
Wirsen, 1979). Noteworthy is that the discovery of chemosynthetic symbiosis at deep-
sea vent sites lead to the realization that this phenomenon occurs in a wide range of 
habitats worldwide,  typically characterized  by high  sulfide  concentrations  and  the 
presence of free-living macroorganisms with reduced digestive systems. This diversity 
of  chemosynthetic  habitats,  as  well  as  their  hosts  and  symbionts,  is  engagingly 
reviewed by Dubilier et al. (2008), and includes sewage outfalls, organic-rich mud 
flats, some shallow-water coastal sediments, whale and wood falls in the deeper ocean, 
cold seeps, mud volcanoes and continental margins, in addition to hydrothermal vents. 
  Deep-sea  hydrothermal  vents,  besides  being  extreme  environments,  also 
represent some  of  the  most dynamic  environments  on  Earth.  With  unpredictable 
temperatures, chemical concentrations, flow dynamics and seasonality, a single vent 
field may often be comprised of completely different fauna from one visit to the next 
(Childress  &  Fisher,  1992).  As  the  vent  matures  and  ages,  early  colonizers  are 
superseded by a succession of other species in parallel with the diminishing thermal 
flow  volume,  temperature  and  amount  of  hydrogen  sulfide  (Van  Dover,  2000). A 
184distinction has been made between deep-sea and shallow-water hydrothermal vents on 
the  basis  of  their  biota.  Tarasov  et  al.  (2005)  have  shown  a  striking  change  in 
hydrothermal vent communities at depths of 200 m (660 ft) based on the occurrence of 
obligate vent fauna. Thus, for the purpose of this study, deep-sea hydrothermal vents 
are those that occur below 200 m.
  In order to discuss deep-sea hydrothermal vents as a potential source for natural 
products  investigations,  here  we  consider  the  geological  setting  and  geochemical 
nature  of  deep-sea  vents  that  impacts  the  biogeography  of  vent  organisms, 
chemosynthesis and the known biological and metabolic diversity of eukaryotes and 
prokaryotes at vent sites, and the handful of small molecule natural products isolated 
to  date  directly from  deep-sea  vent  organisms. Of  critical  importance  too  are  the 
logistics of collecting deep vent organisms, opportunities for recollection, considering 
the dynamic nature of vent sites, and the ability to culture natural product-producing 
deep vent  organisms  in  the  laboratory.  Importantly,  several  of  these  logistics  are 
addressed in this study. 
Geology and Distribution of Deep-Sea Hydrothermal Vents
  Over  300  deep-sea  hydrothermal  vent  sites  are  known  throughout the  world 
(Desbruyères et al., 2006). These vent sites generally occur along a nearly continuous 
underwater  mountain  chain  (mid-ocean ridges) totaling  more  than  75,000  km  that 
remain largely unexplored for hydrothermal  activity (Figure 5.1; Van Dover, 2000).   
Located at the boundaries between the tectonic plates of the Earth’s crust, these mid-
ocean  ridges are  the  sites  of  incremental  seafloor spreading  (spreading  centers)  at 
which molten rock (magma) rises towards the Earth’s surface as the tectonic plates 
move in relation to each other. Hydrothermal vent fields may comprise multiple zones 
of  focused  hot and  diffuse  (low-temperature)  fluid  flows,  and  range  in  size  from 
several hundred to  several  million square  meters around  ridge  axes. Hydrothermal 
185vents  are  also  found  behind  island  arcs  along  active  plate  margins  in  “back-arc 
spreading centers” and active submarine volcanoes or seamounts located in the center 
of  tectonic  plates (Seyfried &  Mottl,  1995).  As  a  result of their  proximity to  the 
countries primarily involved in deep-sea hydrothermal vent research, the most studied 
hydrothermal systems are either in the eastern Pacific (East Pacific Rise and the Juan 
de  Fuca,  Gorda  and  Explorer Ridges) or  the  north-central Atlantic  (northern  Mid-
Atlantic  Ridge).  The  distinct  geological  settings  of  different  hydrothermal  vents 
impact the extent of venting on both spatial and temporal scales, and thus influence the 
biogeography  of  vent  organisms.  Therefore,  variations  in  mid-ocean  ridge  crest 
dynamics between different ocean basins, as well as regional and local differences in 
ridge morphology (valley depth, etc.), which affect bottom currents, style of venting 
and vent longevity, make it important to keep in mind the geographical context of the 
general descriptions of vents and their biota presented here.
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Figure  5.1.  Map  showing  the  major  mid-ocean  ridges  and  known  deep-sea 
hydrothermal  vent biogeographic provinces: Pink, western Pacific; green, northeast 
Pacific;  blue,  East Pacific  Rise;  yellow, Azores;  red,  Mid-Atlantic  Ridge;  orange, 
Indian Ocean. Reproduced with permission from Van Dover et al (2002).  Vents are typically characterized by the mineral composition of their emissions 
and the  morphology of structures built up through mineral deposition: variations in 
fluid composition, temperature, mineralogy, shape and size of deposits exist (Tivey, 
1991).  As  cold  seawater  penetrates  deep  into  the  earth’s  crust  it  is  heated  and 
chemically modified  from interactions with very hot basaltic rock (Edmond et al., 
1982). Hot fluids, exiting vents at up to 400 °C, are enriched with transition metals 
(e.g., aluminum, copper, cobalt, iron, lead, manganese and zinc), silica, sulfides and 
dissolved gases such as hydrogen and methane (Seyfried & Mottl, 1995; Van Dover, 
2000).  The  rapid  mixing  of  these  hydrothermal  fluids  with  the  surrounding  cold 
seawater as they exit from the ocean floor causes changes in pH and temperature and 
the precipitation of metal sulfides and minerals to form particle-rich black plumes and 
columnar  sulfide-rich  black-smoker chimney  structures. At many active  vent sites, 
within a year of a volcanic eruption, mature (> 5 m) black-smoker sulfide chimneys 
are  observed  that  eventually  grow  10-20  m  high  and  may  have  several  high-
temperature  orifices  near  the  top  (Haymon,  1983;  Tivey,  1991).  White-smoker 
chimneys form around intermediate temperature flows (100-300 °C) that facilitate the 
precipitation of silica, anhydrite, and barite as white particles. In addition, there are 
several other structural variations of sulfide-rich mineral deposits, including beehives 
(with horizontal layering and conduits for diffuse fluid flow), flanges (where pooled 
hot fluids are  trapped beneath the  shelf-like  structure) and complex sulfide mounds 
(Van Dover,  2000). The complex  mineralization processes ongoing  in  even mature 
sulfide structures result in convoluted internal plumbing that may create diffuse warm-
water flows at temperatures and mineral fluxes suitable for the growth of organisms. 
In  addition  to  issuing  from  porous  surfaces  of  active  mineral  deposits,  low-
temperature, diffuse flows may also exit directly from fissures in basalt lavas. One of 
the  largest known  hydrothermal  deposits,  “Godzilla,”  is an  extreme  example  of a 
complex sulfide mound (Robigou et al., 1993). This sulfide structure has a diameter of 
12-20 m and towers 55 m (180 ft) above the valley floor of the High-Rise vent field, 
187Juan de Fuca Ridge. Hydrothermal fluids from 30 to 330 °C exit at various tiers of its 
flanges extending  4  to 5 m  (13-16 ft)  away from  the  structure. The  extent of this 
venting  may be  brought into  perspective  by the  observation that it is  common to 
measure  temperature  changes  from  350  to  10  °C  over  a  distance  of  just  a  few 
centimeters  around  the  majority  of  high-temperature  vent  orifices  at  deep-sea 
hydrostatic pressures.
  In  addition to the  particular  morphology of a  deep-sea  vent,  temperature  and 
chemistry fluxes and the duration of hydrothermal activity has a profound effect on the 
composition of vent communities. Where rates of seafloor spreading are more rapid, 
as on the East Pacific Rise, eruptive disturbances are frequent enough that individual 
chimneys or diffuse-flow areas in a vent field may be present for less than 20 years. 
Alternately, in areas where volcanism is less frequent, such as the Main Endeavour 
Field (Juan de Fuca Ridge), some active  mounds are thought to be more than 200 
years old (Van Dover, 2000).
Biogeography and Diversity of Deep-Sea Vent Eukaryotes
  The  dense  invertebrate  communities  typically  associated  with  deep-sea 
hydrothermal  vents exist in  diffuse, warm-water flows that sustain  temperatures of 
10-40 and occasionally up to 60 °C (Van Dover,  2000). Despite  the  high biomass 
associated with hydrothermal vents, there is much lower macrofaunal species diversity 
relative to other deep-sea communities. This is likely a  result of  the  dynamic and 
variable fluid conditions both within and between vent habitats that require specialized 
physiological  and  biochemical  adaptations  (Childress  &  Fisher,  1992;  Van  Dover, 
2000) and favor the emergence of dominant species that succeed in a range of fluid 
conditions (Marcus et al., 2009). However, the full extent of the species present within 
hydrothermal  vent  communities  has  yet  to  be  discovered  considering  the  vast 
188unexplored ocean ridge systems and the report of new species being described every 
two weeks throughout the 1990’s (Childress & Fisher, 1992).
  Over 500 eukaryote species, encompassing 12 animal phyla and more than 150 
new  genera,  have  been  described  in  the  last  three  decades  from  deep vent sites. 
Arthropods  (38.8%),  mollusks (28.6%)  and  annelid  worms  (17.7%)  dominate  the 
megafaunal  vent  communities  throughout  the  world,  while  cnidarians  (4.6%), 
chordates  (3.7%)  and  sponges (1.9%)  are  of notable  presence (Desbruyères et al., 
2006). Although deep ocean currents can disperse larval organisms over vast distances 
to new hydrothermal fields, many hydrothermal vent fields exhibit a unique range of 
habitat diversity and a high degree of endemism (Seyfried & Mottl, 1995; Van Dover, 
2000). The Galapagos Rift and East Pacific Rise of the  Pacific  Ocean have similar 
communities,  whereas  different  vent  communities  on  the  Juan  de  Fuca  Ridge 
(northeast Pacific) share few species (Tunnicliffe & Fowler, 1996). During a visit to a 
mature  hydrothermal  vent site  in  the  eastern Pacific,  one  might expect to observe 
scattered aggregations or “bushes” of siboglinid polychaetes (e.g., the vestimentiferan 
tube worms Riftia pachyptila or Ridgeia pisceae) which, on closer inspection, host a 
mix  of limpets and snails, alvinellid polychaetes (e.g., the palm worm  Paralvinella 
palmiformis)  and  polynoid  polychaetes  (e.g.,  the  scale  worm  Lepidonotopodium 
piscesae), all  cloaked in a  white microbial mat, with occasional hydrothermal vent 
shrimp and Yeti crabs. On the Mid-Atlantic Ridge, vent sites are characterized instead 
by an abundance of hydrothermal vent shrimps (Rimicaris) swarming over chimneys 
near  high  flows  that lack  the  vestimentiferans  and  alvinellids of  the  Pacific  vent 
communities  (Van  Dover,  2000). Nonetheless, at least 40%  of  the  Atlantic  genera 
reported are shared with the Pacific vent fauna. In both oceans, beds of hydrothermal 
vent clams (Calyptogena magnifica) or mussels (Bathymodiolus thermophilus) may be 
observed in lower flow areas. The Kairei and Edmond vent fields of the Indian Ocean 
contain genera shared with either Atlantic or Pacific vents. However, Indian Ocean 
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from either the Atlantic or Pacific (Van Dover et al., 2001). 
  Unlike  communities  in  other  deep-sea  reducing  habitats  (e.g.,  cold  seeps), 
hydrothermal  vent  communities  change  on  time-scales  of  months  to  years,  and 
frequent volcanic activity along ridge systems with medium to fast seafloor spreading 
rates may continually reset vent community development allowing  repeated primary 
successions  to  be  documented  in  conjunction  with  geo-physical  and  -chemical 
parameters (Tsurumi & Tunnicliffe, 2001). Within two years of the eruption of Cleft 
Segment  on  the  Juan  de  Fuca  Ridge  (eastern  Pacific),  tubeworm-associated 
assemblages were well-established at diffuse vents. These communities were observed 
almost annually over the next six years (2-8 years post-eruption), and showed a shift in 
dominance  from  the  alvinellid  polychaete  Paralvinella  pandorae  (20-98%  of  the 
assemblages at year 2) to the limpet Lepetodrilus fucensis by year 7. Most diffuse 
venting had waned by year 5, and all vents were extinct by year 8. In another more 
recent report on succession in diffuse flow vent communities after the 1998 eruption at 
Axial  Volcano  (central  segment,  Juan  De  Fuca  Ridge),  Marcus  et al.  (2009)  first 
examined mature pre-eruption communities using data for 21 low temperature vents 
that were sampled in Axial vent fields in 1986-88 and 1997-99. Species composition 
proved  very similar  among  mature vents and the collections were dominated by a 
small subset of taxa, although the relative dominance of the common species depended 
on vent flow temperature. As observed in earlier studies, alvinellid worms dominate 
higher temperature vents, while limpets dominate lower temperature vents (< 18 °C). 
This  predictability  of  mature  vent  communities  bodes  well  for  natural  products 
investigations  that  require  recollections  to  pursue  preliminary  results  from  broad 
biological activity profiling of initial small-scale, diverse collections. 
  Post-eruption colonization of new vents depends on the species pool available to 
colonize  a site, as well  as the  physico-chemical  characteristics of  a  particular vent 
environment. Marcus et al. (2009) found that Paralvinella pandorae  colonized and 
190dominated the new Axial vent communities within the first year post-eruption. Ridgeia 
piscesae tubeworms took up to 30 months to become well established, by which time 
23 of the 36 known Axial vent and four new macrofaunal species had arrived. This 
may coincide with the tapering of high vent flows to a level where temperature and 
hydrogen sulfide levels were acceptable to juvenile recruits that require both oxygen 
and  sulfide. Interestingly, some  rare  macrofaunal  species showed  rapid recruitment 
and colonization, although they never reached significant abundance. By year 2 after 
the  eruption,  biomass  of  tubeworm-associated  species  had  leveled,  but  animal 
densities remained significantly higher than at the mature vents, suggesting that the 
latter  support  larger  individuals.  This  knowledge  of  the  rates  of  colonization, 
progressive  succession  and ecology of vent communities at different sites may be 
critical  to  the  success  of natural  products investigations that must rely on  limited 
collection opportunities, both spatially and temporally.
  Eukaryotic  microorganisms from both known  and previously undescribed taxa 
have  also been described from deep-sea hydrothermal and cold-seep environments, 
including  those  living  in  association  with  various  invertebrate  species.  Sequence 
comparisons of PCR-amplified small  subunit (SSU) ribosomal  RNA’s were  used to 
characterize  the  diversity  of  eukaryotic  organisms  associated  with  hydrothermal 
sediments from the Guaymas Basin in the Gulf of California (Edgcomb et al., 2002). 
Many of these sequences are related to previously uncharacterized eukaryotes or seem 
to  represent  early  branching  within  well-characterized  eukaryotic  clades.  These 
include  sequences from  certain fungi, green  algae,  diatoms,  water molds, protists, 
acanthareans and radiolarians. Obviously, sequences of phytoplanktonic taxa, such as 
green algae and diatoms, could have been deposited through sedimentation from the 
euphotic zone, and culture-independent molecular surveys do not necessarily reflect 
viable members within sediment samples. However, Atkins et al. (1998) isolated and 
cultured 18 strains of flagellated protists representing nine species from four deep-sea 
hydrothermal  vent sites, including  the Guaymas Basin. This suggests that many of 
191these sequences represent truly unique eukaryotic microorganisms capable of adapting 
to  life  in  extreme  and  dynamic  environments.  In  addition,  the  Deep-sea 
Microorganism Research Group at the Japan Marine Science and Technology Center 
(JAMSTEC) has identified new species of unicellular fungi, typically designated as 
yeasts, associated with the  tubeworm Lamellibranchia sp. and the giant white clam 
Calyptogena s p (Nagahama et al., 2001, 2003). These organisms live  in  cold-seep 
environments where high concentrations of methane and hydrogen sulfide flow from 
the seafloor. 
 T h e   d o m i n a n t   a n d   u b i q u i t o u s   v e n t   s p e c i e s   h i g h l i g h t e d   h e r e   ( a r t h r o p o d s ,  
gastropods and annelids) belong  to taxa widely recognized from other environments 
not to be prolific producers of natural products. However, the vast majority of vent 
invertebrates host epibiotic or endobiotic extracellular or intracellular symbionts, and 
in this respect, could be viewed as the equivalent of shallow-water filter feeders such 
as sponges and tunicates, which are both responsible for tremendous natural products 
diversity from  symbiotic  microbes that account for  up to  40% of their body mass 
(Dunlap et al., 2007). Thus, the crucial question becomes the biological and metabolic 
diversity of the symbiotic, and also free-living, microorganisms associated with the 
dense  vent  invertebrate  communities  (Table  5.1),  which  in  fact  support  primary 
production in those  vent communities via  chemosynthesis. In  addition to providing 
critical  food  resources  to  their  hosts,  epi-  and  endosymbiotic  bacteria  have  been 
proposed  as  sources  of  natural  products  for  deterring  predation  within  these 
communities (Kicklighter et al., 2004). 
  A  variety of  evidence  indicates  that nearly  all  invertebrates  associated  with 
hydrothermal vents acquire much if not all of their needs for fixed carbon and nitrogen 
from  microbial  symbionts,  which  are  dominated  by sulfide-oxidizing  bacteria  that 
require a constant supply of sulfide to specialized host tissues (Kelley et al., 2002). For 
example,  adult vestimentiferan  tubeworms  lack  a  digestive  tract  and  derive  their 
nutrition  solely from  culturing  sulfur-oxidizing  bacteria  within  a  specialized  organ 
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accounts for approximately 16% of the animals’ wet weight and consists primarily of 
symbiont-containing  lobes  (bacteriocytes),  crystals  of  elemental  sulfur  and  blood 
vessels  (Cavanaugh  et  al.,  1981;  Childress  &  Fisher,  1992).  Bacterial  densities 
between 109  and 1011 cells  per gram  of wet tissue  have  been observed within the 
trophosome of the giant vestimentiferan tubeworm, Riftia pachyptila, which is capable 
of  growing  up to  2.0 m  in  length  (Desbruyères et al.,  2006). Although numerous 
reports indicate dominance by only a single bacterial phylotype within trophosomes of 
R. pachyptila and other vestimentiferans, new molecular evidence suggests that a more 
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Table 5.1. Representative bacterial counts and phylogenetic diversity reported from 
different hydrothermal vent niches.
aSample
Description
Temp.
(°C)
Total Bacteria 
Cell Count
Phylogenetic Clusters
(bOTUs)
References
hydrothermal plume ~200 6.3 × 104 –
7.5 × 104 cells mL-1
4 (20) Sunamura et al., 2004
 
hydrothermal fluid 2–208 cND 15 (46) Huber et al., 2003 
dISCD (5 days) 2–300 6.8 × 104 –
2.0 × 107 cells g-1
7 (22) Harmsen et al., 1997; 
Corre et al., 2001 
chimney structure (enrichment 
cultures)
ND 2.2 × 109 cells mL-1 9 (17) Postec et al., 2007 
tubeworm (Riftia pachyptila) ND ND 8 (39) Lopez-Garcia et al., 
2002 
polychaete worms (Paralvinella
palmiformis) ND ND 8 (93)
Alain et al., 2002 
scaly snail (Crysomallon 
squamiferum) ND ND 5 (76)
Goffredi et al., 2004 
microbial mat ~37 ND 3 (18) Moyer et al., 1995 
hydrothermal sediment ND ND 12 (59) Lopez-Garcia et al., 
2003 
hydrothermal sediment cores 2–74 ND 9 (36) Teske et al., 2002 
aNote  that  the  data  referenced  are  from  different  geographical  location;.  bNumber  of  operational 
taxonomic units (OTUs) determined within referenced material; cND, not determined;  dISCD, in situ 
colonization device.diverse community may colonize these and other structures within the trunk of these 
tubeworms (Chao et al., 2007; Harmer et al., 2008). In general, the potential diversity 
of chemosynthetic symbionts, which may arise from many different bacterial lineages, 
has only recently been appreciated with the advent of molecular methods that have 
revealed a remarkable variety of chemosynthetic metabolic pathways (Dubilier et al., 
2008)  discussed  in  more  detail  in  the  following  section.  Other  examples  of  vent 
symbioses include suspension-feeding  hydrothermal vent clams and mussels, which 
gain  approximately 45%  of their  fixed  carbon  from  chemoautolithotrophic  (auto-, 
fixing  inorganic  carbon;  litho-,  oxidation  of  inorganic  electron  donors) 
microorganisms associated  with their gills (Childress & Fisher, 1992; Fisher et al., 
1988). A highly diverse assemblage of episymbionts was identified from the dorsal 
surface of the extremely thermotolerant polychaete Alvinella pompejana (Haddad et 
al.,  1995).  Other  epibiont  communities  include  microbes  “farmed”  on  dense 
aggregations  of  shrimp  at  Mid-Atlantic  Ridge  hydrothermal  vents.  The  shrimps 
compete for space near warm, sulfide-rich water emissions to support their “crop” of 
microorganisms  (Polz et  al.,  1998).  Microorganisms are  also  associated  with  iron 
sulfide-containing sclerites in the foot of a newly described scaly snail, Crysomallon 
squamiferum, from hydrothermal vents in the Indian Ocean (Goffredi  et al., 2004). 
Without these  chemosynthetic  microorganisms,  the  rapid  growth  rates required  to 
prosper and reach reproductive maturity in such an extreme and dynamic environment 
would not be possible (Childress & Fisher, 1992; Nelson & Fisher, 1995).
Chemosynthesis and the Biogeography and Diversity of Archaea and 
Bacteria
  At deep-sea hydrothermal vents, in the absence of light and in the presence of 
hydrothermal fluids rich in minerals, reduced compounds (including  H2S, CH4) and 
CO2,  chemical  energy  replaces  solar  energy  as  the  fuel  that  supports  primary 
194production by chemosynthetic bacteria and archaea (Kelley et al., 2002; Van Dover, 
2000). The Archaea are a distinct domain of microorganisms that have no cell nucleus 
or  membrane-bound  organelles  (the  same  as  “prokaryotic”  Bacteria),  but  possess 
unique  biochemistry and  have  several  metabolic  pathways  that  are  more  closely 
related to those of eukaryotes (especially transcription and translation; Woese, 2004).     
Bacteria and archaea may be suspended in the ambient water column, hydrothermal 
plumes, or attached to rocks, sediment or on/in vent animals, which in turn may feed 
directly on the microbes or engage in symbiotic associations to acquire fixed carbon 
and  nitrogen,  as discussed in the previous section (Haymon, 1983;  Robigou et al., 
1993; Tivey, 1991). Table 5.1 provides a representation of the different vent habitats 
for  microorganisms,  with  representative  bacterial  counts  and  taxonomic  diversity 
reported for each niche. 
  Gradients of temperature and chemistry (including O2) in hydrothermal systems 
support free-living  microorganisms with  a diverse  array of obligate  and facultative 
physiologies and tolerances, and thus microbial diversity correlates closely with major 
element and  volatile  chemistry of vent fluids.  It has been proposed that individual 
microorganisms switch freely between autotrophy (inorganic carbon energy sources) 
and  heterotrophy  (organic  carbon  energy  sources)  depending  on  environmental 
conditions, since heterotrophy yields higher energy when available. However, in the 
absence of a supply of small organic compounds supporting heterotrophic metabolism, 
chemosynthetic  microorganisms  produce  particulate  organic  carbon  for  vent 
communities, and are important as sinks for reduced hydrothermal compounds in the 
global cycling of elements (Van Dover, 2000). Since the concentration of H2S in vent 
fluids is  extremely high  (3 to  110  mmol  per  kg  seawater),  sulfide  oxidation  is a 
dominant microbial chemosynthetic source of energy in vent communities (Kelley et 
al., 2002). The oxidation of reduced compounds such as HS-, H2S, S°, CH4, H2, NH4+ 
or Fe(II)- and Mn(II)-containing minerals provides energy for the synthesis of useable 
organic  carbon from inorganic  sources such as CO2 and  CH4 (Jannasch &  Wirsen, 
1951981;  Van  Dover,  2000).  The  fixation  of  CO2 u s e d  b y  m a n y  o f  t h e s e  
chemoautolithotrophic bacteria is identical to the Calvin-Benson cycle used by plants. 
While aerobic  microbes use  O2 as the  electron acceptor during  the energy-yielding 
chemosynthetic  reaction,  anaerobic  hydrothermal  microorganisms  use  CO2,  Fe3+, 
NO32-, or organic compounds (to oxidize H2; Kelley et al., 2002; Schmidt et al., 2008). 
  Free-living  bacteria  and archaea  are suspended within buoyant vent plumes at 
temperatures reaching  at least 115 °C, and cell densities several orders of magnitude 
more  abundant than  surrounding  seawater can be  detected  hundreds of  kilometers 
away  from  vent  fields  (Jannasch  &  Wirsen,  1979;  Juniper  et  al.,  1998).  These 
microorganisms, also form microbial mats of various colors and morphologies on the 
surface of basalt (Moyer et al., 1994; Santelli et al., 2008), chimney spires (Kormas et 
al., 2006) and within hydrothermal sediments (Lopez-Garcia et al., 2003), where they 
serve  as food for  numerous invertebrate  filter-feeding, grazing  and deposit-feeding 
species (Van Dover & Fry, 1994). They likely also play a significant role in early steps 
of macrofaunal colonization around new vent formations (Alain et al., 2004; Lutz et 
al.,  2001).  Many  anaerobic  microbes  are  also  found  deep  within  the  thermal 
subseafloor (Takai et al., 2004) and chimney walls in close proximity to nutrient-rich, 
acidic  effluent that can vary in temperature  from ≤ 25 °C to 350 °C (Winn et al., 
1986). A steep temperature  gradient exists within  only a few centimeters  of  these 
walls, where variations in the abundance and diversity of bacteria and archaea occur. 
Numerous studies have shown that hyperthermophilic archaea increasingly dominate 
the microbial consortium as effluent temperatures rise from 150 to 300 °C (Harmsen et 
al., 1997; Schrenk et al., 2003; Takai & Horikoshi, 1999; Takai et al., 2001), although 
cell  densities  of  both  archaea  and bacteria  decrease  in  proximity to such  extreme 
temperatures.
  Although there has been tremendous scientific interest in the microbial ecology 
of  “hot-spot ecosystems,”  such as hydrothermal  vents, cold-seeps  and  gas-hydrate 
systems, the distribution and diversity of functional and taxonomic groups of bacteria 
196and archaea within the deep-sea is largely unknown (Jørgensen & Boetius, 2007). The 
diversity of  hydrothermal  vent microbial  communities  cannot truly be  assessed  by 
methods that rely solely on artificial cultivation, since 99% of marine microbes are 
considered unculturable (Amann et al., 1995). These challenges have been overcome 
in part by the application of a molecular phylogeny-based approach using nucleotide-
sequence analysis of the highly conserved gene for the small-subunit (SSU) ribosomal 
RNA molecule (16S rRNA), (Pace, 1997). This approach has revealed that the global 
diversity of microorganisms is  at least 100 times greater  than estimates  based  on 
cultivation-dependent  surveys;  new  phylotypes,  often  representing  major  new 
lineages,  are  consistently  shown  with  each  molecular  analysis  of  microbial 
environments (Pace, 1997; Sogin et al., 2006; Venter et al., 2004). For example, the 
new archaeal phylum “Nanoarchaeota”  (Huber et al.,  2002)  has been  identified  by 
analysis  of  PCR-amplified  SSU  rRNA  genes  from  a  defined  co-culture  of 
hyperthermophilic archaeans, and similar methods have indicated the emergence of a 
newly defined lineage distributed throughout the global deep-sea vent system referred 
to  as the  “Deep-Sea  Hydrothermal  Vent Euryarchaeoic  group”  (DHVEG; Takai  & 
Horikoshi, 1999). 
  At the Josephine Bay Paul Center, Marine Biological Laboratory (Woods Hole, 
MA) and the Joint Institute for the Study of Atmosphere and Ocean, University of 
Washington (Seattle, WA), an alternative approach to the more traditional analysis of 
full-length  16S  rRNA  amplicons  has  been  developed  (Sogin  et  al.,  2006).  This 
approach targets hypervariable regions within 16S rRNAs that can record differences 
between  both  divergent  and  closely-related  organisms and  thus  provide  a  greater 
resolution of microbial diversity and relative abundance (Kysela et al., 2005; Sogin et 
al., 2006). Analysis of 689,720 bacterial and 216,627 archaeal amplicons, targeting the 
V6 hypervariable region, from two low-temperature (~30 °C) diffuse flow vents in the 
northeast Pacific Ocean revealed 30,108 unique bacterial sequences forming  18,537 
phylotypes and 5,979 unique archaeal tag sequences defining 1,931 phylotypes (Huber 
197et  al.,  2007).  By  comparison,  previous  assessments  from  the  same  sites  using 
traditional  PCR-amplified  16S  rRNA  gene  sequence  analysis  identified  only  55 
bacterial and 28 archaeal phylotypes [operational taxonomic units (OTUs)] (Huber et 
al., 2002, 2003). Even more remarkably, this attempt by Huber et al. (2007) to provide 
an exhaustive characterization of bacterial and archaeal diversity at the study sites was 
not successful in the case of the bacteria: statistical analyses of the data from even this 
unparalleled number of bacterial sequences indicated additional, undescribed bacterial 
diversity at every taxonomic level. Hence, much of the microbial diversity reported 
from these environments is likely at best a conservative approximation of their true 
community structure. This strategy of sequencing  the 16S  rRNA V6  hypervariable 
region has also been adopted by the International Census of Marine Microbes, one of 
14 groups within the Census of Marine Life (CoML) initiative. The goal of the CoML 
is to provide an on-line database (first consensus released on October 4, 2010), which 
describes each one of the more than 14 million marine species currently known. Since 
its inception in 2000,  researchers  have  discovered  more  than 6,000  potential  new 
species from microbes to whales in near shore habitats to the abyssal plains, including 
mid-ocean ridges and deep-sea vents (CoML, 2013).
  Bacterial diversity at deep-sea hydrothermal vents, as for non-thermal deep-sea 
environments,  spans  most  of  the  currently  defined  lineages  including  the 
Actinobacteria (high G+C Gram positives; Teske et al., 2002), Firmicutes (low G+C 
Gram  positives  encompassing  the  Bacilli, Clostridia  and  Mollicutes;  Huber  et al., 
2003;  Lopez-Garcia  et  al.,  2003),  and  the  Bacteroidetes  (formerly  Cytophaga-
Flexibacter-Bacteroides) phylum (Alain et al., 2002; Takai et al., 2004). The presence 
of Actinobacteria,  some  of which  have  larger genome  sizes  (over 9  Mb  for some 
Streptomyces and Rhodococcus species), is particularly encouraging  given that they 
are  the most prolific source of natural  product-derived medicines (Bérdy, 2005). A 
correlation between genome  size and secondary metabolic  capacity has emerged in 
recent studies aimed  at evaluating  how  relative  usage  of the  genome  varies with 
198genome size. The functional characterization of 115 completed bacterial genomes in 
the Genbank database showed that the relative proportion of genes for regulation and 
secondary metabolism increases with genome size (Konstantinidis & Tiedje, 2004).
  Notably,  the  relative  distribution  of  bacteria  among  taxonomic  groups  differs 
between deep-sea hydrothermal vent and non-vent environments (Figure 5.2). In fact, 
Actinobacteria form a relatively small portion of the known bacterial diversity at vents 
(Figure 5.2a) compared to other non-thermal environments (Figure 5.2b). However, 
the much higher concentrations of bacteria in hydrothermal versus cold sediments, for 
example  (Teske  et  al.,  2002),  should  lead  to  greater  sampling  efficiency  at 
hydrothermal  vents  and  therefore  favor  these  environments  as  a  source  of 
Actinobacteria as well as other likely natural product producers. The Proteobacteria 
(Gram-negative)  form  the  largest bacterial  phylum, comprising  approximately one 
third of all known bacteria, and represent a diverse range of organisms with varying 
genome sizes and life histories. This phylum includes sulfur-oxidizing bacteria (e.g., 
Beggiatoa  species),  methanotrophs  (e.g.,  Methylobacter  species)  and  nitrifying 
bacteria  (e.g.,  Nitrococcus  species)  as  well  as  bacteria  responsible  for  animal 
bioluminescence  (e.g., some Vibrio species). In addition, β-, γ- and δ-subclasses of 
Proteobacteria include some gliding forms, predatory species of which have unusually 
large  genome  sizes and are thought to  secrete  antibiotics to weaken or immobilize 
their prey (Nett & Konig, 2007).
  The  non-vent deep-sea  bacteria  comprise  highest numbers of  γ-proteobacteria 
followed by α-proteobacteria, Firmicutes, Actinobacteria and δ-proteobacteria (Figure 
5.2b). In  contrast, ε-proteobacteria  dominate  deep-sea vent microbial  communities, 
although other subclasses of Proteobacteria (γ-, α- and δ-) and the Aquificae (a small 
group of thermophilic/hyperthermophilic chemolithotrophic bacteria) are also found 
widely in a variety of vent habitats including  sulfide structures, hydrothermal fluids, 
sediments and microbial mats (Takai  et al., 2006). The ε-proteobacteria  subclass is 
ubiquitous  in  Nature  and  incorporates  sulfur-metabolizing  and  microaerophilic 
199bacteria,  including  many  enteric  mammalian  pathogens  (e.g.,  Helicobacter  and 
Campylobacter species). The success of ε-proteobacteria, including a high degree of 
endemism to very specific habitats, is attributed in large part to the genomic plasticity 
of these  bacteria, which lack many DNA-repair genes (Nakagawa  et al., 2007). At 
hydrothermal  vents,  species  of  Arcobacter,  Sulfurovum,  Sulforimonas, 
Hydrogenimonas, Nitratiruptor and many other genera play a key role in early steps of 
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Figure  5.2.  Relative  abundances  of  bacterial  phyla  (including  classes  of 
Proteobacteria)  found in  the  deep-sea  as determined  by 16S  rRNA gene  sequence 
analysis  and  reported  in  the  Ribosomal  Database  Project  (RDP,  http://
rdp.cme.msu.edu/): (a) hydrothermal vent samples and (b) non-thermal water column 
and sediment samples (Cole et al., 2007; Cole et al., 2009). Note that these data do not 
include  16S  rRNA  V6  hypervariable  region  sequences,  but  those  data  show 
comparable diversity and relative abundances of phylogenetic groups (Huber  et  al., 
2007).microbial  and  invertebrate  colonization  processes  through  the  cycling  of  sulfur, 
hydrogen,  nitrogen and carbon at vent fields (Alain et al.,  2004; Nakagawa  et al., 
2005; Takai  et al., 2006). Although the  known  genome  sizes of  members of these 
genera fall between 1.8 and 2.6 Mb, some ε-proteobacteria  have  been observed  as 
filamentous aggregations (Cary et al., 1997;  Goffredi  et al., 2004;  Harmsen et al., 
1997; Santelli et al., 2008), the formation of which may rely on chemical signaling. 
Notably, recent metagenomics analyses of water-column bacteria reveal that deep-sea 
bacterial  communities  have  a  larger  average  genome  size  than  surface-dwelling 
species and are characterized by a higher metabolic diversity and genomic plasticity 
(Konstantinidis et al., 2009).
  The  diversity of archaea  within microbial  communities associated  with  active 
chimney  structures  can  vary  from  a  single  species  (invertebrate  symbionts  and 
populations deep within chimney structures) to more complex communities. To date, 
phylotypes from every known and newly discovered marine Archaea group have been 
observed in deep-sea hydrothermal fields throughout the world (Figure 5.3a). While 
the  archaea  are  generally  associated  with  small  genome  sizes  (<  2-3  Mb), 
methanogens of the genus Methanosarcina have genome sizes of 3 to 5.7 Mb, and are 
found ubiquitously in diverse habitats. These unusual archaea possess all three known 
pathways for methanogenesis and can utilize nine different methanogenic substrates. 
They comprise a  significant portion of  the largely (formally) unclassified  deep-sea 
archaea (Figure 5.3b), and have also been detected in hydrothermal sediments from 
the Guaymas Basin (Teske et al., 2002) and high temperature chimneys in the Lost 
City Hydrothermal Field (Mid-Atlantic Ridge; Brazelton et al., 2006). 
201Figure 5.3. Relative abundances of phyla and component classes of archaea found in 
the deep-sea as determined by 16S rRNA gene sequence analysis and reported in the 
Ribosomal  Database  Project (RDP,  http://rdp.cme.msu.edu/):  (a)  hydrothermal  vent 
samples and (b) non-thermal water column and sediment samples (Cole  et  al.,  2007; 
Cole  et  al.,  2009). Note that these data do not include 16S rRNA V6 hypervariable 
region sequences, but those data show comparable diversity and relative abundances 
of phylogenetic groups (Huber et al., 2007).
Natural Products from Deep-Sea Vent Environments
  It is widely accepted that the production of natural products represents a critical 
chemical  defense  mechanism  adopted  by  organisms  that  lack  physical/structural 
defenses against predation (Hay, 1996). The occurrence of isolated pockets of dense 
vent  communities  in  the  vast  expanse  of  sea  floor  otherwise  devoid  of  standing 
biomass implies the presence of defense mechanisms against predation by generalist 
202feeders. An obvious conclusion is that the extreme and dynamic nature of deep-sea 
vent habitats, including high levels of normally toxic abiotic chemical species such as 
H2S, is responsible for the persistence of vent communities in the presence of high 
densities of predatory fishes and crabs.  However, Hay and colleagues (2004) have 
investigated  the  feeding  deterrent  effects  of  H2S-rich  blood  from  tubeworms  and 
chemical  extracts  from  unpalatable  deep-sea  vent  organism  tissues  on  readily 
accessible  shallow  water  generalist  feeders  (two  crab  and  two  fish  species). 
Remarkably, none of the predators was deterred from feeding by the presence of H2S 
in the offered food. In contrast, food containing chemical extracts from select tissues 
of certain polychaetes and bivalves was not accepted. Of 12 deep-sea vent species 
investigated,  five  possessed  tissues  that  deterred  feeding  (Riftia  pachyptila, 
Lamellibrachia  luymesi,  Seepiophila  jonesi,  Archinome  rosacea,  and  Calyptogena 
magnifica). This chemical  ecological  study provides strong  support for  the  use  of 
natural product chemical defenses by deep-sea vent organisms. Additionally, anaerobic 
cycling of carbon often requires close associations of interdependent microorganisms, 
and  these  microbial  interactions  may be  supported  by an  efficient communication 
network  of  small  signaling  molecules  of  potential  utility  for  human  health 
applications.
  In addition to the specialized equipment needed to survey and sample the ocean 
floor,  the  generally  accepted  pre-1960’s  paradigms  that  the  deep  ocean  lacked 
invertebrate  biological  diversity  and  that  most  important  groups  of  antibiotic- 
producing bacteria were not indigenous in the oceans, delayed NPs investigations of 
the  deep sea  and also near-shore sediment-derived  marine microbes. In the  last 35 
years,  new,  more  cost-effective  technologies  in  deep-sea  research  have  resulted in 
literature reports of natural products from deep-sea cnidarians, sponges, echinoderms, 
bacteria,  fungi  and  archaea  collected  from  bathyal  (200-4,000  m)  and  abyssal 
(4,000-6,500  m)  ocean depths, as reviewed  by Skropeta  (2008). Nevertheless,  the 
number of natural products from the deep sea (> 200 m) is only 1-2% of the more than 
20322,000 marine natural products reported in the last fifty years. The Skropeta review 
provides a graphical profile of the numbers of new compounds isolated through 2007 
by depth range  (below 50 m), which shows 267 new marine  compounds collected 
from depths below 200 m. Of these, only two new molecules are attributable to deep-
sea hydrothermal vent organisms, both archaea. In separate reports, anaerobic cultures 
of Thermococcus S 557 (cultured under N2, 85 °C) and methanogenic Methanococcus 
janaschii  (cultured  under  H2,  CO2,  85  °C)  produced  isoprenyl  glycerol  ethers  1 
(Gonthier et al., 2001) and 2 (Comita et al., 1984), respectively. However, these and 
other  known  archaeal  glycerol  ethers  may  be  classified  as  primary  rather  than 
secondary metabolites: archaea are characterized by the production of thermally and 
chemically stable ether-containing membrane lipids. The only deep vent invertebrate 
metabolites reported to date are bathymodiolamides A (3) and B (4; Andrianasolo et 
al., 2011). These  were obtained from the  hydrothermal  vent mussel  Bathymodiolus 
thermophilus  collected  from  around  hydrothermal  vents  at 1,733  m  in  the  Mid-
Atlantic  Ridge. In  an apoptosis induction  assay,  compounds 3  and  4  inhibited the 
growth of HeLa cervical carcinoma cells (IC50 = 0.4 and 0.5 µM, respectively) and 
MCF7 breast cancer cells (IC50 = 0.1 and 0.2 µM, respectively).
  The  2009  reports  of  the  loihichelins  and  ammonificins  A  and  B  may  be 
considered to be  the  first publications on  new natural products from deep-sea vent 
environments. Loihichelins A-F (5-10) are amphiphilic peptidic siderophores isolated 
from cultures of the heterotrophic bacterium Halomonas LOB-5 collected from Loihi 
Seamount (east of  Hawaii,  -1174  m;  Homann et al., 2009),  and are related to the 
amphibactins, aquachelins and marinobactins from ubiquitous marine bacteria (Vraspir 
& Butler, 2009). With their octapeptide polar head groups and relatively short fatty 
acid moieties, the loihichelins are the most hydrophilic of the  reported amphiphilic 
siderophores, which all chelate Fe(III) via the bidentate coordination of two ornithine 
hydroxamate  groups and  a  β-hydroxyaspartate  residue.  Three  2  L  cultures  of  the 
bacterium provided 8 mg of loihichelin C for 1D and 2D NMR spectroscopy. These 
204data confirmed the structural information gained for all six loihichelins by amino acid 
analysis using Marfey’s method, peptide sequencing by tandem mass spectrometry and 
fatty  acid  analysis  by  GC-MS.  Halomonas  strains  are  broadly  distributed  in 
association  with  deep-sea  volcanic  weathered  basalt  and  sulfide  rocks  in  low-
temperature hydrothermal vent fields, and possess the functional capability of Fe(II) 
and Mn(II) oxidation (Homann et al., 2009). It is not known whether the loihichelins 
serve a  role  only in the acquisition of iron as a  trace nutrient or  whether they are 
required for energy generation by Halomonas during the metabolism of reduced Fe 
(II).
  Four brominated  hydroxyethylamine  chroman  compounds,  ammonificins A–D 
(11–14),  were  reported  from  the  chemolithotrophic  bacterium  Thermovibrio 
ammonificans (Phylum Aquificae, Order Aquificales), which was isolated  from  the 
walls of an active deep-sea hydrothermal vent chimney on the East Pacific Rise (9°50′ 
N; Andrianasolo et al., 2009; 2012). Optimal growth of this thermophilic anaerobe is 
seen at 75 °C (pH 5.5, 2% w/v NaCl) in the presence of H2 and CO2 with nitrate or 
sulfur  as  the  electron  acceptor,  which  generates  ammonium  or  hydrogen  sulfide, 
respectively. A 5 L culture produced 40 g  wet weight of bacterial mass from which 
milligram  quantities  of  11–14  were  isolated.  Interestingly,  the  original  isolation 
attempt only afforded ammonificins A (11) and B (12), which did not correlate with 
the biological activity of the crude extract in an apoptosis induction assay. The authors 
concluded that this was possibly due to minor inseparable contaminants which could 
be responsible for the  original activity of the parent extract. In re-isolation  efforts, 
these minor components were identified as ammonificins C (13) and D (14), which 
induced  apoptosis  in  apoptosis-competent  primary  baby  mouse  kidney  (BMK) 
epithelial  cells at 2  and  3  µM,  respectively.  Noteworthy is that staurosporine  (an 
apoptosis inducer) induced apoptosis at 0.1 µM in the same assay. Nevertheless, this is 
the first report of a natural product that induces apoptosis from a cultured deep-sea 
hydrothermal vent bacterium.
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206Results and Discussion
Method Development
  Collection of Deep-Sea Vent Organisms
  Analytical tools for molecular  structure  elucidation  have  progressed to  permit 
routine  characterization  of  microgram  quantities  of  pure,  unprecedented  natural 
products.  However,  the  characterization  of new chemotypes from  complex  extract 
mixtures that also comprise a substantial mass of inorganic contaminants still requires 
significant biomass of  source organisms.  Ideally, field collections of deep-sea  vent 
invertebrates with their associated symbionts and collectable microbial mats may need 
to  be one  half to several  liters in  volume, with the possibility of  recollection, and 
laboratory cultivation of microorganisms of interest is highly desirable. Therefore, the 
logistics and potential yields of deep-sea vent collections are critical considerations, 
together with the observation that to date most hydrothermal vent microorganisms are 
extremely resistant to routine cultivation.
  Deep-water collections can be made in a nonselective sense by dredging, trawling 
and  coring,  which  in  turn  damages  a  significant  portion  of  non-targeted  benthic 
communities and structures. However, advances in deep-sea submersible technology 
over the last 30 years have made nearly every niche of the  deep ocean accessible. 
Deep-sea  submersibles  impose  minimal  environmental  impact  while  allowing 
important  ecological  observations  and  biological  collections.  However,  the  costs 
incurred for only 4-5 hours of collection time precludes their extensive use in routine, 
non-collaborative  collection  operations  (Cragg  et al.,  1999;  Gage  &  Tyler,  1991). 
Thus,  sample  collections  from  hydrothermal  vents  and  cold  seeps  are  conducted 
exclusively  by  scientific  institutions  that  operate  manned  submersibles  (Human 
Occupied  Vehicles,  HOV),  remote  operated  vehicles  (ROVs)  or  autonomous 
207underwater vehicles (AUVs). As noted above, the most studied hydrothermal systems 
are  in the eastern Pacific and the north-central Atlantic  Oceans (Van Dover, 2000). 
This is mostly due to their proximity to the countries primarily involved in deep-sea 
hydrothermal vent research. Table 5.2 lists some of the institutions and their associated 
submersibles  with  maximum  depth.  Access  to  collections  of  hydrothermal  vent 
samples  may  occur  through  research  collaboration  with  these  institutions:  direct 
participation in research cruises carrying out submersible operations yields good bulk 
of field-collected material in our experience.
  In collaboration with the NOAA Vents program at Oregon State University and 
Pacific  Marine  Environmental  Laboratory  (PMEL)  we  have  collected  several 
microbial  mat and  invertebrate  samples  during  the  New  Millennium  Observatory 
(NeMO)  expeditions (2009–2012)  to an  active  deep-sea  volcano, Axial  Seamount 
(Figure  5.4).  The  2009  and  2010  field  collections  are  the  focus  of  the  research 
presented here. Axial Seamount is located along the Juan de Fuca Ridge in the Pacific 
Ocean approximately 480 km (300 mi) west of Cannon Beach, Oregon. The caldera of 
this active submarine volcano (Figure 5.4) contains three distinct hydrothermal fields: 
a  northern  vent  field  (CASM,  Canadian  American  Seamount  Expedition),  a 
southwestern  vent field  (ASHES, Axial  Seamount Hydrothermal  Emissions  Study) 
and  within the 1998 lava flow region along the southeast portion of the caldera (Baker 
et al., 1999). Since the 1998 eruption, the  NeMO Project was initiated to study the 
geology, chemistry and biology of  this active  volcano (NeMO, 2013). Notably, an 
eruption of this volcano was predicted to occur before 2014, which was based on a 
deflation-inflation  cycle  observed  from  bottom  pressure  recorders  that  were 
continuously monitored and maintained during NeMO expeditions from 1998 to 2010. 
In  fact,  during  the  NeMO  2011  cruise  extensive  new  lava  flows  revealed  that a 
massive  eruption  had occurred  along  the  upper  south rift zone  at Axial  Seamount 
(Chadwick et al., 2012; Dziak et al., 2012). Thus, as a part of a decade long study of 
vent fluid chemistry and microbial diversity, a  major focus of many of the NeMO 
208expeditions  is  to  deploy  and  collect  geological  monitoring  devices  and  sample 
hydrothermal  vent  fluids  (Chadwick  et  al.,  2010).  As  such,  many of  the  ROV’s 
resources for collecting (e.g. single chamber vacuum slurp vs. multiple chamber slurp) 
and storing large-scale samples (e.g. one small bio-box), as well as the aliquoted time 
to achieve such tasks, are limited in terms of manageable weight on the submersible 
and priority. Therefore, in order to maximize sampling potential with minimal impact 
to  the  ongoing  research  efforts  of  NOAA  Vents  Program  scientists  and  their 
collaborators, we developed several lightweight syringes from materials obtained at 
our local  hardware  store.  Importantly,  these  syringes could be  used by the ROV’s 
manipulator arms to collect small (< 100 mL) or large (> 400 mL) samples of bacterial 
mats  or  sediment  (Figures  5.5  and  5.6,  respectively).  During  the  NeMO  2010 
expedition these syringes were used to collect diverse samples of microbial mats and 
sediment that were the focus of several cultivation experiments.
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Institution Submersible Maximum Depth (m)
Australia’s Commonwealth Scientiﬁc Industrial
and Research Organization (CSIRO) AUV ABE 2,500
The Canadian Scientiﬁc Submersible Facility ROV ROPOS 5,000
Florida Atlantic University’s Harbor Branch
Oceanographic Institution (HBOI)
HOV Johnson-Sea-Link I
and II 1,000
The Hawaii Undersea Research Laboratory (HURL) HOV Pisces IV and V 2,000
Institut français de recherche pour l'exploitation
de la mer (Ifremer)
HOV Nautile
ROV Victor
6,000
6,000
The Japan Marine Science and Technology Center 
(JAMSTEC)
HOV Shinkai-6500
ROV Kaiko
ROV Kaiko 7000 (II)
6,500
a11,000
7,000
The Monterey Bay Aquarium Research
Institute (MBARI) ROV Tiburon 4,000
PP Shirshov Institute of Oceanology,
Russian Academy of Sciences HOV Mir I and II 6,000
MARUM-Center for Marine Environmental Sciences,
University of Bremen ROV QUEST 4000 4,000
Woods Hole Oceanographic Institute (WHOI) HOV Alvin 4,500
Woods Hole Oceanographic Institute (WHOI) ROV Jason (II) 6,500
Table 5.2. Scientific Institutions that Operate Deep-Sea Submersibles.
 a lost at sea in 2003. References: (Desbruyeres et al., 2006; Verenium, 2013)	
 To collect large biological samples, the ROV Jason II is also capable of collecting 
microbe-bearing  rocks  or  bulk  invertebrate  material  to  stow  in  its  “biological 
box”  (Figures  5.7  and  5.8).  In  particular,  numerous  unsuccessful  methods  were 
attempted to collect the blue carpet-like mats of the ciliate Folliculinopsis sp., which 
secrete  and  dwell  in  chitinous  sheaths  (loricae)  that  are  strongly attached  to  the 
substratum and to each other. Ultimately, a piece of volcanic basalt (9.2 kg) containing 
a mat of Folliculinopsis sp. was collected (Figure 5.7 C; sample J2-525-Mat-22) and 
processed on board the R/V Thompson to remove the organism for natural products 
investigations. In addition, a bright orange filamentous mat growing  on a tubeworm 
assemblage, which was originally identified as a possible sponge, was collected using 
the  same  grab  technique  employed  to  collect the  blue  mat (Figure  5.7  C;  sample 
J2-520-T07). Here we report the biological and chemical profiling of these and other 
samples collected during the 2009 and 2010 NeMO expeditions (Tables 5.3 and 5.4, 
respectively).
210Figure 5.4. Bathymetry map of the Axial Volcano (Seamount) caldera located along 
the Juan de Fuca Ridge in the Pacific Ocean approximately 480 km (300 mi) west of 
Cannon Beach, Oregon. J2-520 represents the first logged dive for the ROV Jason II 
during  the  2010  New Millennium  Observatory (NeMO)  expedition  at Marker 113 
(-1522 m). Image credit: William W. Chadwick, Jr., Oregon State University.
211Figure 5.5. (A) Modified Sharpvet nylon  syringe (100 mL, small  syringe) used to 
collect isolated pockets of microbial mats and/or sediment. (B, C) ROV Jason II using 
a small syringe to collect a white microbial mat (J2-521-Mat 37) at Mushroom Vent 
located on  the Axial  Seamount.  (D)  Sediment collected with a  small  syringe  near 
Marker 33 along the east caldera at Axial Seamount (J2-525-SED-01).
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A B
C DFigure 5.6. (A) Picture of a large syringe (400 mL) made from materials purchased 
from a local hardware store. (B, C) ROV Jason II using a large syringe to collect an 
orange microbial mat (J2-525-Mat 25) growing  on an extinct chimney (El Antiguo; 
1522 m) located in the International District of the Axial Seamount. This chimney also 
appeared to contain veins of ferric iron on which the mat was located. (D) Processing 
of the J2-525-Mat 25 sample on board the R/V Thompson. Individual samples were 
aliquoted into 50  mL conical tubes for  storage  at -80 °C or  further  processed  for 
culture enrichment experiments. (E) Third generation syringe sampler made by a local 
machine shop, which was designed to be used by the  main manipulator arm of the 
ROV Jason II or HOV Alvin. This syringe (E) was recently used to collect microbial 
samples during two separate expeditions made in 2012: Axial Seamount (NeMO) and 
NE Lau Basin (Submarine Ring of Fire).
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C
D
EFigure 5.7. (A) Blue carpet-like mats of the marine ciliate Folliculinopsis sp. in close 
proximity to limpets and scale worms covered in white filamentous microbial mats. 
(B) ROV Jason II manipulator collecting  volcanic rock  and associated blue mat at 
Marker  N3  (Magic  Carpet;  1525  m)  on Axial  Seamount.  (C)  Stowing  a  piece  of 
volcanic basalt (9.2 kg) containing a mat of Folliculinopsis sp (J2-525-Mat-22).
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CFigure 5.8. (A, B) Orange microbial mat growing on a tubeworm assemblage located 
near  the  Marker  113  vent site  (1523  m)  at Axial  Seamount.  Tubeworms  and  the 
associated orange  mat (J2-520-T07) were collected using  the  ROV Jason II robotic 
arm (grab technique).
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CTable  5.3.  Summary  of  June  2009  Axial  Seamount  collections  of  deep  vent 
invertebrates for natural product investigations.
Organism description Number of 
collections
Range of Collection 
Volumes
Tubeworms (Ridgeia piscesae) 4 1-3 L
Bacterial mats (5 white, 1 peach) 6 50 mL–1.5 L
Blue protozoan mat (Folliculinopsis sp.) 1 100 mL
Palm worms (Paralvinella palmiformis) 2 100, 600 mL
Pandorae worms (Paralvinella pandorae) 1 100 mL
Limpets (Lepetodrilus fucensis) 3 300 mL
Scale worms (mixed taxa) 1 100 mL
Mixed (unsorted) collections 3 1 L
216Table 5.4. List of August 2010 Axial Seamount collections of deep-vent microbial 
samples for natural product investigations.
Sample ID Location Collection (Method) Volume Depth (m)
J2-520-T07 Marker 113
orange filamentous mat/large 
tubeworms (grab) 500 mL 1522.9
J2-520-Mat-19 Bag City white microbial mat/limpets (slurp) 10 mL 1531.0
J2-520-Mat-25 Vixen white microbial mat (large syringe) 50 mL 1533.8
J2-520-Mat-36 Casper sediment (small syringe) 10 mL 1534.4
J2-521-SED-01 West rim of caldera sediment (core) – 1415.0
J2-521-SED-02 West rim of caldera sediment (core) – 1415.0
J2-520-SED-03 West rim of caldera sediment (core) – 1415.0
J2-521-Mat-08 Styx orange microbial mat (large syringe) 50 mL 1543.2
J2-521-Mat-17 Gollum
white microbial mat/palm worms 
(slurp) 50 mL 1541.2
J2-521-Mat-37 Mushroom white microbial mat (small syringe) 25 mL 1542.0
J2-522-Bio-07 Bag City
white filamentous mat/large 
tubeworms (grab) 4 L 1531.0
J2-522-Mat-02 Marker 33 white microbial mat/limpets (slurp) 10 mL 1520.0
J2-523-Mat-05 El Gordo (Mkr 151)
white filamentous mat at base of 
tubeworm assemblage (slurp) 1 L 1521.8
J2-523-Mat-10 9 Meter
blue ciliate mat, Folliculinopsis sp. 
(scraped with temp probe) 1 mL 1518.5
J2-523-Mat-20 Escargot
blue ciliate mat, Folliculinopsis sp. 
(small syringe) 1 mL 1518.0
J2-523-Mat-24 Diva orange microbial mat (small syringe) 10 mL 1520.0
J2-523-Mat-34 El Antiguo orange microbial mat (large syringe) 100 mL 1520.0
J2-523-CHY-15 Escargot chimney spire (grab) – 1519.6
J2-525-SED-01 East rim of caldera sediment (small syringe) 50 mL 1518.5
J2-525-Mat-21 Magic Carpet
blue ciliate mat, Folliculinopsis sp. 
(slurp) 1 mL 1524
J2-525-Mat-22 Magic Carpet
blue ciliate mat, Folliculinopsis sp. 
(grab, large rock) – 1525
J2-525-Mat-25 El Antiguo orange microbial mat (large syringe) 100 mL 1521.9
217  Cultivation of Deep-Sea Vent Actinobacteria
  Cultivation of microorganisms was central  to methods used in early studies of 
microbial  communities to determine  community diversity,  biomass  and  production 
rates (Karl, 1995). However, most hydrothermal vent microorganisms are extremely 
resistant  to  cultivation,  which  might  be  expected  considering  the  extreme 
environments they inhabit (Jørgensen & Boetius, 2007). Cultivation strategies utilizing 
various in situ colonization devices including vent cap chambers (Reysenbach et al., 
2000), pumice filled stainless-steel pipes (Takai et al., 2003), titanium-mesh catheters 
(Higashi et al., 2004) and titanium-sheathed thermocouple arrays (Page et al., 2008) 
showed  moderate  success  in  culturing  some  of  these  microbes  in  their  natural 
environment  for  the  study of  in  situ  physiological  expression  (see  Table  5.2  for 
example studies; Postec et al., 2007). Advances in laboratory cultivation have allowed 
fairly accurate replications of temperature, nutrient composition and pressure, which 
have  greatly  increased  the  diversity  of  cultured  microbes  from  previously 
“uncultivated” microorganisms (Baross & Deming, 1995; Jannasch et al., 1996; Postec 
et al., 2007).  It should be noted that the  current upper limit for hyperthermophiles 
isolated in culture is 115 °C (Holden & Daniel, 2004), although Baross and Deming 
have  reported  (unreplicated)  evidence  for  a  consortium  of  growing 
“superthermophiles”  in fluids collected from  black  smokers (the  hottest vents) and 
maintained in culture at 150-250 °C under 265 atm (Baross & Deming, 1995).
  Considerable  effort  has  been  applied  to  the  large-scale  cultivation  of 
hyperthermophilic  anaerobes  to  investigate  their  potential  biotechnological 
applications  (Holden  &  Daniel,  2004).  Numerous  biotechnology  companies  are 
actively involved in product development from  thermophilic  vent organisms. These 
biotechnological interests have focused mainly on the use of whole cells, for example, 
sulfate-reducing  bacteria in waste management processes (Muyzer  & Stams,  2008) 
and also the development of new enzymes (NEB, 2013;  Verenium, 2013) and exo-
polysaccharides  (Nichols  et  al.,  2005)  to  improve  agriculture,  biotechnology, 
218cosmetics, pharmaceutics and even bone healing (Zanchetta et al., 2003). There is also 
a  focus  on  laboratory cultivation  of deep vent microbes at the  Center for  Marine 
Biotechnology  at  Rutgers  University,  where  they  have  developed  laboratory 
techniques to culture tubeworms together with their symbiotic bacteria (Lutz, 2008). 
Other  successes  in  laboratory  culture  of  potential  natural  product  producing 
microorganisms include the isolation of 38 actinomycetes from the Mariana Trench 
sediments (using marine agar and culture media selective for actinomycetes; Pathom-
aree  et  al.,  2006).  These  bacteria  were  assigned  to  the  Dermacoccus,  Kocuria, 
Micromonospora, Streptomyces, Tsukamurella, and Williamsia genera based on 16S 
rRNA analysis.  Furthermore,  nonribosomal  peptide  synthetase  (NRPS)  genes were 
detected in more than half of the isolates and type I polyketide synthases (PKS-I) were 
identified in five of the 38 strains. In contrast, there are few reported culture efforts of 
likely small molecule NPs-producing  microbes (e.g., Actinobacteria) from  deep-sea 
hydrothermal vents.
  Alternately, national culture collections are a source of microbial vent samples. 
For example,  JAMSTEC promotes collaborative efforts with industry through their 
Cooperative  Research  Project  for  Extremophiles  program  (JAMSTEC,  2013). 
Similarly,  the  Brittany Microbe  Culture  Collection  (BMCC)  allows  academic  and 
industrial access to over 1,300 microorganisms isolated from deep-sea hydrothermal 
vents  by Ifremer  (2013).  In  the  United  States,  only the  American  Type  Culture 
Collection (ATCC) publicly lists over 750 extremophile microorganisms available for 
purchase  that include  archaea,  sulfur oxidizers,  methylotrophs,  alkaliphiles,  sulfate 
reducers, thermophiles,  psychrophiles, halophiles and acidophiles. However, only a 
small  portion  (<  20)  are  from  hydrothermal  vents  (ATCC,  2013).  This  may be  a 
reflection  of  the  difficulties  in  obtaining  pure  cultures  of  these  extremophiles 
consistent  with  ATCC  standards,  or  the  result  of  undisclosed  collections  due  to 
agreements between researchers and private corporations.
219  Based on the reports of actinomycetes isolated from deep ocean sediments and 
hydrothermal  vent  environments,  we  performed  a  series  of  selective  cultivation 
methods to recover actinomycetes from microbial mats and sediments collected from 
Axial Seamount. Several recent reports document the successful isolation and culture 
of deep-sea actinomycetes in low-nutrient media (Gontang et al., 2007; Pathom-aree et 
al., 2006). Furthermore, many common strains of marine microbes, identified either 
microscopically or genetically, are not adapted for growth in media containing high 
concentrations of nutrients (Connon & Giovannoni, 2002; Zengler et al., 2002) or only 
produce secondary metabolites in source-deficient media (Tormo et al., 2003). Thus, 
media  (see  Supporting  Information,  Table  S-5.2)  and  sample  processing  methods 
(Jensen et al., 2005) that have resulted in the high recovery of actinomycetes from 
deep ocean and tropical marine sediments were used for the on-site culturing of deep-
vent actinomycetes.
Biological Screening of Deep-Sea Vent Organisms
  Extract Library Preparation and Bioassay Development
  Prior to biological screening, a fractionation library was prepared from aqueous 
(MeOH–H2O) and organic (MeOH–CH2Cl2 1:1) extracts obtained for several of the 
“bulk” collections (~50 mL) of deep-vent invertebrates and microbial mats collected 
during NeMO 2009 and 2010 expeditions to Axial Seamount (Tables 5.3 and 5.4). In 
addition,  a  number  of small  samples (15-50  mL) of deep-sea vent organisms were 
provided by Verena  Tunnicliffe (UBC) and Craig  Moyer (WWU) from  collections 
made during expeditions (1991–2002) to various hydrothermal vent sites in the Pacific 
Ocean.  Importantly,  these  latter  samples  were  used  to  develop  the  extraction, 
analytical  and screening  methods used to evaluate the more  recent Axial  Seamount 
collections  (2009,  2010).  A  typical  fraction  scheme,  as  used  for  cyanobacterial 
extracts,  utilizes  normal  phase  vacuum  liquid  chromatography (NP-VLC)  using  a 
220stepped  solvent  gradient  of  hexanes  to  EtOAc  to  MeOH  to  create  a  first-tier 
fractionation series (Figure 5.9). This scheme works well to separate highly lipophilic 
compounds from more hydrophilic  material,  the  latter  of which  generally contains 
secondary metabolites of interest. However, in the deep-vent extracts, many of the 
first-tier VLC fractions also contained a high degree of elemental sulfur (5-10 % of 
dry  mass  of  organism).  Surprisingly,  the  sulfur  compounds  did  not  affect  our 
biological  assays,  which  is similar  to  the  lack of  feeding  deterrent effects of H2S 
reported by Hay et al. (1996). Nonetheless, to more accurately assess the biological 
activity of a fractionation library, it is imperative to remove nuisance compounds that 
may alter the final concentration, solubility or integrity of test compounds. A majority 
of the sulfur from the organic extracts was therefore removed by solvating the extract 
in 100 % dichloromethane (CH2Cl2) and reducing the temperature (-20 to -80 °C) until 
crystals of sulfur precipitated out of solution. Importantly, this extract pre-treatment   
resulted in a  significant reduction in the  amount of sulfur observed throughout the 
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Figure  5.9.  General  bioassay-guided  fractionation  scheme  for  organic  extracts 
showing the typical number of fractions collected at each chromatographic separation 
step and their corresponding eluting solvent.
Biologically Active 
Fractions 
NP-VLC (silica) 
Organic Extract  
(MeOH/CH2Cl2 1:1)  
A 
100 %  
Hex  
C 
  20 % EtOAc/
Hex  
E 
60 % EtOAc/
Hex  
G 
100 % EtOAc  
H 
25 % MeOH/
EtOAc  
I 
100 % MeOH  
F 
80 % EtOAc/
Hex  
B 
10 % EtOAc/
Hex  
D 
40 % EtOAc/
Hex  
RP-SPE (C18) 
H-5  
100 % CH2Cl2  
H-2  
70 % MeOH  
H-4  
100 % MeOH  
H-1  
50 % MeOH  
H-3  
85 % MeOH  
Reversed phase HPLC 
H-3E   H-3B   H-3D   H-3A   H-3C   H-3F   H-3G   H-3H  fractionation scheme, and reduced the amount of in vacuo bumping (often resulting in 
sample loss) during  the  concentration steps of each sample. In several instances, a 
small sample/extract mass made  it essential to  conserve  these limited  materials by 
minimizing  the  number  of chromatography steps. Thus,  these  crude  extracts were 
directly  processed  over  reversed  phase  C18  reversed-phase  (RP18)  solid-phase 
extraction (SPE) cartridges to generate first-tier fractions (Figure 5.9). 
	
 A  high  throughput  microtiter-plate  (96-well  format)  antimicrobial  assay was 
developed  according  to  Casey et al.  (2004),  Smith  et  al.  (2008)  and  the  Clinical 
Laboratory Standards Institute’s methods for dilution susceptibility testing (2009) as a 
primary screen to evaluate the  deep-vent fractionation library and identify potential 
antimicrobial compounds. This assay has several advantages over the disk diffusion 
method in that it requires less sample material, allows high throughput screening  of 
HPLC or LC-MS  peak libraries in a relatively short amount of time, and replaces 
subjectivity associated with visual assessments of zones of inhibition (e.g. irregular 
zones due to  in-growth and  poor sample diffusion)  with a  quantitative  measure  of 
efficacy (e.g. optical density). Furthermore, this assay allows the generation of dose-
response curves for test organisms exposed to a bioactive compound, which can be 
used  to  extrapolate  the  minimal  inhibitory  concentration  (MIC):  “the  lowest 
concentration  of  an  antimicrobial  agent  that  prevents  visible  growth  of  a 
microorganism in an agar or broth dilution susceptibility test” (CLSI, 2009), for the 
bioactive compound. It is important to  note that our  initial  antimicrobial  screening 
strategy,  which  was  used  to  assess  the  collections  described  here,  tested  against 
standard (non-resistant)  strains of  Escherichia  coli  (Gram-negative  bacterium) and 
Staphylococcus aureus (Gram-positive bacterium). However, in collaboration with Dr. 
Aleksandra  Sikora  (Oregon  State  University)  this  assay has  recently  evolved  to 
include a panel of clinically-relevant multi-drug resistant human pathogens including 
methicillin-resistant  Staphylococcus  aureus  (MRSA;  ATCC®  BAA-1720™), 
gentamycin and vancomycin-resistant Enterococcus faecalis (ATCC® BAA-1720™), 
222Escherichia coli O157:H7 (Sikora et al., 2009), Vibrio cholerae O1 El Tor (N16961, 
ATCC® 39315D-5™) and Pseudomonas aeruginosa PAO. These more robust strains 
are  currently  being  used  to  screen  extract  libraries  of  deep-vent  microorganisms 
collected during NeMO 2011 and 2012, and NE Lau Basin expeditions, which are the 
subject of a separate, ongoing project in the McPhail laboratory.
  Screening of Deep-Sea Vent Invertebrates and Microbial Mats
  Preliminary screening  in our microtiter plate-based antimicrobial assay against 
Escherichia  coli,  Staphylococcus aureus,  and  in  a  biofilm  adherence  assay  using 
Mycobacterium  avum  A5,  identified  several  possible  antimicrobial  and/or  biofilm 
inhibitor leads (Table 5.5). In particular, multiple VLC fractions of a filamentous mat 
(DSV-09-14) collected from tubeworm casings (Ridgeia piscesae) showed promising 
activity profiles against both E. coli and S. aureus (256 µg/mL, < 50% cell viability) 
and  reduced  the  biofilm  formation  of  M.  avum  (250  µg/mL,  >  20%  reduction). 
Fractions E (60% EtOAc–hexanes) and F (80% EtOAc–hexanes) were the most active 
and  were  therefore  subjected  to  RP18  SPE  and  RP-HPLC  to  yield  four  minor 
compounds (0.3, 0,4, 0.6, and 0.7 mg), and one major compound (15, 3.3 mg). 1H and 
13C NMR data (Figure 5.10) coupled with a [M]+ peak at m/z 386.3 in the EIMS of 15 
suggested  a  molecular  formula  of  C27H46O,  and  identified  this  compound  as 
cholesterol (15). Analysis of the 13C NMR spectra for each of the minor compounds 
revealed a close resemblance to the major sterol. Interestingly, analysis of the active 
fractions of DSV-09-15, a peach colored microbial mat, also resulted in the isolation 
of 15, and several sterol-like compounds. However, in subsequent antimicrobial assays 
none of these compounds were active. In an attempt to identify any minor metabolites 
that may account for the  observed parent fraction  bioactivity,  a  trace  HPLC  peak 
observed throughout each active sample that displayed a matching retention time and 
UV  signature  was  targeted  for  analysis.  Collectively,  these  peaks  resulted  in  the 
isolation  of  several  putative  phthalates  (plasticizers).  Further  testing  of  these 
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Table 5.5. Antimicrobial activity of organic extracts and VLC fractions from deep-sea 
hydrothermal vent invertebrates and microbial mat collections.
% Cell Viabilityc % Cell Viabilityc % Biofilm Formationd
Sample ID
(collection date, dive #)a Extract / Fraction IDb E. coli S. aureus Mycobacterium avium
small tubeworms DSV-Eve-7a 100 100 -21
(07-26-1994, AD-2805) DSV-Eve-7b 100 10 -30
DSV-Eve-7c 100 100 100
DSV-Eve-7d 100 100 100
palm worms DSV-F27-8a 100 100 13
(07-27-1991, AD-2420) DSV-F27-8b 100 100 100
DSV-F27-8c 100 100 100
DSV-F27-8d 100 100 100
sulphide worms DSV-F8/9-9a 100 100 100
(07-15-1991, AD-2408) DSV-F8/9-9b 100 100 -22
DSV-F8/9-9c 100 100 47
DSV-F8/9-9d 100 100 100
giant clams, Calyptogena sp. DSV-MV-10 100 100 6
(06-27-1992, R-787-14-01) DSV-MV-10 aq 100 100 –
hairy vent snail, Alvinoconcha sp. DSV-BB-11 100 100 100
(04-02-2004, R-192-F2) DSV-BB-11 aq 100 100 –
palm worms DSV-09-12A 96 92 100
(06-21-2009, AD-4522) DSV-09-12B 89 93 -2
DSV-09-12C 64 100 100
DSV-09-12D 100 89 100
DSV-09-12E 90 90 -8
DSV-09-12F 91 78 100
DSV-09-12G 100 100 100
DSV-09-12H 71 100 1
DSV-09-12I 100 82 76
tubeworms, Ridgeia piscesae; DSV-09-13a 81 98 100
white filamentous mat; scale DSV-09-13b 100 83 9.3
worms; snails; and palm worms,
Paralvinella palmiformis
(06-16-2009, AD-4517)
white filamentous mat from DSV-09-14A 75 92 -10
tubeworms, Ridgeia piscesae DSV-09-14B 49 88 -55
(6-21-2009, AD-4522) DSV-09-14C 51 85 -38
DSV-09-14D 72 77 -38
DSV-09-14E 50 39 -36
DSV-09-14F 23 6 -21
DSV-09-14G 83 78 -44
DSV-09-14H 80 100 -53
DSV-09-14I 74 92 59225
Table 5.5 (continued). Antimicrobial activity of organic extracts and VLC fractions 
from deep-sea hydrothermal vent invertebrates and microbial mat collections.
% Cell Viabilityc % Cell Viabilityc % Biofilm Formationd
Sample ID
(collection date, dive #)a Extract / Fraction IDb E. coli S. aureus Mycobacterium avium
peach colored microbial mat DSV-09-15 88 10 –
from rock substrate DSV-09-15A 0 0 –
(06-19-2009, AD-4520) DSV-09-15B 42 0 –
DSV-09-15C 62 0 –
DSV-09-15D 0 10 –
DSV-09-15E 100 71 –
DSV-09-15F 100 79 –
DSV-09-15G 100 78 –
DSV-09-15H 100 85 –
DSV-09-15I 100 100 –
blue ciliate mat,  DSV-09-16 53 12 –
Folliculinopsis sp. DSV-09-16A 0 0 –
(6-21-2009, AD-4522) DSV-09-16B 65 92 –
DSV-09-16C 25 0 –
DSV-09-16D 100 22 –
DSV-09-16E 40 62 –
DSV-09-16F 36 100 –
DSV-09-16G 100 80 –
DSV-09-16H 93 91 –
DSV-09-16I 88 91 –
blue ciliate mat,  DSV-10-17B3 93 0 –
Folliculinopsis sp. DSV-10-17C 78 44 –
(09-05-2010, J2-525) DSV-10-17D1 65 0 –
DSV-10-17E 100 0 –
DSV-10-17F 100 100 –
DSV-10-17G 100 86 –
DSV-10-17H 100 65 –
DSV-10-17I 100 100 –
aDeep-sea submersible designations: AD, Alvin Dive; J2, Jason II; R, Ropos.
bFractionation  level  designated  by  letter  following  sample  number  (e.g.  A–I  represents  VLC 
fractionation scheme; a–d represents RP18 SPE; no  letter represents organic  parent extract and aq = 
aqueous parent extract).
cCell viability was determined after 16 hours (256 µg/mL)  in a  microtitier plate-based antimicrobial 
assay using non resistant Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) cells and is 
reported as the percentage of viable cells relative to the vehicle control.
dPercent biofilm formation represents the percent of biofilm coverage for Mycobacterium avium A5 in 
treated wells (250 µg/mL) relative to the vehicle control. A reduction (reported as a negative value) in 
biofilm coverage of > 20% represents the inhibition of M. avium biofilm formation. Assay performed by 
Sasha Rose and Luiz Bermudez at Oregon State University as previously described (Carter et al., 2003).compounds revealed that S. aureus (32 µg/mL, 2% cell viability) and E. coli (32 µg/
mL, 60% cell viability) were  highly sensitive  to these  nuisance  compounds. These 
compounds may have been introduced into each sample during the pre-fractionation 
process  to  remove  sulfur,  which  involved  several  filtration steps using  glass-fiber 
filters that may have contained trace amounts of phthalates. Importantly, a Büchner 
funnel  with  a  sintered  glass  disc  was  used  in  place  of  these  filters  during  all 
subsequent  pre-fractionation  steps,  and  resulted  in  fewer  instances  of  phthalate 
contamination.
  The  25%  MeOH–EtOAc  VLC  fraction  (H)  of  DSV-09-14  (white  filamentous 
mat) was the largest fraction (946 mg) and initially did not show antimicrobial activity 
at  256  µg/mL,  but  did  inhibit  the  biofilm  formation  of  M.  avium.  The  selective 
inhibition of biofilm formation, without an antimicrobial effect, is generally preferred 
in the screening of biofilm inhibitors. However, after RP18 SPE using a gradient from 
50%  MeOH-H2O  to  100%  MeOH,  the  100%  MeOH  fraction  (82.6  mg)  showed 
significant activity against S. aureus (MIC = 64 µg/mL). Interestingly, the 13C NMR 
spectrum matched the sterol fingerprint of 15 (Figure 5.10), although the latter was 
shown to be inactive. Thus, it is likely that the presence of a minor compound may 
account for the observed activity of this sample.
  Fractions from 2009 (DSV-09-16) and 2010 (DSV-10-17) collections of a blue 
carpet-like mat identified as a  folliculinid ciliate  (Folliculinopsis sp.;  Kouris et al., 
2007)  were  subjected  to  bioassay-guided  fractionation  following  microtiter  plate-
based  antimicrobial  assays against S. aureus and E. coli.  Interestingly,  DSV-09-16 
fractions A–F showed activity against both Gram-positive and Gram-negative bacteria, 
while DSV-10-17 fractions B–E were active only against S. aureus (Table 5.5). The 
major difference  between these  two samples was the presence of  small  gastropods 
(limpets  and  snails)  in  the  2009  collection,  which  were  removed  from  the  2010 
collection prior to extraction. This suggests that the gastropods Gram-negative active 
metabloite  or  that  folliculinid  ciliates  may  produce  different  natural  products  in 
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Figure 5.10. (A) 1H (700 MHz) and (B) 13C (175 MHz) NMR spectra for cholesterol 
(15) obtained from a white filamentous microbial mat (DSV-09-14E/F).
                                                                   
   
 
   
 
                
 
   
                                                        
 
   response to the gastropods and any associated microbial consortia. However, 1H and 
13C NMR profiling of these lipophilic fractions (2009 and 2010) revealed the presence 
of  a  majority  of  sterols  in  these  fractions.  In  order  to  avoid  further  isolation  of 
cholesterol (15), the more polar fractions G and H, which did not show antimicrobial 
activity,  were  further fractionated and profiled by NMR and  HPLC and individual 
peaks were collected and subjected to additional bioassays in conjunction with LC-
MS/MS profiling to identify and de-replicate active components within each fraction. 
In particular, fractions F (80% EtOAc–hexanes) and G (100% EtOAc) of the  2009 
extract lead to the isolation of several oxysterols in sub-milligram quantities. Notably, 
the  ESIMS  spectrum  of  the  major  component DSV-09-16F2/G2  (0.9  mg)  showed 
major ions at m/z 439 [M + Na]+  and m/z 855 [2M + Na]+. Additional analysis by 
HRTOFMS suggested a molecular formula of C27H44O3 (m/z 439.3183 [M + Na]+) or 
C54H88O6 (m/z 855.6473 [2M + Na]+) for the 2M ion series. Analysis of the 13C NMR 
spectrum (Figure 5.11 B) showed twice the number of carbon atoms (C54) expected for 
the  putative  [M + Na]+  molecular  formula  (C27), suggesting  that DSV-09-16F2/G2 
may be a non-symmetrical dimer. The terpenoid nature of this sample was evident in 
the 1H NMR spectrum (Figure 5.11 A), which showed 10 methyls (δH 0.60–1.17), four 
oxygenated  methine  protons  (δH  3.18–4.46),  and  numerous  overlapped  aliphatic 
protons. Importantly, integration of the  1H NMR spectrum showed that the  sample 
comprised two sterol-like compounds present in a 2:3 ratio (Figure 5.11 A). Given the 
small amount of material  available  for structural  elucidation, no further attempts to 
separate  these  compounds  were  made.  Instead,  analysis  of  the  2D  NMR  spectra 
(HSQC,  HMBC,  COSY)  for  DSV-09-16F2/G2  allowed  the  assignment  of  each 
component. Interestingly, a literature search of the individual structures show that 16 
is melithasterol A isolated from a gorgonian coral Melithaea ocracea collected near 
the Okinawa Islands (Kobayashi & Kanda, 1991), and that 17 is a known sterol 5α,6α-
epoxy-3β,7α-dihydroxycholest-8(14)-ene isolated from the sponge Ircinia fasciculata 
Pallas in the Indian Ocean (Venkateswarlu et al., 1996). Thus, the isolation of epoxy 
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Figure  5.11.  (A)  1H  (700  MHz)  NMR  spectrum  of  DSV-09-16F2/G2  with  key 
integrals labeled to show a 2:3 ratio of 16 to 17. (B) 13C (175 MHz) NMR spectrum 
for 16/17.
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(17) H   sterols from this heterogeneous microbial assemblage poses additional questions as to 
the  biogenetic  origin  of  these  metabolites,  which  were  also  detected  in  the  2010 
collection that did not contain gastropods.
  Scanning  electron  microscopy  images  (Kouris  et  al.,  2007)  of  the  recently 
described deep-vent Folliculinopsis ciliate species reveal a close epibiotic association 
of densely packed short-rod and coccoid-shaped bacteria (~0.9 µm in length) present 
on the ciliate body (zooid) and peristomal lobes (arm-like extensions) protruding from 
the mouth of the lorica (tube). Folliculinids, like other ciliates, are known bacterivores 
that use  their peristomal  lobes to collect bacteria or  other  food sources from  their 
surrounding environment, which are then “packaged” into vacuoles in the cytostome 
and transported to the cytoplasm for ingestion by phagocytosis. However, Kouris et al. 
(2007)  also  report  an  even  distribution  of  vacuolated,  intact bacteria  among  the 
Folliculinopsis sp. ciliate cortex, which is typically devoid of digestive enzymes. This, 
they suggest is evidence  of  an  endosymbiotic  relationship between the  ciliate  and 
intracellular  bacteria.  The  bacteria  were  subsequently  confirmed  to  be  sulfide-
oxidizing  autotrophic symbionts that are likely the primary source of carbon for the 
ciliates  (Kouris et al.,  2010).  Furthermore,  the  latter  study found that a  recurrent 
assemblage  of  invertebrates  was  associated  with  these  sessile,  colonial  forming 
folliculinid ciliates. Notably, juvenile Lepetodrilus fucensis limpets were among  the 
dominant macrofaunal species observed in these mats, which typically form at areas of 
diffuse flow, while adult L. fucensis limpets only occupied areas of intense vent flow 
that did not contain blue mats (Kouris et al., 2010). Thus, juvenile limpets may use the 
folliculinid  mats  as  a  safehaven  from  its  predators  and/or  sequester  secondary 
metabolites as a  feeding  deterrent, similar to the defense strategy of many shallow 
water marine gastropods (e.g. sea hares and nudibranchs) and tunicates (Fontana et al., 
2012).  Interestingly,  Bergquist  et  al.  (2007)  identified  39  macrofaunal  and  9 
meiofaunal  taxa  associated  with  a  single  aggregation  of  the  tubeworm  Ridgeia 
piscesae  that was collected from  the Main Endeavor segment of the  Juan de Fuca 
230Ridge. Of these, a Clypeosectus curvus snail (gastropod) was found to feed selectively 
on an unidentified blue pigmented ciliate also present in the tubeworm aggregation. 
Although C. curvus was not detected in any of the Axial Seamount blue mats, Kouris 
et  al.  (2010)  do  report  the  major  presence  of  the  snail  Depressigyra  globulus. 
Furthermore, stable isotope analysis, coupled with microscopic observations of “bluish 
pigmentation” in the tissues of this snail and L. fucensis limpets, suggested that these 
gastropods  were  feeding  to  some  extent on  the  blue  mats.  These  reports  contrast 
starkly with our observations of Folliculinopsis sp. mats at the  Marker N3 (Magic 
Carpet)  vent  site,  where  a  clear  boundary  was  typically observed  between  white 
filamentous  bacteria  inhabiting  numerous  species  of  macrofauna  and  substratum 
surfaces and the  blue carpet-like  mats of  Folliculinopsis sp. (Figure  5.7 A and B). 
Importantly, limpets, snails and  scale  worms  appeared to graze  only on  the  white 
bacterial mats at these  boundaries. Furthermore, the blue mats have occupied more 
than 70% of the substratum within an area of 10 to 20 m2 at this site for more than 10 
years (Kouris et al., 2007), suggesting minimal grazing occurs on this Folliculinopsis 
species. Based on these observations and putative defensive roles of pigments derived 
from  marine invertebrates (Bandaranayake,  2006),  the  dark purple-teal fractions of 
DSV-09-16 and DSV-10-17 were pooled and investigated further.
  Initial HPLC profiles of the pigment-containing peaks displayed broad, irregular 
peak  shapes  that  were  not  readily  reproducible.  These  properties  coupled  with 
preliminary LC-MS data suggested that the pigmented compounds were related to the 
pyrroloiminoquinone  class  of  alkaloids.  Importantly,  the  highly cytotoxic  (L1210 
mouse lymphocytic leukemia cells, ED50 < 100 ng/mL) pryrroloiminoquinone-related 
discorhabdin C (18) from a red-brown Latrunculia sponge collected in New Zealand 
(Perry et al., 1986) has been reported as a dark purple formate salt in pure form (Na et 
al., 2009). In addition, the marine ascidian Clavelina sp. collected from shallow water 
reefs off Wakaya  Island in  Fiji  (Copp et al., 1991) produces a cytotoxic (HCT116 
human colon carcinoma cells, IC50 = 0.5 µg/mL) dark blue (trifluoroacetate salt, TFA) 
231pyrroloiminoquinone derivative, wakayin (19). A common theme reported throughout 
the isolation of pyrroloiminoquinone-related alkaloids is their isolation as an acid salt 
derivative due to the positive charge maintained on the imine moiety in solution. This   
likely explains the broad chromatographic peaks that were observed without the use of 
an acid modifier in the HPLC mobile phase.
 
  Prior to using acid to aid in the isolation of these compounds, a small aliquot of 
the  DSV-09/10 pigments was treated with  0.1N TFA to assess whether or not acid 
would affect the sample’s integrity. Immediately following the dropwise addition of a 
catalytic  amount  of  TFA,  the  solution  transitioned  from  dark  purple-teal,  to  dark 
brown-green and finally to a red-brown solution. Interestingly, the addition of base 
(1N NaOH) to the latter solution resulted in the transition back to the original color, 
followed  by  the  precipitation  of  a  dark  green  “fluffy”  precipitate.  Several 
pyrroloiminoquinone-related acid salts have been reported as dark brown-green (Na et 
al.,  2009)  or  red-brown  solids  (E.  W.  Schmidt  et  al.,  1995),  suggesting  that  the 
observed pH-dependent color change in the Folliculinopsis extract corresponds to a 
free  base  (pH >  8, purple)  or  acid  salt (pH <  6,  red)  of  the  major compound(s). 
Unfortunately, attempts to dissolve an appreciable amount of the “fluffy” precipitate 
were  unsuccessful  using  numerous solvent combinations with and  without acid  or 
base, which prevented the acquisition of spectroscopic and biological data. It should 
be noted, that a relatively small percentage of the dark green precipitate was solvated 
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Wakayin (19)in dimethyl sulfoxide  (DMSO)  and was moderately cytotoxic to NCI-H460 human 
lung  cancer  cells  (55%  cell  viability  at  ~30  µg/mL).  However,  given  that  the 
concentration  of individual  test solutions are  based  on their  dry mass  and assume 
100% solubility in the  test solvent, the true activity of this pigment is significantly 
underestimated in this assay. 
  A portion of the remaining colored fraction (0.48 g) was subjected to Sephadex 
LH-20 (280 mL; 9:1 MeOH–CH2Cl2) to yield two minimally separated bands: a dark 
purple band (fractions 50–54, 12.6 mg) and a teal-green band (fractions 55–60, 63.7 
mg). The latter fraction was subsequently fractionated on Sephadex  LH-20 (45 mL; 
100% MeOH). However, the sample degraded to a tan-brown color midway through 
the  elution  process,  and  could  not  be  eluted  from  the  column,  and  thus  was not 
recoverable from the column bed material. To avoid degradation of the purple pigment 
(50–54) on LH-20, these fractions were subsequently filtered over RP18 SPE cartridges 
and profiled by HPLC with and without the use of TFA (0.05%) in the mobile phase. 
Unfortunately, this sample also degraded, and attempts to recollect this organism from 
the July 2011 NeMO expedition at Marker N3 (Magic Carpet) were thwarted by the 
discovery that this site is now buried by nearly 4 m of new volcanic basalt from an 
underwater  volcanic  eruption  that  occurred  at  Axial  Seamount  in  April  2011 
(Chadwick et al., 2012).
	
 Screening of Deep-Sea Vent Actinobacteria from Culture
  From a total of 22 sediment and microbial mat samples (Table 5.4) collected from 
Axial Seamount during the NeMO 2010 expedition, 77 unique bacterial strains were 
identified  based  on  their  colony color  and  morphology.  Of  these,  64  strains gave 
positive results for partial  16S  rRNA gene sequences (see  Supporting  Information, 
Table S-5.1) and, based on NCBI nucleotide BLAST analysis, 8 strains (12.5%) were 
identified as members of the Actinomycetales (Figure 5.12). These actinomycetes are 
233closely  related  to  seawater-requiring  actinomycetes  of  the  genus  Dietzia  (strains 
RJ004, RJ043, RJ051, RJ053 and RJ056) and Rhodococcus (strains RJ040 and RJ054; 
Figure 5.12). The remaining strain, RJ076, was identified as Microbacterium sp. and 
clustered  with  several  actinomycetes  reported  from  deep-sea  vents  and  thermal 
sediments.  However,  several  of  these  strains  are  closely  associated  with  the 
actinomycete Propionibacterium acnes, a bacterium normally associated with human 
skin.  Thus,  the  previously reported clones  likely represent contaminants  from  the 
handling of these samples. Remarkably, the relationship of these clones (Figure 5.12,   
clones LC1022b39, a2b011 and SC-NB05) with P. acnes was not addressed, and these 
strains continue to  be reported as deep-vent associated  actinomycetes in the  major 
databases. Although RJ076 is not closely associated with this group, Microbacterium 
spp. are common clinical isolates (Gneiding  et al., 2008). Given that this sample, a 
relatively large chimney spire, was handled quite extensively during its removal from 
the submersible collection platform, it is likely that this strain is also a skin-associated 
bacterium. Thus, the final number of deep-sea hydrothermal actinomycetes isolated 
from the 2010 sampling is seven, representing only two genera. Of these, two Dietzia 
strains (RJ053  and  RJ056)  share  identical  16S  rRNA sequences and  were isolated 
from the same collection.
  Prior to large-scale fermentation studies for natural products production, each of 
the unique strains (six total) were analyzed for genes representative of the biosynthetic 
enzymes  of  type  I  polyketide  synthases  (PKS-I)  and  non-ribosomal  peptide 
synthetases  (NRPS).  Notably,  a  Dietzia  sp.  (RJ004),  isolated  from  the  bore  of  a 
chimney  spire  collected  near  the  Escargot  vent,  and  a  Rhodococcus  sp.  (RJ054), 
isolated  from  a  tubeworm-associated  orange  mat at Marker 113  (Figure 5.8), were 
both positive for putative NRPS genes, while the Dietzia sp. also contained putative 
PKS-I genes. These positive strains, along with those that were negative for NRPS and 
PKS-I genes, were cultivated using a variety of different culture conditions according 
the “OSMAC (One Strain MAny Compounds)” approach described by Zeeck and co-
234workers (Bode et al., 2002). In this approach, minimal and  random changes to the 
cultivation  parameters  such  as  media  composition,  aeration,  light,  temperature  or 
shape and volume  of the culture flask have resulted in the elicitation of secondary 
metabolites in a number of fungal and bacterial strains. Unfortunately, this process, as 
well as many traditional cultivation methods, has not resulted in the production of any 
bioactive natural products from our isolated Dietzia and Rhodococcus strains to date. 
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RJ043  Axial Seamount, Juan de Fuca Ridge
Dietzia sp. L200B.327 (EU935242.1)  Liliput Vent Field, Mid-Atl. Ridge
Dietzia natronolimnaea LLA (DQ333285.1)  Sediment from an alkaline lake
Dietzia psychralcaliphila (JQ895015.1)  Dokdo Island, Korea
Dietzia maris DSM 43672T (X79290.1) Marine sediment
RJ056  Axial Seamount, Juan de Fuca Ridge
RJ053  Axial Seamount, Juan de Fuca Ridge
RJ004  Axial Seamount, Juan de Fuca Ridge
RJ040  Axial Seamount, Juan de Fuca Ridge
RJ054  Axial Seamount, Juan de Fuca Ridge
RJ051  Axial Seamount, Juan de Fuca Ridge
Dietzia sp. CNJ898 (DQ448696.1) Deep-sea sediment
Gordonia terrae ATCC 25594T (X81922.1) Soil
Mycobacterium poriferae (AF480589.1) Marine sponge
Rhodococcus marinonanscens ATCC 35653T (X81933.1) Deep-sea sediment
Rhodococcus sp. SCSIO 10197 (JN582176.1) Marine sediment
Rhodococcus fascians ATCC 12974T (X81930.1)  Plant pathogen
Rhodococcus sp. (AJ002093.1)  Deep-sea sediment
RJ076  Axial Seamount, Juan de Fuca Ridge
Nocardioides basaltis J112 (NR 044419.1)  Jeju Island, Korea
Nocardioides ganghwensis JC2055 (AY423718.2)  Tidal flat sediment
Actinomyces clone LC1022b39 (DQ228573.1)  Lost City, Mid-Atl. Ridge
 Actinobacteria clone a2b011 (DQ228573.1)  Guaymas Basin
 Actinobacteria clone Sc-NB05 (AB193919.1)  Suiyo Seamount
 Propionibacterium acnes ATCC 6919T (AB042288.1)  Human skin
Micromonospora sp. CNS-766 (KC473457.1)  Deep-sea sediment
Salinospora arenicola ATCC BAA-917T (AY040619.2)  Marine sediment
Salinospora arenicola CNS-051 (DQ448715.1)  Deep-sea sediment
Salinospora tropica CNB440T (AY040617.3)  Marine sediment
Salinospora sp. CNS143 (DQ092624.1)  Deep-sea sediment
 Actinobacteria clone a2b024 (AF419678.1)  Guaymas Basin
 Actinobacteria clone a2b044 (AF419679.1)  Guaymas Basin
 Actinobacteria clone MabSd-NB (AB193930.1)  Suiyo Seamount
 Actinobacteria clone Ma-NB03 (AB193880.1)  Thermal sediment, Mariana Trough
 Deinococcus radiophilusT (Y11333.1) 
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Figure 5.12. Phylogenetic tree  showing  the relationship between the cultured Axial 
Seamount actinomycetes and nearest type  strains (T) based on Maximum-likelihood 
(PhyML)  analysis  of  SSU  (16S)  rRNA gene  sequences.  Deinococcus  radiophilus 
(Deinococcus-Thermus phylum) is included as an outgroup. Labels on the terminal 
nodes  indicate  the  taxa,  strain,  GenBank  accession  numbers  in  parenthesis,  and 
collection sites for relevant strains. Bootstrap values (in percent) calculated from 1,000 
resamplings using the maximum-likelihood method are shown at the nodes for values 
≥ 60 %. The scale bar indicates 0.1 expected nucleotide substitutions per site.This is consistent with a lack of natural products reported for actinomycetes of these 
two genera, despite their isolation in a number of marine natural product studies.
  To  assess the  microbial  diversity of the  tubeworm-associated  orange  mat that 
yielded  the  cultured  Rhodococcus s p .  ( R J 0 5 4 )  a c t i n o m y c e t e ,  w e  u s e d  a  
pyrosequencing strategy similar to that described in the seminal work of Sogin et al. 
(2006).  We  obtained  120,378  high-quality  sequence  reads  (69.2%  of  all  reads) 
spanning the V3 to V6 hypervariable region of 16S rRNA gene present in the genomic 
DNA  pool  of  this  sample.  Of  these,  84.7%  were  of  the  genus  Thioploca 
(gammaproteobacteria)  and  4.4%  were  members  of  the  Desulfonema g e n u s  
(deltaproteobacteria), while Actinomycetales comprised only 0.137% (165 reads) of 
the  sequenced community. Furthermore, a majority of actinomycetes in this dataset 
belonged  to  the  mineral-sulfide-oxidizing  acidophiles  of  the  Acidimicrobineae 
subclass (147 reads), with Saxeibacter sp. (7), Planosporangium sp. (5), Kutzneria sp. 
(2), Actinospica sp. (1), Conexibacter sp. (1) and unclassified PeM15 (1) comprising 
the  remaining  reads.  Interestingly,  16S  rRNA  gene  sequences  for  Dietzia  and 
Rhodococcus members were not detected in this genomic DNA sample, suggesting an 
incomplete sampling of the community. This is possibly due to the complexity of the 
sample  (e.g.  tubeworms  and  other  invertebrates,  orange  and  white  filamentous 
bacteria,  sediment  and  seawater),  which  required  the  generation  of  several  sub-
samples for storage and further processing, where each sub-sample likely comprised a 
different subset of  the  community.  Thus,  to  estimate  the  species  richness  for  the 
tubeworm-associated orange mat, rarefaction curves were generated for the number of 
Operational Taxonomic Units (OTUs) present at a 3% divergent level in the genomic 
DNA sequence dataset (Figure  5.13). In general, greater than 97% identity between 
ribosomal RNA sequences defines membership in the same microbial species (Schloss 
&  Handelsman,  2005).  Although  this  distinction  is  not  without  controversy 
(Stackebrandt & Goebel, 1994), we chose a 3% divergent level because it allows our 
work to be compared to other deep-vent microbial diversity studies. The rarefaction 
236curve  generated  for  the  1233  OTUs  defined  by this  method  does  not  approach 
asymptotic  shape  at the  3%  divergent level  (Figure  5.13).  Furthermore,  similarity 
groups defined at relatively large genetic distances (5% and 10%) show a similar slope 
in the rarefaction analysis (Figure 5.13), indicating that additional sampling will likely 
lead to increased coverage of the community diversity within this sample.
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Figure 5.13. Rarefaction analysis for the number of OTUs present at 3%, 5% and 10% 
divergent levels within the ribosomal RNA dataset obtained from an orange microbial 
mat (J2-520 T07) collected from Axial Seamount at Marker 113.
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  No assessment of the potential for discovery of new chemical templates can be 
made based on the results obtained here and the sole reports to date of the loihichelins 
and  ammonificins  from  deep-sea  vent  organisms.  New,  more  advanced  deep-sea 
research technology and molecular techniques similar to those  already employed at 
Verenium  (2013)  and  other  research  institutions  are  aimed  at  screening  a  more 
inclusive  genetic  assembly  and  may  permit  a  molecular  genomics  approach  to 
accelerate  natural  product  discoveries  from  deep-sea  vent  environments.  Thus, 
biodiscovery within these environments appears still to be in its infancy, as the full 
extent of the biological diversity present has yet to be realized. This may, in part, be 
due to the costs of sampling in the deep ocean (e.g., a 30 day expedition cruise costs 
roughly US $1 million with average daily operating costs of about US $30,000; Ruth 
2006)  versus  terrestrial  and  shallow  marine  sampling  costs.  Notably,  decreasing 
numbers of microorganisms with depth to almost undetectable levels are observed in 
deep ocean cold sediment cores (Parkes et al., 1994), which have been the major focus 
of most deep ocean natural products investigations. In contrast, 16S rRNA analysis of 
hydrothermally active sediments from the Guaymas Basin (Gulf of California) show 
high abundance and diversity of bacteria and archaea (Teske et al., 2002). However, 
Sogin and colleagues have shown that new molecular approaches aimed at defining 
the “rare biosphere,” which is typically masked by conventional molecular techniques, 
show  an  even  greater  diversity than  previously estimated  by 16S  rRNA analysis 
(Huber  et  al.,  2007;  Sogin  et  al.,  2006).  This  diversity  is  mirrored  in  our 
pyrosequencing  efforts  for  only  one  sample.  Furthermore,  as  the  cost  of 
pyrosequencing  becomes more  manageable, analyses such as these  can be  used to 
drive  the  selection of sampling  sites and cultivation  media that may afford higher 
yields of culturable  microorganisms or the  selective isolation of minor community 
members  for  natural  products  investigations.  Thus,  a  more  successful  sampling 
238strategy,  in  terms  of  increasing  the  likelihood  of  collecting  a  larger  biomass and 
potentially more diverse community, may be to target hydrothermal vent communities 
of the deep-sea. However, as with any potential natural products source, the logistics 
of  collecting  organisms,  extracting  metabolites  from  complex  sample  matrices, 
assessing bioactivities and culturing  natural-product producing  microorganisms must 
be addressed. Several of these logistics were  addressed in this work, providing key 
methodologies  that  may  accelerate  natural  product  investigations  from  deep-sea 
hydrothermal vent organisms in our laboratory.
239Experimental
  General  Experimental  Procedures.  NMR  data  was  acquired  in  CDCl3  and 
referenced to residual CHCl3 chemical shifts (δC 77.2, δH 7.26) on a Bruker Avance III 
700 MHz spectrometer equipped with a 5mm  13C cryogenic  probe. High-resolution 
mass spectrometry for each compound was performed in positive ion mode on an AB 
SCIEX Triple TOF 5600 mass spectrometer. LC-ESIMS data were obtained on an AB 
SCIEX 3200 Q TRAP mass spectrometer. HPLC was performed using  a  Shimadzu 
dual  LC-20AD  solvent  delivery  system  with  a  Shimadzu  SPD-M20A  UV/VIS 
photodiode array detector.
  Collection of Deep-Sea Vent Samples. Using the HOV Alvin and ROV Jason II, 
samples were collected during  NeMO 2009 (HOV Alvin) and 2010 (ROV  Jason II)   
expeditions from hydrothermal vent fields throughout the Axial  Seamount caldera, 
located on the Juan de Fuca Ridge. Microbial mats and loose sediment were collected 
using the syringe samplers described in this study or with the pump-operated suction 
sampler  on  the  submersible.  Larger  organisms,  rocks  and  chimney  spires  were 
collected using  the submersible  manipulator arm and stowed in a closed biological 
box.  Sediment cores (~20 to 30  cm)  were  obtained  using  a  hollow coring  device 
operated by the submersible.
  DNA  Extraction,  PCR  Gene Amplification,  and  454  Pyrosequencing.  For 
genetic  screening  (16S  rRNA,  NRPS  and  PKS-1)  and  pyrosequencing  studies, 
genomic  or  community  DNA  was  extracted  using  the  Wizard  Genomic  DNA 
purification kit (Promega Inc., A1120), following the manufacturer’s protocol. DNA 
concentration and purity was measured using a NanoDrop® spectrophotometer.
  The 16S rRNA bacterial gene sequence of each cultured deep-vent bacterium was 
amplified from genomic DNA using  the eubacterial primers 27F and 1492R (Lane, 
1991). Sequences were amplified from approximately 50 ng of gDNA using GoTaq® 
Hot  Start  polymerase  (0.5  µL,  Promega)  according  to  the  manufacturer’s 
240specifications. Polymerase  chain reactions (PCR)  were performed  in an Eppendorf 
Mastercycler® gradient thermal cycler (Eppendorf, Hauppauge, NY, USA) as follows: 
initial denaturation at 96 °C for 4 min; 35 cycles of 96 °C for 1 min, 55 °C for 1 min, 
72 °C for 1 min; and a final elongation at 72 °C for 10 min. PCR products were gel-
purified, cleaned with the QIAquick® Gel Extraction kit (cat. no. 28704, Promega) 
and  directly sequenced on  an ABI  3730  capillary sequencer  by the  Oregon  State 
University Center for Genome Research and Biocomputing (CGRB) DNA Sequencing 
Core  Facility.  The  16S  rRNA partial  gene  sequences were  inspected  visually and 
assembled  using  CAP3  (X.  Huang  &  Madan,  1999).  The  resulting  contigs  were 
analyzed for chimeric sequences using Pintail (Ashelford et al., 2005) and compared 
to sequences in the Ribosomal Database Project database (http://rdp.cme.msu.edu) and 
GenBank (http://www.ncbi.nlm.nih.gov).
  Degenerate  primers targeting  adenylation domain sequences (NRPS): A3F (5′-
GCSTACSYSATSTACACSTCSGG-3′),  A7R  (5′-SASGTCVCCSGTSCGGTAS-3′) 
and  ketosynthase  to  methyl-malonyl-CoA  trasferase  domains  (PKS-I):  K1F  (5′-
TSAAGTCSAACATCGGBCA-3′),  M6R  (5′-CGCAGGTTSCSGTACCAGTA-3′) 
were used to interrogate the genomic DNA from each cultured actinomycete (Ayuso-
Sacido & Genilloud, 2005). Sequences were amplified from approximately 50 ng  of 
gDNA  using  GoTaq®  Hot  Start  polymerase  (0.5  µL,  Promega)  according  to 
manufacturer’s specifications. PCR was performed as follows: initial denaturation at 
95 °C for 5 min; 35 cycles of 95 °C for 30 s, 55 °C (K1F/M6R) or 59 °C (A3F/A7R) 
for 2 min, 72 °C for 4 min; and a final elongation at 72 °C for 10 min. PCR products 
were purified and sequenced as described for 16S rRNA.
  For 454  pyrosequencing  of  community DNA, primers flanking  the  V3  to V6 
hypervariable region of  bacterial  16S rRNAs (Escherichia  coli positions 341-1046) 
were  designed  to  include  the  Roche  454 A  or  B  sequencing  adaptor  (shown  in 
lowercase)  fused  to  the  5′  end  of  primer  A-341F  (5′-gcctccctcgcgccatcag-
CCTACGGGAGGCAGCAG-3′;  Sogin  et  al.,  2006)  and  B-1046R  (5′-
241gccttgccagcccgctcag-CGACAGCCATGCANCACCT;  Yu  &  Morrison,  2004).  PCR 
amplicon libraries were generated from genomic  DNA (3-10 ng) using  GoTaq Hot 
Start polymerase (0.5 µL, Promega), 5X Reaction Buffer (10 µL), 10 mM dNTPs (1 
µL), 25 mM MgCl2 (3 µL), and a 0.4 µM concentration of each primer in a reaction 
volume of 50 µL. Polymerase chain reactions (PCR) were performed in an Eppendorf 
Mastercycler gradient thermal cycler (Eppendorf, Hauppauge, NY, USA) as follows: 
initial denaturation at 96 °C for 2.5 min; 25 cycles of 96 °C for 30 s, 64 °C for 50 s, 72 
°C for 1 min; and a final elongation at 72 °C for 10 min. PCR reaction products were 
gel purified and cleaned using the QIAEX II gel extraction kit (Qiagen, Valencia, CA), 
following the manufacturer's protocol. The quality of the PCR product was assessed 
on a Bioanalyzer 2100 (Agilent, Palo Alto, CA) prior to 454 sequencing. Emulsion 
PCR and 454 sequencing (Roche 454 GS Junior) were performed by the Oregon State 
University Center for Genome  Research and Biocomputing  DNA Sequencing  Core 
Facility. 454 tag sequences were trimmed to remove primers and low-quality data, and 
analyzed using the mothur software package (Schloss et al., 2009).
  Phylogenetic Analysis.  The  16S  rRNA gene  sequences from Axial  Seamount 
cultured  isolates were  compared to  sequences within  the  NCBI  GenBank database 
(http://www.ncbi.nlm.nih.gov),  and  the  nearest  type  strains  were  imported  into 
Geneious 5.6  (Drummond et al.,  2010), screened for chimeric sequences using  the 
computer program Mallard (Ashelford et al., 2006) and aligned using  the ClustalW 
feature in Geneious. The resulting alignment was edited to exclude gaps and missing 
data, except for  partial  16S  rRNA sequences.  The  evolutionary relationship of the 
Axial  Seamount Actinobacteria  was compared with other strains of Actinobacteria 
using the phylogenetic maximum likelihood (PhyML v3.0; Guindon & Gascuel, 2003) 
algorithm in Geneious, performed with 500 bootstrap replicates using the GTR model 
with the number of rate categories set to 4.
  Extraction and Isolation Procedures. Field-collected samples of deep-sea vent 
invertebrates and microbial mats were stored at -80 °C until their processing. Samples 
242were lyophilized before sequential, exhaustive extractions in 50% aqueous methanol 
(MeOH)  and  50%  MeOH  in  dichloromethane  (CH2Cl2)  to  produce  aqueous  and 
organic extracts, respectively. All organic extracts were subjected to bioassay-guided 
fractionation via NP-VLC using  a stepped solvent gradient of hexanes to EtOAc to 
MeOH to produce nine fractions (A, B, C, D, E, F, G, H and I). All biologically active 
fractions  were  subjected  to  additional  bioassay-guided  fractionation  via  RP18 S P E  
using  a  stepped  solvent gradient of  MeOH–H2O from  50% MeOH–H2O  to  100% 
MeOH, followed by 100% CH2Cl2. For DSV-09-14, the RP18 SPE fractions eluting in 
100% MeOH from the active VLC parent fractions (E = 60% EtOAc–hexanes and F = 
80% EtOAc–hexanes) were subjected to RP-HPLC using a linear gradient of 90% to 
100% MeOH over 30 min, followed by 100% MeOH for 10 min (column: Synergi 
Fusion-RP, 10 x  250 mm, 3.0 mL/min) to yield cholesterol (6.7 mg, tR =  31.1 min). 
For DSV-09-16, fraction F (80% EtOAc–hexanes) was selectively active  against E. 
coli (36% cell viability at 256 µg/mL) and, given a limited sample  mass (4.2 mg), 
filtered over a RP18 SPE cartridge in 100% MeOH before proceeding directly to RP-
HPLC. Isocratic RP-HPLC (column: Synergi Fusion-RP, 10 x 250 mm, 92% MeOH–
H2O, 3.0 mL/min) of the SPE-filtered fraction yielded a single major chromatographic 
peak that was collected (0.2 mg, tR = 14.0 min) and pooled with a corresponding peak 
from fraction G (0.7 mg, tR = 14.0 min) using the same HPLC conditions. This pooled 
sample  (0.9 mg) comprised  a  2:3  mix  of  melithasterol  A and  5α,6α-epoxy-3β,7α-
dihydroxycholest-8(14)-ene  as  determined  by  NMR  spectroscopic  methods. 
Subsequent LC-MS  profiling  (Synergi  Fusion-RP, 2 x  100 mm, 0.2 mL/min, linear 
gradient of  60  to  100%  MeOH  in  0.1%  [v/v]  aqueous  TFA)  of  fraction  G from 
DSV-10-17 yielded  m/z 439.3 and 855.6 (16 and  17, [M + Na]+  and  [2M + Na]+, 
respectively) at the same retention times as 16 and 17 purified from the DSV-09-16 
collection.
  Following collection, deep-vent sediment and microbial mat samples were dried 
overnight under ambient conditions in a  sterile  petri  dish. A polyester fiber-tipped 
243sterile swab was pressed into the dried sample once and then onto the agar surface in a 
radial, clockwise pattern from the outermost edge to the center of the culture plate 
approximately 25 to 30 times, creating  a serial-dilution effect. Cultures of deep-vent 
actinomycetes were grown using  a variety of different growth conditions including 
different mediums (see  Supporting  Information, Table  S-5.2),  various  culture flask 
sizes and shapes, different temperatures, with or without shaking and/or light. Cultures 
were also harvested at different time points, at which time an absorbent resin (either 
Amberlite XAD-16 or HP-20, 20 mg/mL) was added to each flask and agitated gently 
for  2h.  The  resin  was  recovered  and  washed  with  deionized  water  and  eluted 
exhaustively with either acetone or MeOH. Alternatively, cultures were harvested via 
centrifugation at 12,000 rpm (0 °C) in 250 mL centrifuge bottles. The supernatant was 
extracted with EtOAc and the bacterial pellet was resuspended in 100% MeOH and 
heated to 40 °C for 2 h to lyse the cells, before evaporation to dryness. The dried 
extract, containing the lysed cells, was resuspended in 100% CH2Cl2 and partitioned 
with deionized water to remove cellular debris (generally located at the CH2Cl2/H2O 
solvent  interface).  Organic  extracts  from  the  cultured  material  were  subjected  to 
bioassay-guided fractionation as described previously. For small scale cultures, where 
minimal quantities were afforded, extracts were filtered over RP18 SPE cartridges and 
analyzed directly by LC-MS and RP-HPLC, with peak libraries generated in 96-well 
plates for biological testing. 
  Cholesterol (15): white, amorphous solid; 1H and 13C NMR data, see Figure 5.10 
and  Spectral  Database  for  Organic  Compounds,  Number  887  (SDBSWeb,  2013); 
LREIMS m/z 386.3 [M]+.
  Melithasterol A (16): white, amorphous solid; 1H and 13C NMR data, see Figure 
5.11 and Kobayashi & Kanda (1991); HRTOFMS m/z 439.3183 [M + Na]+ (calcd for 
C27H44O3Na, 439.3188), m/z 855.6473 [2M + Na]+ (calcd for C54H88O6Na, 855.6479). 
  5α,6α-epoxy-3β,7α-dihydroxycholest-8(14)-ene (17):  white,  amorphous solid; 
1H and 13C NMR data, see Figure 5.11 and Venkateswarlu et al. (1996). HRTOFMS   
244m/z 439.3183 [M + Na]+ (calcd for C27H44O3Na, 439.3188), m/z 855.6473 [2M + Na]+ 
(calcd for C54H88O6Na, 855.6479).
  Antibacterial Assay.  Antibacterial  activity was  determined  using  a  microtiter 
dilution method (96-well plate) based on several methods: Casey et al. (2004), Smith 
et al. (2008)  and the  Clinical  Laboratory Standards Institute’s methods for dilution 
susceptibility testing (2009). Crude extracts were tested at 500, 250, 125, and 62.5 µg/
mL  against  Escherichia  coli  and  Staphylococcus  aureus.  Bacterial  strains  were 
cultured as follows: S. aureus in tryptic soy broth (Becton, Dickinson and Co.) and E. 
coli. in Luria-Bertani liquid medium (Becton, Dickinson and Co.). On the day of the 
assay, the test organisms were grown in 5 mL aliquots of their respective medium with 
shaking  (200 rpm) at 37 °C until the broth reached an optical density (OD600) of 0.1 
(usually 4 to 6 hours). A stock suspension (1:800) of each strain was generated in 
sterile media from  the respective  0.1 absorbance culture for approximately 5 × 105 
cells/mL, determined by direct microscopic  count using  a Petroff-Hausser (Hausser 
Scientific) counting chamber. For all experiments, 200 µL of this stock suspension was 
added to 96-well tissue culture-treated microtiter plates (Greiner Bio-One) containing 
lyophilized test compounds, and incubated without shaking at 37 °C for 16 h. Optical 
densities (600  nm) were  measured on a  SpectraMax190 (Molecular Devices) plate 
reader before and after incubation to calculate the final OD600 values (ODFinal = T16 - 
T0). Each microtiter plate also contained a serially diluted positive control (ampicillin 
or kanamycin at final concentrations ranging from 0 to 256 µg/mL), negative controls 
(vehicle-treated cells and untreated cells), and a contamination control (medium only). 
Percentage  growth inhibition  was  determined  relative  to  the  vehicle  control OD600 
values,  with  the  viability  of  vehicle-treated  control  cells  defined  as  100%  in  all 
experiments.
  Biofilm assay. The inhibition of Mycobacterium avium A5 biofilm formation was 
performed  by  Sasha  Rose  and  Luiz  Bermudez  at  Oregon  State  University  as 
previously described (Carter et al., 2003). 
245  Cell Viability Assays. Cytotoxicity of the organic extract and crude fractions of 
DSV-09-16  and  DSV-10-17  was  evaluated  in  human  NCI-H460 lung  cancer  cells 
(ATCC, Manassas, VA) as previously described (Thornburg et al., 2011), with minor 
modifications. Cells were seeded into 96-well plates (5,000 cells per well) in 50 µL of 
medium 16 h before treatment. Approximately 2 h before treatment, test samples were 
generated from a stock solution (6 mg/mL, 100% DMSO) that was serially diluted in 
serum-free medium. Following  aspiration of seed growth medium, test samples (50 
µL) were added to seeded cells at final concentrations ranging from 0.01 nM to 10.0 
µM. Each 96-well plate also contained untreated and vehicle-treated control cells. Cell 
viability  was  determined  after  48  h  treatment  using  a  standard  3-(4,5-
dimethylthiazol-2-yl)-2,5,diphenyly tetrazolium bromide  (MTT) assay as previously 
described (Thornburg  et al., 2011). The cytotoxicity of each purified compound was 
assessed in  at least three  independent cultures with  the  viability of vehicle-treated 
control cells defined as 100% in all experiments. Dose response curves were plotted 
using GraphPad Prism® (v5.0) and IC50 values were derived from nonlinear regression 
analysis.
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.Table S-5.2. List of isolation and growth mediums used to culture deep-sea 
hydrothermal vent microorganisms.
Media Constituents
A1 (HV) 18 g agar, 100 mg humic acid sodium salt in 0.2 N NaCl, 1 liter natural seawater and 
cyclohexamide (100 µg/mL)
A2 (SMP) 8 g noble agar, 0.5 g mannitol, 0.1 g peptone, 800 mL natural seawater and 200 mL DI 
water, cyclohexamide (100 µg/mL) and rifampicin (5 µg/mL)
A3 (SNC) 18 g agar, 800 mL natural seawater and 200 mL DI water, cyclohexamide (100 µg/mL)
and novobiocin (25 µg/mL)
A4 (SPC) 18 g agar, 800 mL natural seawater and 200 mL DI water, cyclohexamide (100 µg/mL)
and polymixin B sulfate (5 µg/mL)
CAM 5 g glucose, 5 g NaCl, 3 g NaNO3, 2 g sodium acetate, 1 g sodium propionate, 1 g 
casamino acids, 1 mL trace metals, 950 mL DI water and 50 mL DI water containing 50 
mg K2HPO4
STM 10 g starch, 4 g peptone, 4 g yeast extract, 1g CaCO3, 100 mg KBr, 40 mg Fe2(SO4)3 and 
1 liter Instant Ocean (30 g/L)
SWYE 23.4 g NaCl, 10 g peptone, 6.9 g MgSO4ŋ7H2O, 3g yeast extract, 0.75g KCl and 1 liter 
DI water
TCG 5 g caseine digest, 4 g glucose, 3 g tryptone and 1 liter Instant Ocean (30 g/L)
Trace Metals 520 mg Na2EDTA, 178 mg FeSO4ŋ7H2O, 23.2 mg Co(NO3)2ŋ6H2O, 14.8 mg       
ZnSO4ŋ7H2O, 10 mg MnCl2, 6.2 mg H3BO3, 3.6 mg NaMoO4ŋ2H2O, 2.7 mg       
NiSO4ŋ6H2O, 1.7 mg CuCl2ŋ2H2O and 100 mL DI water
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266  Marine natural  product compounds, like their terrestrial counterparts, display a 
remarkable  chemical  diversity  that  occupies  biologically  relevant  chemical  space 
(Clardy &  Walsh,  2004;  Dobson,  2004). This is  evidenced  by the  nearly 45%  of 
approved drugs from 1981–2010 that owe their origins to natural products (Newman 
&  Cragg,  2012).  Remarkably,  anticancer  and  anti-infective  agents  (99  and  104, 
respectively;  excluding  biologicals and  vaccines)  were  almost exclusively derived 
from  natural  products  during  this  time  period  (79.7%  and  75.0%,  respectively). 
Somewhat  surprising  is  that only four  marine-derived  drugs  have  been  approved 
(1981–2011):  brentuximab  vedotin  (Adcetris®;  “Seattle  Genetics,”  2013),  eribulin 
mesylate (Halaven®; “Eisai Oncology,” 2013), trabectedin (Yondelis®; “PharmaMar,” 
2013b), and ziconotide (Prialt®; Bingham et al., 2010). However, the history of marine 
natural  products is relatively short compared  to that of  terrestrial  natural products, 
which  is  further  exemplified  by  the  more  than  175,000  unique  natural  products 
characterized to date, with about 22,000 derived from marine sources (Blunt et al., 
2012), suggesting that an enormous potential for natural products discovery still exists 
in the marine environment. Thus, the challenge is to discover new chemical scaffolds 
from the many unexplored repositories of the marine environment.
  The  focus of this research was to  investigate  the natural  products potential of 
phylogenetically diverse organisms from rare or extreme ecosystems, such as the Red 
Sea  and  deep-sea  hydrothermal  vents,  respectively.  It  is  hypothesized  that  the 
‘extreme’  environmental  conditions  of  deep-sea  vents,  coupled  with  the  high 
biodiversity  and  dense  microbial  communities  found  within  these  environments, 
drives the  development of unique secondary metabolites involved in their chemical 
defense or communication. Furthermore, a fundamental problem, especially in marine 
natural products isolation, is a limited/inaccessible supply of the source organism as 
well  as  the  impracticality  of  a  synthetic  supply  given  the  complexity of  natural 
products (Koehn & Carter, 2005). Thus, our sampling strategy involved the cultivation 
of microorganisms from the Red Sea and deep-sea vents to circumvent the potential 
267supply  bottleneck,  and  to  survey  the  culture-dependent  diversity  within  these 
environments.
  In general, primary productivity in the Red Sea is low, with a pronounced South 
to North decrease due to a lack of winter upwelling and higher evaporation rate to the 
North  (Fenton  et  al.,  2000).  This  likely explains  the  disproportionate  number  of 
biologically  active  natural  products  from  marine  organisms  in  this  challenging 
environment. Notably, the chemistry of Red Sea  cyanobacteria is unreported in the 
literature, although a wealth of unusual specimens growing  in low abundance were 
observed and recently collected for laboratory cultivation in this study. Importantly, 
five new culturable strains of cyanobacteria (see Appendix) were characterized based 
on  their  morphology and  16S  rRNA  gene  sequence,  and  deposited  in  the  NCBI 
GenBank database (http://www.ncbi.nlm.nih.gov). These  include three Leptolyngbya 
strains (accession  numbers JX470180,  JX481735  and JF518829),  a  Moorea  strain 
(JX470179) and a Symploca sp. (JX481736). Of these,  three  strains were found to 
produce new metabolites with nanomolar cytotoxicity to cancer cells. These include 
grassypeptolides D and E (HeLa cervical carcinoma cells, IC50 = 335 and 192 nM, 
respectively),  apratoxin  H  (H460  human  lung  cancer  cells,  IC50  =  3.4  nM),  and 
leptochelin (H460 human lung cancer cells, IC50 = 153 nM). 
  Although  the  cyanobacterial  strains  documented  here  were  collected  from  a 
relatively isolated and unique habitat, the compounds reported mostly show structural 
motifs comparable to cyanobacteria  collected pantropically, which  poses additional 
questions as to the biogenetic origin of these metabolites, and further exemplifies the 
ability of marine cyanobacteria to adapt to a wide range of habitats (Whitton, 2012). 
These investigations did not translate to the production of chemical scaffolds unique to 
Red Sea  cyanobacteria. However, it should be noted that additional  strains that we 
isolated from the Red Sea collection have been resistant to large-scale cultivation, or 
do not provide sufficient biomass, even after years of culture harvests (e.g. Symploca 
sp. RS04; JX481736). Further characterization of these strains, as well as attempts to 
268optimize culture conditions, may provide new, exciting chemical entities. Additionally, 
each  of  the  natural  product-producing  strains  expresses  at least  two  biosynthetic 
pathways, as evidenced by the isolation of biosynthetically distinct metabolites. There 
biosynthetic potential may be further exploited with the “OSMAC (One Strain MAny 
Compounds)” cultivation methods described in Chapter Five (Bode et al., 2002). In 
addition,  characterization  of  the  biosynthetic  genes  within  the  grassypeptolide-
producing Red Sea Leptolyngbya sp. RS03 (JF518829), which is currently the only 
known  producer  of  grassypeptolides  in  laboratory  culture,  and  the  leptochelin-
producing Leptolyngbya sp. RS02, would shed light on their biosynthetic origins as 
well as aid in the production of an increased supply of these metabolites or additional 
analogues  for  mechanism  of  action  and  structure-activity  relationship  studies, 
respectively. Notably, the apratoxin A biosynthetic gene cluster was recently identified 
from a single cyanobacterial cell using a genome sequencing technique that relies on 
454 pyrosequencing (Grindberg et al., 2011).
  Despite the extreme conditions of deep-sea hydrothermal vents, and in contrast to 
the  Red  Sea,  deep-vent  organisms  exist  as  islands  of  highly  dense  and  diverse 
communities. Although  this diversity has  not yet  correlated  to new/unprecedented 
natural products isolation in our laboratory, the putative identification of nonribosomal 
peptide synthetase (NRPS) and type I polyketide synthase (PKS) genes in several of 
the isolated actinomycetes and α- and γ-proteobacteria suggests that these genetic loci 
may be  silent or “cryptic.” Thus, further attempts to induce  the biosynthesis of the 
putative metabolites could include co-culturing of these isolates with other deep-vent 
microbes,  antibiotic-resistant  strains,  or  entirely  different  taxa  (e.g.  fungi).  A co-
cultivation strategy has been employed in several recent studies and has resulted in the 
activation of silent gene clusters and production of new natural products (reviewed in 
Scherlach and Hertweck, 2009; Brakhage and Schroeckh, 2011; Onaka et al., 2011). 
Furthermore,  the  Clardy  and  Lewis  groups  have  isolated  previously  uncultured 
bacteria  in  the  presence  of  “helper  strains”,  which  had  originated  from  the  same 
269environment (D'Onofrio et al., 2010). Remarkably, subsequent investigations revealed 
that  the  newly  cultured  strains  were  dependent  on  the  presence  of  siderophores 
produced by the helper strain. This strategy, coupled with additional tailoring  of the 
isolation medium to match the suspected environmental conditions, may expand the 
culturable range of deep-vent bacteria for natural products investigation.
  Of  the  reported  compounds  from  deep-vent  organisms  to  date,  only  the 
ammonificins, and loihichelins are likely true secondary metabolites. The loihichelins 
are known siderophores that chelate Fe(III), while the ammonificins contain functional 
groups that have been shown to coordinate the binding of metals ions in other marine 
metabolites  (Michael  &  Pattenden,  1993;  Vraspir  &  Butler,  2009).  Given  the 
geochemical  complexity  of  hydrothermal  vent  environments,  coupled  with  the 
chemosynthetic nature of vent primary productivity, it is likely that many if not all 
deep-vent bacteria produce compounds capable of binding reduced metals. Thus, these 
compounds may serve a role in the metabolism of metals for energy generation, or the 
acquisition of a trace nutrient, or may serve to reduce the toxicity of metal-enriched 
hydrothermal  fluids.  A  similar  functionality  may  be  attributed  to  cyanobacterial 
metabolites isolated in this research, which include the grassypeptolides, as described 
by Kwan et al. (2010), and leptochelin (Chapter Four). As reviewed in Chapter Four, 
many metal-complexing secondary metabolites are also cytotoxic to mammalian cells, 
suggesting  a  dual  functionality  for  these  compounds  in  the  producing  organism. 
Furthermore, metal-binding natural products may also affect multiple cellular targets 
and/or biochemical pathways. This ‘one-two punch’ typically leads to unprecedented 
cytotoxic  potency in  cancer  cells.  Thus,  the  challenge  for  future  natural  products 
investigations  is  to  develop  methods  for  the  production  (e.g.  metal-free  culture 
medium)  and recovery of  intact metal  complexes or  potential  chelators, which are 
often  degraded  under  reverse-phase  chromatographic  conditions,  from  marine 
invertebrates  and  microorganisms  inhabiting  these  unique  environments.  Methods 
similar to those recently developed by Jaspars and colleagues (Wright et al., 2008), 
270which rely upon size-exclusion chromatography (SEC-HPLC column) and inductively 
coupled  plasma  mass  spectrometry  (ICP-MS),  an  elemental  mass  spectrometric 
technique, should be  very productive for the screening  and isolation of metabolites 
complexed to transition metals.
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Figure A-1. Laboratory cultures and their corresponding photomicrographs (x400 and 
x1000, respectively) for filamentous marine cyanobacteria isolated from the Red Sea. 
(a) Leptolyngbya sp. RS01 (JX470180); (b) Leptolyngbya sp. RS02 (JX481735); (c) 
Leptolyngbya sp. RS03 (JF518829). Scale bar = 10 µm.
a
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Figure A-2. Laboratory cultures and their corresponding photomicrographs (x400 and 
x1000, respectively) for filamentous marine cyanobacteria isolated from the Red Sea. 
(a) Symploca sp. RS04 (JX481736); (b) Moorea sp. RS05 (JX470179). Scale bar = 10 
µm.
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